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  Dedicated to my parents 
 Bovines microRNomics: Bedeutung während der Eizellreifung 
und die Pathophysiologie des Endometriums 
 
MikroRNAs (miRNAs), die bereits für die Regulierung von posttranskriptionalen Genen 
bekannt sind, konnte eine essentielle Rolle für die Entwicklung von Tieren und Krankheiten 
nachgewiesen werden. In dieser Studie wurden bovine miRNAs während der Eizellenreifung 
identifiziert und mittels verschiedener Methoden das Expressionsprofil untersucht. miRNAs, die 
eine neuartigen molekulare Signatur auf Grundlage einer subklinischen Endometritis zeigten 
wurden mit Hilfe eines integrativen Untersuchungsansatzes erforscht. Zuerst wurde die 
Identifikation und die Erstellung von Expressionsprofilen von miRNAs während der bovinen 
Eizellenreifung mittels des „miRCURYTM locked nucleic acids (LNA) array“ (Exiqon, 
Vedbeak, Denmark) durchgeführt. Dieser Microarray besteht aus 454 bekannten Sonden von 
Mensch, Maus und Ratten miRNAs. Die Ergebnisse zeigten 59 unterschiedlich exprimierte 
miRNAs, von denen 31 hauptsächlich in unreifen und 28 in reifen Eizellen überexprimiert 
wurden. Hierbei wurden mit verschiedenen Ansätzen 32 neue orthologe bovine miRNAs 
identifiziert. Des Weiteren wurden erste Versuche durchgeführt, um die spezifischen 
Funktionen von miR-99a und miR-100 innerhalb eines „in-vitro“ Kumuluszellen Modells zu 
untersuchen. Die Ergebnisse zeigten, dass miR-99a und miR-100 die Expression des bovinen 
tribbles homologue 2 Gens (TRB2) runter regulieren. Zum Anderen wurde mittels eines 
genomweitem RT² miRNA PCR Arrays, bestehend aus 354 gut beschriebenen humanen 
miRNA Primern, an uterinen Cytobrush-Proben von Kühen die entweder an subklinischer 
Endometritis erkrankt oder gesund waren, Expressionsanalysen durchgeführt. Das Ergebnis 
dieses Versuches zeigte abweichende Expressionen von 23 miRNAs in Geweben von Kühen 
mit subklinischer Endometritis im Vergleich zu den gesunden Tieren. Interessanterweise 
konvergieren die mittels der Igenuity Pathway Analyse(IPA), identifizierten Gennetzwerke, 
bekannten Pathways sowie biologische Funktionen mit den Signalwegen und zellulären 
Aktivitäten innerhalb des Endometriums während des Östruszyklus und der Trächtigkeit. Des 
Weiteren bestätigte der Luziferase Assay die vorangegangenen Informationen der 
bioinformatischen Auswertung und ermöglichte uns einen schlüssigen Zusammenhang 
zwischen der veränderten miRNA Expression und den Zielgenen abzuleiten. Zusammengefasst, 
zeigt die Identifikation sowie das dynamischen Expressionsmuster der bestimmten Klasse von 
miRNAs während der bovinen Eizellreifung ihren potentiellen Einfluss auf die frühe 
Embryonalentwicklung; wohingegen die unterschiedliche Expression der uterinen miRNAs bei 
Tieren mit subklinischer Endometritis möglicherweise die uterine Genregulation beeinträchtigt. 
.
 Bovine microRNomics: Implications during oocyte maturation 
and pathophysiology of endometrium 
 
MicroRNAs which are known for posttranscriptional gene regulation are evidenced for 
their essential role during animal development and disease. In this study, identification 
and expression profiling of bovine miRNAs during oocyte maturation are scrutinized 
using heterologous approach, while miRNA regulated novel molecular signature 
underlying bovine subclinical endometritis was dissected using an integrative approach. 
Primarily, identification and expression profiling of microRNAs during bovine oocyte 
maturation was investigated using miRCURYTM locked nucleic acids (LNA) array 
(Exiqon, Vedbaek, Denmark) microarray that consist of 454 capture probes for human, 
mouse and rat miRNAs. The result revealed differential expression of 59 miRNAs, of 
which 31 and 28 miRNAs were found to be preferentially expressed in immature and 
matured oocytes, respectively. Here, 32 new bovine orthologous miRNAs were 
identified using a heterologous approach. Furthermore, the preliminary attempt to 
dissect the specific function of miR-99a and miR-100 in invitro cumulus cell showed 
that both miRNAs down regulate bovine tribbles homologue 2 (TRB2). On the other 
hand, genome wide RT² miRNA PCR array consisting of 354 well characterized human 
miRNA primers was used to analyze miRNA expression in the uterine cytobrush 
samples taken from cows with subclinical endometritis and healthy. The result showed 
the aberrant expression of 23 miRNAs in cows with subclinical endometritis as 
compared to the healthy ones. Interestingly, the Ingenuity Pathway Analysis (IPA) for 
high ranking target genes of aberrantly expressed miRNAs identified gene networks, 
canonical pathways and biological functions that converged to array of signaling 
pathways and cellular activities inherent to the endometrium during estrous cycle and 
pregnancy. Furthermore, the luciferase assay data substantiated the primary information 
from bioinformatic prediction and enabled us to deduce a convincing link between the 
aberrantly expressed miRNAs and target genes. Taken together, identification and 
dynamic expression pattern of certain class of miRNAs during bovine oocyte 
maturation suggests their potential involvement in early embryo development; where as, 
aberrant expression of uterine miRNAs in animals with subclinical endometritis 
potentially interfere with the tight uterine gene regulation.  
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INTRODUCTION 1 
1.  General introduction 
 
The ability to improve reproductive efficiency in bovine is dependant up on a solid 
understanding of reproductive physiology. The capacity of a cow to conceive and 
maintain pregnancy mainly depends on the complex and coordinated actions of 
hypothalamic-pituitary-gonadal axis and its regulation of the ovarian, uterine and 
oviductal tissues (Carletti and Christenson 2009). The female reproductive tract 
responds to the cyclic changes in pituitary and ovarian hormones to provide an optimal 
environment for oocyte development, a suitable site for implantation and pregnancy. 
There is an ever increasing evidence that establishment of pregnancy and offspring 
health are strongly linked to oocyte developmental competence where follicular 
environments both prior to and during ovulation ultimately dictates the developmental 
competence of the pre-implantation embryo (Sirard et al. 1998, Sirard 2001, reviewed in 
Sirard et al. 2006). Once the blastocyst is in the uterus, successful embryo implantation 
is a marking event for the commencement of pregnancy establishment (Das 2009, Dey 
et al. 2004). This complex developmental process involves a reciprocal dialogue 
between the blastocyst and uterus (Wang and Dey 2006) which signals the necessity of 
both competent embryo and receptive uterine for successful pregnancy.  
 
The developmental events during oocyte maturation and pre-implantation embryo 
development are synchronized with the proliferation and differentiation of specific 
uterine cell types, primarily under the direction of ovarian estrogen and progesterone 
that make the uterus conducive to accept the blastocyst for implantation (Dey et al. 
2004, Paria et al. 2001, Red-Horse et al. 2004). The molecular mechanisms that operate 
behind developmentally competent oocyte/blastocyst and a receptive uterine is known 
to be complex and tightly controlled (Barnea 2001, Savaris et al. 2008, Sirard et al. 
2006), where deviations are evidenced to contribute or solely cause poor quality oocyte 
/embryo and non-receptive uterus (Christiansen et al. 2006, Germeyer et al. 2010, Lee et 
al. 2007). The interplay between the ovary and uterus via estrogen and progesterone 
dictate the hierarchical instruction executed to effect highly regulated gene expression 
in an optimal time frame. 
 
Gene expression regulation is an integral component of molecular program that drive 
mammalian development. A unique feature of preimplantation embryonic development 
INTRODUCTION 2 
is the presence of maternally stored RNAs and proteins in mature, unfertilized eggs. As 
it is observed in mice, fertilization triggers the degradation of oocyte-stored transcripts, 
where 90% maternal transcript turnover is complete at the 2-cell stage (Tang et al. 
2007). From this perspective, it appears compelling to hypothesize and test the dynamic 
expression of bovine microRNAs during oocyte maturation to meet the timely 
requirement of protein during pre-implantation embryo development and the necessity 
of maternal transcript clearance following embryonic genome activation. 
 
Uterine diseases such as bovine subclinical endometritis perturb the hypothalamic and 
pituitary function thereby negatively affecting oocyte maturation and developmental 
competence, ovulation, pre-implantation embryo development and receptive uterine 
(Sheldon et al. 2006). Studies have shown that pathogen associated molecules disrupt 
endocrine function in the female reproductive tract of cattle (Herath et al. 2006, Herath 
et al. 2007, Herath et al. 2009a) in which the cumulative effect end up in compromised 
fertility. The molecular mechanism that leads to compromised fertility caused by 
bacterial infection during subclinical endometritis include direct interference of 
bacterial lipopolysacharides (LPS) with the hypothalamus pituitary secretion or 
induction of inflammatory response through Toll-like receptors (TLRs) that might cause 
premature luteusis (Herath et al. 2007, Herath et al. 2009a, Sheldon et al. 2009). This 
proposed model appears inconclusive as knowledge on the regulatory role of 
microRNAs in the intrinsic cellular processes of mammalian endometrium is 
increasingly building. Hence, we hypothesized the possibility of microRNA centered 
molecular mechanism governing the association of subclinical endometritis with 
reduced cattle fertility. In line with this, we propose microRNA regulated molecular 
roadmap that might alternatively lead to the disruption of the hypothalamus pituitary 
function and subsequently reduce cattle fertility. 
 
Currently, enormous experimental evidences are building that unraveled the striking 
role of microRNAs in post-transcriptional gene regulation in the course of animal 
development and disease. Thus, with this work, identification and expression profiling 
of bovine miRNAs during oocyte maturation are scrutinized for the first time, while 
detection of aberrantly expressed microRNAs and associated pathways pioneered the 
move to unravel molecular mechanism underlying the pathophysiology of the uterus in 
the context of bovine subclinical endometritis from the miRNA perspective. Hence, we 
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apparently addressed constraints of bovine reproductive success with respect to post-
transcriptional gene regulation by microRNAs from two complementary perspectives; 
oocyte maturation and pathophsylogy of the uterus. 
 
1.1.  Bovine oocyte maturation 
 
The mammalian oocyte undertakes a highly complex journey during which it 
successively acquires a series of characteristics necessary for fertilization and the 
development of a healthy embryo (Sirard 2001, Sirard et al. 2006). Ovarian 
folliculogenesis begins during the pre-natal days with the breakdown of germ cell 
clusters and formation of primordial follicles which are the smallest ovarian follicle 
units continuously recruited to grow in to primary and more advanced ovarian follicles 
(Pepling and Spradling 2001). In bovine, these primordial follicles arrest at meiosis I of 
prophase (Sirard 2001) and the dogma is that the ovary is endowed with finite number 
of oocytes, resting in the primordial follicle.  
 
As follicles grow and an antrum is formed, granulosa cells separate into two 
anatomically and functionally distinct sub-types: the cumulus granulosa cells (CC), 
those surrounding and in intimate metabolic contact with the oocyte; and the mural 
granulosa cells (MGC), the cells lining the follicle wall forming a stratified epithelium 
with the basal lamina. The cumulus – oocyte complex (COC) is then formed by highly 
specialized cumulus cells that  have trans-zonal cytoplasmic processes which penetrate 
through the zona pellucida and abut the oocyte membrane (Albertini et al. 2001). 
Molecules that are necessary for oocyte growth pass from cumulus cells to the oocyte 
via gap junction where as oocyte secreted factors pass from the oocyte to the cumulus 
cells (Simon et al. 1997). 
 
Sirard et al. (2006) precisely described different types of competence expressed by 
oocytes that include the ability to resume meiosis, to cleave upon fertilization, to 
develop into a blastocyst, to induce pregnancy and to generate healthy offspring. The 
follicular influence on oocyte competence could be dissected into two phases, namely, 
the pre-antral and growing phases (Sirard et al. 2006). Follicles from the preantral phase 
never complete meiosis as a result of incomplete meiotic, cytoplasmic and molecular 
maturation (Fair et al. 1995). However, a variable level of developmental competence 
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has been reported for the oocytes in the growing phase, where, limited (Blondin and 
Sirard 1995, Sirard 2001) and loss (Blondin and Sirard 1995) of competence were 
observed during the early growth phases and late atreitic phase respectively. The 
acquisition of developmental competence is the reflection of oocyte maturation which 
depends on the correct dynamics of chromosome separation, the redistribution of 
cytoplasmic organelles and the storage of mRNA, proteins and transcription factors 
(Albertini 1992, Hosoe and Shioya 1997, Rodriguez and Farin 2004, Stojkovic et al. 
2001, Thibault et al. 1987). Transcription in cattle oocyte essentially ceases when the 
follicle reach 3 mm diameter (Fair et al. 1997). Short burst of transcription in the 
cumulus-oocyte-complex during the initial hours of maturation is required for 
spontaneous meiotic resumption, if the bovine oocyte is aspirated from an antral follicle 
with a diameter greater than 3 mm. Before chromatin condensation, some transcription 
can be detected in the germinal vesicle (GV) of the oocyte, but it is no longer detectable 
after GV breakdown (GVBD), whereas polyadenylation appears intense at least up to 
metaphase I (Tomek et al. 2002). Despite transcription is quiescent or less significant 
during the transition from GV stage to MII oocyte, translation of selected maternal 
transcripts is quite apparent which makes the role of microRNAs as post-transcription 
gene regulators inevitable and pressing. Fair et al. (2007) showed the differential 
expression of transcripts in invitro matured and immature bovine oocytes which 
underlines the tight temporal control of protein synthesis required for oocyte maturation 
and in preparation of subsequent fertilization and early embryo development. Except 
few documented evidences on the role oocyte microRNA in Zebra fish as means of 
maternal transcript turn over (Giraldez et al. 2006) and the necessity of maternal 
microRNA for mouse zygotic development (Tang et al. 2007), knowledge on bovine 
oocyte microRNAs remained open research area until this work pioneered the 
identification and expression profile of microRNAs during oocyte maturation. 
Therefore, this study was conducted with the following objectives: (i) to investigate the 
expression pattern of bovine miRNAs during oocyte maturation (ii) to identify new 
microRNAs which are not documented in bovine (iii) to trace some specific functions of 
selected microRNAs in invito cultured cumulus cells. 
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1.2.  Pathophysiology of the uterus in the context of bovine subclinical endometritis 
 
Reduced reproductive performance in dairy cattle is often caused by uterine disorders. 
Endometritis is one of the most commonly observed dairy cattle reproductive disorders 
that usually leads to reduced fertility (Knutti et al. 2000). Clinical endometritis is 
characterized by the presence of purulent (>50% pus) or mucopurulent (approximately 
50% pus, 50% mucus) uterine exudates in the vagina, 21 days or more post partum with 
out systemic signs of illness (LeBlanc et al. 2002) while, subclinical endometritis is 
described as inflammation of the uterus with out clinical signs but characterized by 
increased number of polymorphonuclear neutrophils (PMN) in the endometrium 
(Sheldon et al. 2006) with threshold level of 5 % (Gilbert et al. 2005). The incidence of 
clinical and subclinical endometritis in dairy cattle was reported to be 53 % at 40–60 
days post partum, and often found to be associated with delayed conception and 
increased culling (Gilbert et al. 2005). The higher fertilization rate (90%) reported in 
bovine (Dalton et al. 2001, Pomar et al. 2005) is usually followed by magnificent 
proportion of embryo loss between day 8 and 17 of pregnancy (Humblot 2001, Thatcher 
et al. 2001) indicating implantation and maintenance of pregnancy are critical phases 
after fertilization. 
 
Experimental evidences showed the negative impact of subclinical endometritis on 
dairy cattle fertility (Gilbert et al. 2005, LeBlanc et al. 2002). The inflammatory 
response to post partum bacterial infection during subclinical endometritis is associated 
with the expression of pro-inflammatory mediators (Gabler et al. 2009, Herath et al. 
2009b) which affect embryonic development by acting either on the oocyte (Soto et al. 
2003), developing embryo (Buford et al. 1996, Soto et al. 2003), endometrium 
(Davidson et al. 1995, Skarzynski et al. 2000) and/or hypothalamic-pitutary-gonadal 
axis (Alpizar and Spicer 1994, Petroff et al. 2001). 
 
It is well known that successful embryo implantation is a gateway to pregnancy 
establishment and requires synchronized development of the embryo to the active stage 
of the blastocyst, differentiation of the uterus to the receptive state, and a ‘crosstalk’ 
between the blastocyst and uterine luminal epithelium (Dey et al. 2004). The attachment 
reaction coincides with the extensive proliferation and differentiation of uterine stromal 
cells into decidual cells (decidualization) at the site of implanting blastocyst. However, 
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luminal epithelial cells at the site of blastocyst apposition progressively undergo 
apoptosis with the succession of implantation. As the uterus is a dynamic physiological 
system in which cellular proliferation, differentiation, including the terminal 
differentiation and apoptosis occur in a temporal and cell-specific manner during 
pregnancy (Das 2009). Cell cycle is the most tightly regulated cellular phenomenon 
where normal operation involves complex interplay of cyclins, cyclin dependent kinases 
(CDKs) and CDK inhibitors (Sherr and Roberts 1999). In vivo and in vitro animal 
model studies have shown the need for regulation of specific uterine genes both at 
transcriptional and translational levels (Achache and Revel 2006, Horcajadas et al. 
2007). MicroRNAs emerged as potent regulators of gene expression in mammalian 
reproductive tract in normal as well as diseased condition. Aberrant miRNA expression 
is associated with a number of human diseases and fertility disorders of female 
reproductive tract. When functionally interpreting differential expression miRNAs in a 
certain diseased condition, it is important to recognize that up-regulation of a specific 
microRNA represses target mRNA translation, whereas down-regulation relieves the 
suppressive effect. The combined effect of multiple miRNAs will dictate a particular 
disease outcome. 
 
Different animal models have shown the role of microRNAs in normal physiological 
processes of uterine (Chakrabarty et al. 2007, Hu et al. 2008). However, a number of 
experimental procedures using animal models have also identified numerous transcripts 
associated with mammalian uterine disease and theses transcripts encode for the 
proteins involved in broad signaling pathways. These pathways mediate inflammation, 
tissue remodeling, apoptosis, cellular proliferation, angiogenesis and wound healing 
(Arimoto et al. 2003, Hull et al. 2008, Matsuzaki et al. 2001). This implies that aberrant 
expression of miRNAs in the uterine likely result in the miss expression of target 
transcripts affecting the corresponding signaling pathways. With this line, studies 
elucidated the role of microRNAs in the development and progression of mammalian 
uterine diseases (Ohlsson Teague et al. 2009b, Pan and Chegini 2008). 
 
Our knowledge regarding molecular mechanism underlying bovine subclinical 
endometritis was significantly limited and with this experiment, we intended to out line 
the underlying molecular mechanism potentially induced by subclinical endometritis 
and lead to reduced dairy cattle fertility. Thus, the present study tested the hypothesis 
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that aberrant expression of miRNAs and dys-regulation of their respective molecular 
networks and pathways could be triggered by subclinical endometritis. Hence, this study 
was conducted with the following major objectives: (i) to detect aberrantly expressed 
miRNAs in cows with subclinical endometritis (ii) to trace the target genes regulated by 
the aberrantly expressed microRNAs using bioinformatic prediction (iii) to figure out 
the molecular networks, biological functions and canonical pathways that these 
miRNAs potentially regulate (iv) to substantiate bioinformatically predicted microRNA 
and target genes interaction using luciferase reporter assay. 
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2.  Literature review 
 
2.1.  Bovine folliculogenesis 
 
Development of mammalian oocyte begins with the formation of primordial germ cells 
(PGCs) in the embryo and is followed by oogonial proliferation by mitosis, and 
initiation of meiosis I as primary oocytes (reviewed in Song and Wessel 2005). Gametes 
develop from PGCs that are established during early embryogenesis. In mammals, the 
PGCs appear to be induced de novo from other cells in early gasrulating embryo which 
have an extra gonadal origin and navigate through various tissues to reach the somatic 
gonad. The mechanisms of PGC migration are highly conserved in divergent animal 
classes and involve intrinsic and somatic cues, attraction and repulsion and amoeboid 
motility (Matova and Cooley 2001, McLaren 2003). Once in the gonad, the germ cells 
begin to actively divide mitotically and become either oogonia or spermatogonia. In 
most animal species, the oogonia divide to form cluster of interconnected cells. As the 
meiotic process is initiated, oogonia germ cells are referred as primary oocytes (Matova 
and Cooley 2001). Female germ cells begin entry into prophase I of meiosis and arrest 
in the diplotene stage of the first meiotic division until the resumption of meiotic 
division. 
 
Female gametes are stored within the ovary in the form of primordial follicles, which 
are comprised of small non growing functionally immature oocytes surrounded by a 
single layer of flattened granulosa cells (Figure 2.1). In mammals, all the oocytes (eggs) 
that will be used over a female's lifetime are present in the ovary at birth in a finite pool 
(Hirshfield 1991). From the pool of primordial follicles, some are stimulated to grow 
and enter development into primary, secondary or antral follicles. Transition from 
primordial follicle to primary follicle is marked by an increase in oocyte diameter, 
companion granulosa cell proliferation and change of shape from flattened to cuboidal 
(Skinner 2005). Throughout the reproductive lifespan of most mammals, continuous 
trickles of primordial follicles are released from dormancy and enter the growing 
follicle pool. Once growth is initiated, the follicle embarks on a complex path of 
development during which the oocyte progresses through a series of highly co-ordinated 
phases of development that are necessary for the successful ovulation and fertilization. 
During postnatal life, ovarian follicles continue to grow, mature and either ovulate or 
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regress in a cyclic fashion. This process begins as soon as the pool of primordial 
follicles established in the ovary and continues until the pool is exhausted (Hutt and 
Albertini 2007). 
 
It is now widely accepted that the oocyte plays a very active role in promoting follicle 
growth and directing granulosa cell differentiation (Gilchrist et al. 2004). The oocyte 
manipulates its own environment to ensure it is adequately supported throughout pre-
antral, antral and pre-ovulatory development. The influence of the follicular 
environment on the oocytes acquisition of developmental competence is better 
understood when folliculogenesis is dissected into a number follicular phases that 
include; the preantral phase, the growing phase, the early atretic phase, the late atretic 
phase, the dominant phase, the plateau phase, the pre-ovulatory phase and the LH phase 
(Sirard et al. 2006). 
 
Figure 2.1: The diagram summarizes the process of ovarian follicle development and 
growth, from oocyte nests present in the fetal ovary through follicle growth, ovulation 
and CL formation (Hernandez-Ochoa et al. 2009). 
 
The pre-antral phase of folliculogenesis is characterized by zona pellucida formation, 
granulosa cell proliferation, which is at first slow, the recruitment of theca cells to the 
follicular basal lamina and a dramatic increase in oocyte volume (Pedersen 1969). Pre-
antral follicle growth occurs independently of extra-ovarian hormonal stimuli (Kumar et 
al. 1997) and its regulation predominantly involves direct interactions between 
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granulosa cells and oocytes and the local production of growth factors. In particular, 
two oocyte specific members of the transforming growth factor (TGF)β super family, 
growth differentiation factor 9 (GDF-9) and bone morphogenetic protein 15 (BMP-15), 
have been shown to play important regulatory roles during pre-antral follicle 
development (Hanrahan et al. 2004).  
 
The growing phase commences when the small antral follicles start to respond to FSH 
either in a normal estrous cycle leading to a single dominant follicle or in an ovarian 
stimulation scheme which leads to ovulation in a multi-dominant paradigm (Blondin 
and Sirard 1995). These follicles contain oocytes with 2-4 layers of cumulus cells and 
show very limited signs of atresia. The antral follicles that are under the influence of 
FSH, it is difficult to aspirtate from the living animals and when removed in the 
growing phase they display very limited competence (Blondin and Sirard 1995, Merton 
et al. 2003). However, once follicles reach a diameter of 8.5 mm in non-stimulated 
animals, they acquire LH receptor in the granulosa layers and become less dependant on 
the FSH support. In cows, only the follicle corresponding to the dominant follicle 
reaches this status during each follicular wave. It is possible to induce the production of 
several of these follicles with exogenous FSH support and, surprisingly, when oocytes 
are collected in the active growing phase, they also display low developmental 
competence even if their size often exceeds 7-9 mm (Ginther et al. 2000, Sirard 2001). 
In the early atretic phase, the subordinate follicles and the dominant follicle contain 
oocytes of relatively high developmental potential taking blastocyst rate as a measure. It 
is suggested that similarities between maturing dominant follicle and follicles in the 
early phase of atresia might send similar maturation promoting signal to the oocyte 
(Vassena et al. 2003).  
 
The late atretic phase is characterized by the presence of oocytes with a disrupted 
cumulus layer which can be easily classified and result in a poor development rate to the 
blastocyst stage. The atretic follicles above 5 mm (large subordinates that are striving 
for dominance) often contain oocytes with partially expanded outer layers of cumulus 
(as if the oocyte was trying to mature) and consequently display the cumulus 
morphology change normally occurring after the LH surge (Blondin and Sirard 1995). 
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During the dominant phase, the dominant follicle shows a fast growth rate for few days 
and then reaches a slower growth rate correlated with higher estradiol out put which 
indicate further follicular differentiation (Ginther et al. 2000). Once these changes occur 
the developmental potential of the oocyte rapidly increases (Vassena et al. 2003). 
However, if there is a persistent corpus luteum that produces a high level of 
progesterone, the dominant follicle will not ovulate and the next follicular wave will 
soon start. Experimental evidence shows that prostaglandin injection can lead to 
ovulation of these follicles and subsequent pregnancy following insemination provides 
additional evidence that these follicles still contain good oocytes (Twagiramungu et al. 
1995).  
 
The plateau phase is a phase that occurs between the establishment of dominance and 
the resultant reduction of growth and the preovulatory period where progesterone 
concentration decreases dramatically with increasing LH pulsatility (Greve et al. 1983). 
This phase is followed by the preovulatory phase which is characterized by low 
progesterone concentrations and can be obtained with out stimulation on days 19-20 of 
the estrous cycle or with prostaglandin injection any time after wave emergence or with 
FSH stimulation and prostaglandin. The oocytes obtained from in these conditions have 
a competence level close to that of oocytes that mature in vivo (Humblot et al. 2005).  
 
2.1.1.  Oocyte somatic cell interaction during folliculogenesis 
 
The mammalian oocyte is surrounded by layers of granulosa and theca cells, growth and 
development of the somatic and the oocyte occur in a highly coordinated and mutually 
interdependent manner (Gilchrist et al. 2004). During folliculogenesis, when antrum is 
formed, granulosa cells separate in to anatomically and functionally distinct sub-types: 
the cumulus granulosa cells (CC), those surrounding and in intimate metabolic contact 
with the oocyte; and the mural granulosa cells (MGC), the cells lining the follicle wall 
forming a stratified epithelium with the basal lamina. Cumulus – oocyte complex is 
formed as the highly specialized cumulus cells penetrate the zona pellucida with trans-
zonal cytoplasmic processes and abut the oocyte membrane (Albertini et al. 2001). The 
oocyte achieves this by secreting soluble growth factors, oocyte-secreted factors 
(OSFs), which act on neighboring follicular cells to regulate a broad range of GC and 
CC functions (Buccione et al. 1990). Molecules that pass via gap junctions include 
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ions, metabolites, and amino acids that are necessary for oocyte growth, as well as small 
regulatory molecules that control oocyte development. This mode of communication in 
the ovary is essential for development and fertility, and is thought to play a key role in 
disseminating local and endocrine signals to the oocyte via the cumulus cells (Gilchrist 
et al. 2004). 
 
Oocyte secreted factors regulate folliculogenesis by modulating a broad range of 
activities associated with the growth and differentiation of granulosa cells. Oocytes 
secrete potent mitogenic factors that promote mural granulosa and cumulus cell DNA 
synthesis and cell proliferation (Lanuza et al. 1998, Li et al. 2000). The oocyte 
mitogenes interact with key known granulosa cell regulators such as FSH, IGF-I and 
androgens augmenting their growth promoting activities (Hickey et al. 2004, Li et al. 
2000). Oocytes potently regulate granulosa/cumulus cell differentiation. For instance, 
oocytes modulate FSH-induced progesterone and estradiol synthesis by mural and 
cumulus granulosa cells (Li et al. 2000) and suppress FSH-induced luteinizing hormone 
receptor (LHR) mRNA expression (Eppig et al. 2002). Oocytes also regulate the 
granulosa cell activin-follistatin-inhibin system (Lanuza et al. 1998). The implications 
of this communication loop are not yet fully clear, but it is likely to have local 
consequences for follicular growth/differentiation, and intriguingly, because inhibin acts 
primarily on the pituitary, the oocyte may indirectly regulate secretion of key endocrine 
hormones such as FSH. The potential broader implications for fertility are clearly 
profound. 
 
2.1.2.  Oocyte developmental competence 
 
Studies have shown the influence of oocyte quality on the developmental potential of 
embryo in bovine. Sirard et al. (2006) described the levels of oocyte competence which 
characterize developmental potential of  oocyte. This includes; ability to resume 
meiosis, ability to cleave following fertilization, ability to develop to the blastocyst 
stage, ability to induce pregnancy and bring it to term, ability to develop to term in good 
health. 
 
When mammalian oocytes are removed from follicles, they spontaneously resume 
meiosis (Edwards 1965). Observation of first polar body extrusion marks meiotic 
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resumption. In bovine, the ability to form a metaphase plate is acquired by the oocyte 
before antrum formation when it reachs full size in the growing follicle (Sirard et al. 
1998). Unlike in other species, the capacity to reach metaphase I and metaphase II 
seems to be acquired in bovine at the same time (Hampl and Eppig 1995, Sirard et al. 
1998). In mouse, cAMP level within the oocyte has been shown to play a critical role in 
maintaining oocyte meiotic arrest. High levels of cAMP prevent oocyte spontaneous 
maturation in vitro, while a decrease in oocyte cAMP is associated with the resumption 
of meiosis (Schultz et al. 1983). It is observed that LH stimulation disrupts the 
interaction between oocyte and the follicle cells leading to a decrease in oocyte cAMP 
and subsequent re-entry into the cell cycle (Dekel 1988, Edry et al. 2006). 
 
Fully grown mammalian oocyte has an intrinsic potential of the capacity to cleave 
following fertilization as simple activation stimulus such as electrical current and 
ethanol can trigger cleavage. Failure in cleavage doesn’t necessarily show the inability 
of the oocyte to undergo the first cell division as it may be also due to a dysfunctional 
sperm that failed to activate the oocyte (reviewed in Sirard et al. 2006). However, 
experimental evidences show that there is a significant difference in cleavage rate 
between fetal (36.7 %) and adult cow oocytes (49%) (Chohan and Hunter 2004) 
suggesting the possibility of maternal effect that could result in reduced cleavage rate. 
 
Provided that a fertilized oocyte is maintained in the proper culture condition, it is 
supposed to reach the blastocyst stage with in 6-9 days to have a significant chance of 
inducing pregnancy and producing an offspring (reviewed in Sirard et al. 2006) . Large 
proportion of early embryos that do not reach the blastocyst stage are usually blocked at 
or close to the maternal to zygotic transition (MZT)-stage, which occurs at the eight-cell 
stage in bovine (Barnes and First 1991) suggesting that these incompetent oocytes fail 
to appropriately activate the embryonic genome. The early developmental program 
embedded in the oocyte through the accumulation of proteins and RNA is likely to be 
responsible for the proper execution of the embryonic genome activation. The use of 
transcription inhibitors such as a-amanitin during the first few days following 
fertilization results in normal cleavage until the four- to eight-cell stage. Thus, 
transcriptional activation of the new embryonic genome is required for development 
beyond MZT (Barnes and First 1991). Such activation may depend on the activation or 
translation of some maternal transcription factors already stored in competent oocytes 
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that make this activation possible (Vigneault et al. 2004). Blastocyst quality varies 
depending on different criteria such as number of cells, trophectoderm to inner - cell 
mass ratio, blastocoele expansion. The ability of the oocyte to survive cryopreservation 
and induce a pregnancy is also affected by their apparent morphology as well as by their 
origin (in vitro or in vivo). From this, one can predict that good blastocysts can result in 
pregnancy (reviewed in Sirard et al. 2006).  
 
Peterson and Lee (2003) reported all blastocysts are not equal and do not always result 
in a pregnancy once transferred in suitable recipients, partly this failure is attributed to 
the recipient. Despite this fact, blastocysts that originate from oocytes matured in vitro 
result in lower rates of gestation compared to their in vivo counterparts (Peterson and 
Lee 2003). The ability to go to term is influenced by events occurring before the 
blastocyst stage and could be explained by either faulty culture conditions and/or by the 
incomplete oocyte programming before aspiration from its follicle.  
 
Some studies indicate that induction of follicular differentiation by manipulation of the 
ovarian stimulation protocol, namely FSH starvation or coasting, can result in the 
recovery of germinal-vesicle stage (immature) oocytes where most are capable of 
developing to the blastocyst stage following completion of in vitro procedures. 
Moreover, the embryonic developmental rates obtained from this procedure equal or 
even surpass the blastocyst rates obtained with in vivo matured oocytes submitted to in 
vitro fertilization and culture although the two were not compared in the same 
experiment (Blondin et al. 2002). Overall, the comparison between the in vivo matured 
and the in vitro matured oocyte recovered at different times before the LH surge support 
a progressive influence of the follicular differentiation on oocyte competence. 
 
There is now considerable evidence that production of bovine embryos in vitro can 
result in the large offspring syndrome (Young et al. 1998). The principal cause could be 
related to the oocyte maturation period, possibly due to an incomplete acquisition of 
developmental competence at onset of maturation as mentioned above, or as a 
consequence of sub optimal culture conditions. Therefore the follicular environment 
could have an influence not only on oocyte quality and female fertility but on the 
offspring's health as well. It is known that the uterine environment can affect fetal 
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development and impact the offspring's health but the ovarian influence is becoming an 
additional source of epigenetic influence that must be explored (Lucy 2003). 
 
2.1.3.  Oocyte maturation 
 
Oogenesis is characterized by a unique process of cell division occurring only in 
gametes, called meiosis; whose goal is the production of haploid cells highly specialized 
for fertilization. In the majority of species, the oocyte arrests in different stages of 
meiotic division, in particular, the block occurring in the first meiotic prophase (PI) 
marks the state of immature oocyte characterized by a prominent nucleus called the 
germinal vesicle (GV), which contains de-condensed transcriptionally active chromatin 
(Voronina and Wessel 2003). Generally, meiotic resumption is manifested by germinal 
vesicle breakdown (GVBD) followed by progression by metaphase I (MI) or II (MII) 
where it undergoes a second arrest that is removed after successful completion (Sirard 
2001). 
 
Oocyte maturation is a long process during which oocytes acquire their intrinsic ability 
to support the subsequent stage of development in step wise manner, ultimately 
reaching activation of the embryonic genome (Ferreira et al. 2009). Eppig (1996) 
defined oocyte maturation as the period of progression from the first to the second 
meiotic arrest and involves coordinated nuclear and cytoplasmic maturation. Nuclear 
and cytoplasmic maturation are complex, distinct and appreciably interlinked that occur 
simultaneously at determined time, even though the molecular programming of the 
cytoplasm may have already started during the phase of oocyte growth (Ferreira et al. 
2009). 
 
2.1.3.1.  Nuclear maturation 
 
Nuclear maturation starts with the GVBD, ends at the meiosis exit, and is marked by the 
presence of the two polar bodies (reviewed in Sirard et al. 2006). In mammals, the 
luteinizing hormone surge initiates the transition from prophase I (PI) through MI to 
MII (Moor et al. 1981). In some species, including cattle, oocytes undergo maturation as 
soon as they are isolated from their follicles or the external milieu, suggesting that these 
elements contain substances preventing meiosis resumption of Prophase I arrested 
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oocytes (Tsafriri and Pomerantz 1986). Cytoplasmic maturation is a more obscure 
process and involves both morphological and molecular alterations (Tosti 2006). 
Another important factor responsible for meiosis resumption is the M-phase promoting 
factor (MPF). Nonetheless, most of the work on MPF has been carried out with frog and 
starfish oocytes and accumulated evidences demonstrate that this complex function 
exists in other animal models, such as mammals (Yamashita et al. 2000). Studies have 
provided evidence that meiosis arrest and resumption are modulated by numerous 
messengers. The involvement of cyclic nucleotides in the maintenance of meiotic arrest 
was shown where elevated levels of cyclic adenosine monophosphate and related 
substances such as GPR3, act by preventing spontaneous maturation and/or blocking 
GVBD in vitro reviewed in (Tosti 2006).  
 
2.1.3.2.  Cytoplasmic maturation 
 
For deductive purpose, Ferreira et al. (2009) subdivided cytoplasmic maturation into 
three main events: redistribution of cytoplasmic organelles, dynamics of cytoskeletal 
filaments, and molecular maturation.  
 
The redistribution of organelles such as mitochondria and the cortical granules occurs 
along with the progression of the oocyte to metaphase (Assey et al. 1994). The 
movement of mitochondria to areas of high energy consumption is crucial for the 
oocytes and the embryo blastomere during critical periods of the cell cycle (Hyttel et al. 
1986). During oocyte maturation, mitochondria synthesize the ATP necessary for the 
synthesis of proteins where, the synthesized protein supports the completion of 
subsequent maturation processes and early embryo development (Stojkovic et al. 2001).  
A study showed that mitochondria of invitro matured oocyte move from a more 
peripheral position to a more disperse distribution throughout the cytoplasm after 12-18 
h of culture (Hyttel et al. 1986). During in vivo maturation, mitochondria movement 
also appear to have more peripheral distribution before the LH surge showing a 
clustered cortical formation in the final stages of nuclear maturation and a more 
dispersed distribution after the extrusion of the polar body (Hyttel et al. 1986). 
However, cortical granules show dispersed distribution in cluster through out  the 
cytoplasm in GV stage oocyte (Hosoe and Shioya 1997) and when oocyte maturation 
advances to MII stage, the granules are distributed throughout the inner surface close to 
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the plasma membrane a pattern strategically arranged to await for spermatozoon entry 
and egg activation (Thibault et al. 1987) 
 
The cytoskeletal filaments are dynamic and adaptable structures that can remain 
unchanged or undergo modifications according to the needs of the oocyte or the cell. 
This is a key process that is responsible for chromosome segregation during meiosis and 
mitosis and trafficking molecules and organelles inside somatic cells or oocytes. During 
the GV stage of oocyte growth, the spatial rearrangement of the organelles is related to 
the modified organization of the cytoskeleton that forms a network in which the 
organelles encased by a membrane move and occupy defined positions (Albertini 1992). 
When entering the M phase of the cell cycle (meiosis in the case of female gametes) 
microtubule asters appear close to the condensed chromatin in bovine oocytes after 
GVBD. Furthermore, during the transition from the GV stage to anaphase I, the 
microfilaments or actin filaments are distributed in the cortical area below the oolemma, 
without connecting to the microtubules (Li et al. 2005). In metaphase I (MI), the 
microtubules are nucleated by tubulin polymerization in the oocyte cytoplasm with the 
centrosome, forming the meiotic spindle and the metaphase plate in which the 
chromosomes are arranged in an equatorial manner (Albertini 1992). In MI, the 
metaphase plate is proportionally larger than that formed in MII and in this phase the 
actin filaments are abundantly distributed in the cortical region but are absent among the 
microtubules. The spindle is barrel-shaped and its poles are flattened (Li et al. 2005). 
Although the microfilaments are absent among the microtubules, there seems to be an 
interaction between these polymers since the polarized movement of the chromosomes 
also depends on processes mediated by actin filaments. When entering the M - phase of 
the cell cycle (meiosis in the case of female gametes) microtubule asters appear close to 
the condensed chromatin in bovine (Kim et al. 2000). 
 
Molecular maturation corresponds to the phases of oocyte growth and maturation and it 
involves the transcription, storage and processing of the mRNAs expressed by the 
chromosomes, which will be further translated into proteins by the ribosomes. The 
proteins derived from these mRNAs are involved both in maturation and in subsequent 
cellular events such as fertilization, pronucleus formation and early embryogenesis. 
Thus these proteins are being stored until the appropriate time for their utilization. Gene 
expression ceases in oocyte after the resumption of meiosis and hence what was 
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produced during the growth phase will be metabolized at the appropriate time (Sirard 
2001). The mRNA transcribed during the molecular maturation of the oocyte is 
accumulated in a stable and transiently inactive manner (Tomek et al. 2002). The 
biosynthetic machinery of the cytoplasm processes this mRNA into ribonucleoprotein 
particles where the mRNA will be protected from nucleolytic degradation and remains 
stored until the signals for translation are generated during maturation and early embryo 
development (Fulka et al. 1998).  
 
2.1.4. Transcription factors as mammalian oocyte gene expression regulators 
 
Development of the egg in mammals begins with the formation of primordial germ cells 
(PGCs) in the embryo and is followed by oogonial proliferation by mitosis and initiation 
of meiosis I as primary oocytes (reviewed in Song and Wessel 2005). In the course of 
development, oocyte must undergo several developmental transcriptions during which it 
acquires a specialized extracellular matrix and synthesizes a unique set of proteins in 
order to become a fertilizable egg. A hallmark of the oocyte across many species is its 
high level of transcription, reflecting the importance of maternal mRNAs and proteins 
that are crucial for supporting not only the growth of the oocyte but also the newly 
fertilized zygote (Wassarman and Kinloch 1992).  
 
Transcriptional regulation of the oocyte was discovered following the investigations of 
structures with in the oocyte nucleus that led to our understanding of the transcriptional 
units (reviewed in Song and Wessel 2005). The observation of lamp brush 
chromosomes, readily observed in the growing oocytes of organisms that produce large 
eggs (reviewed in Song and Wessel 2005) highlighted the concept of gene expression 
for the first time. In many species maternal RNA has high complexity and sufficient to 
support all the needed protein biosynthesis required during early development. Until 
zygotic gene activation, the zygote is supported by maternal mRNAs transcribed and 
translated during oogenesis. The oocyte specific transcriptional mechanisms rely on 
differential regulation of shared or common factors that result in oocyte – specific 
activity (reviewed in Song and Wessel 2005).   
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2.1.4.1.  Oct-4: germ cell specific transcription factor 
 
Orthologs of Oct-4 in mice, bovine and human share highly conserved genomic 
organization and regulatory regions (Kurosaka et al. 2004) and during gonadal 
development, transcription of the germ cell specific transcription factor Oct-4 in mouse 
and human germ cells remain high until the onset of meiosis (Pesce and Scholer 2000). 
The transcription of Oct-4 in oogonia and spermatogonia is downregulated at specific 
stages of oogenesis and spermatogenesis (Kurosaka et al. 2004). In mouse oocytes, Oct-
4 mRNA and protein are down-regulated when the oocyte enters prophase of the first 
meiotic division and are re-expressed near oocyte maturation (Pesce et al. 1998a). This 
suggests that Oct-4 may play a role in the growth or acquisition of meiotic competence 
of oocytes, and/or it may be involved in the transcriptional repression of oocyte-specific 
genes as Oct-4 is transcribed minimally during a time when the oocyte is undergoing an 
overall increase in transcriptional activity. Moreover, Oct-4 is transcribed abundantly at 
oocyte maturation when transcriptional activity in the oocyte decreases dramatically 
(Pesce et al. 1998b). Oct-4 mRNA is uniformly expressed through out the morula stage 
and becomes restricted to the inner cell mass of the blastocyst. However, after embryo 
implantation in mouse, its transcription is restricted to the epiblast and ES cells. The 
expression of this transcription factor is then progressively downregulated during 
gastrulation and eventually confined to the PGCs (Pesce and Scholer 2000). During 
mouse implantation, Oct-4 potentially up regulates Fibroblast Growth Factor- 4 (FGF-4) 
and Osteopontin (OPN) and in vivo models have shown that FGF-4 tends to stimulate 
ICM growth or maintenance (Wilder et al. 1997) and is involved in the establishment of 
the primitive endoderm and OPN is endodermal-specific, extracellular phosphoprotein 
that mediates adhesion by interacting with integrins (Guo et al. 2002).   
 
2.1.4.2.  FIGa: a transcription factor that regulates zona pellucida genes 
 
Folliculogenesis specific basic helix-loop-helix (FIGa) is a germ cell specific 
transcription factor (in mice) that regulates the coordinated transcription of the three ZP 
glycoproteins, ZP1, ZP2 and ZP3 and may regulate additional pathways critical for 
ovarian development (Dean 2004). The ZP proteins form an extracellular matrix that 
surrounds the growing mammalian oocyte and are critical for sperm activation and for 
the block to polyspermy. Studies show that mouse ZP3 is composed of primary species 
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– specific sperm receptor of the oocyte, binding sperm via O-linked oligosaccharide and 
induce the sperm acrosome reaction. Mouse ZP2 acts as a secondary sperm receptor and 
plays a role in the prevention of polyspermy, while ZP1 cross-links the other two ZP 
proteins (Wassarman et al. 2004). FIGa is expressed in both the testis and ovary, but is 
expressed most abundantly in the ovary of mouse. Its expression is first detected in 
oocytes at E13.5 in mice and its transcript persists in oocytes into adulthood. Mice 
lacking FIGa are unable to express ZP genes or form primordial follicles, resulting in 
massive depletion of oocytes and sterility (Liang et al. 1997).  
 
2.1.4.3.  NoBox: oocyte-specific genes transcription regulator 
 
NoBox is detected at the transcript level in maurine oocytes from primordial through 
antral follicles however this transcript is not observed in somatically derived granulosa 
cells, theca cells, and corpora lutea (Suzumori et al. 2002). NoBox protein localizes to 
the nuclei of germ cells and primordial follicles in the mouse ovary. Disruption of 90% 
of the NoBox coding region including the homeodomain in the mouse resulted in 
infertile female mice, while males were unaffected. Further examination indicated that 
in NoBox -/- ovaries, Oct-4, Rfpl4, Fgf8, Zar1, Dnmtlo, Gdf9, Bmp15, and H1oo 
transcripts were down – regulated (Rajkovic et al. 2004). As the transcription of NoBox 
precedes the transcription of the above mentioned genes, it is plausible that NoBox may 
directly or indirectly regulate these genes which are important for oocyte and early 
embryo development (Rajkovic et al. 2004).  
 
2.1.4.4.  ALF: general transcription factor 
 
A set of general transcription factors are necessary for an accurate initiation of 
transcription. Alf (TFIIAT) is a counterpart of the large α/β subunit of the general 
transcription factor TFIIA and interacts with the small TFIIA subunit to form a 
hetrodimeric complex that stabilizes binding of TBP (TATA-binding protein) to core 
promoter DNA. In mice, ALF is expressed in ovary. In immature Xenopus oocytes, the 
maternal TFII α/β mRNAs are translationally repressed through a conserved 3’ UTR, 
and ALF compensates for the maternal storage and inactivation of TFIIα/β mRNAs. 
When oocytes commit to meiosis, a transition from TFIIα/β to ALF occurs, and during 
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maturation, fertilization, and early embryogenesis, ALF is inactivated and replaced by 
somatic TFIIα/β (Han et al. 2003). 
 
2.2.  Discovery of microRNAs as posttranscriptional gene regulators 
 
MicroRNAs (miRNAs) are small 21-nucleotide-long noncoding RNAs that have 
emerged as key posttranscriptional regulators of gene expression in metazoan animals, 
plants, and protozoa. Lee et al. (1993) uncovered a novel form of gene regulation in C. 
elegans by pioneering the identification of lin-4 and its protein coding target lin-14. The 
lin-4 gene encodes a 21 nt small RNA that can partially base pair at multiple sites of lin-
14 3’UTR causing diminished lin-14 protein level (Lee et al. 1993, Wightman et al. 
1993). Since the lin-14 mRNA levels and polyribosome association appeared to be 
unaffected by lin-4 regulation, the model emerged that microRNAs inhibit protein 
expression at the translational level (Olsen and Ambros 1999). Let-7 was the second 
miRNA gene to be discovered and identified to regulate late larval development in C. 
elegans by inhibiting lin-41 expression (Reinhart et al. 2000, Slack et al. 2000). Based 
on the lin-4/lin-14 paradigm, it was predicted that let-7 recognition of let-7 
complementary sites containing mRNAs would inhibit their translation (Slack et al. 
2000). Shortly after the discovery of let-7 in worms, this gene was shown to be 
conserved broadly in many animal species (Pasquinelli et al. 2000). The term 
‘microRNA’ was first coined in 2001 when tens of small RNAs with regulatory 
potential were discovered in C. elegans (Lau et al. 2001, Lee and Ambros 2001). 
 
Forward genetics methods were instrumental in identifying the first miRNA genes, lin-4 
and let -7. Analysis of a C. elegans mutant with a defective cell lineage indicated that a 
mutation in a small noncoding RNA, lin-4, was responsible for the phenotype (Lee et al. 
1993). In contrast to lin-4, let-7 was found to be conserved in wide range of phylogentic 
taxa (Pasquinelli et al. 2000) indicating that miRNA- mediated gene regulation might be 
common biological phenomenon. In spite of lin-4 and let-7, forward genetics 
approaches yielded only four additional miRNAs; bantam, miR-14 and miR-278 in 
Drosophila melanogaster (Brennecke et al. 2003, Teleman et al. 2006, Xu et al. 2003) 
and lys-6 in C. elegans (Johnston and Hobert 2003). Only few miRNAs were identified 
using the forward genetics method and explanations include the small size of miRNAs 
and their potential tolerance to mutations that do not affect the seed sequence make 
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miRNA genes difficult – to – hit targets in mutagenesis. Besides, many miRNAs may 
not be recognized in a phenotype driven screen because of functional redundancy 
(Abbott et al. 2005). Hence, the preferred approach to de novo identification of 
miRNAs is to sequence size fractionated cDNA libraries. 
 
2.2.1.  MicroRNA biogenesis 
 
Primary (Pri)-miRNA transcripts with stem-loop regions are usually transcribed by 
RNA polymerase II (Lee et al. 2004) and occasionally by RNA polymerase III 
(Borchert et al. 2006). The stem-loop precursor (pre)-miRNA is released following 
cleavage event catalyzed by the nuclear microprocessor complex that contains RNase 
III Drosha (Lee et al. 2003) and exported from the nucleus by exportin (Lund et al. 
2004). The 60-90 nt miRNA precursors form the stem loop structure and ribonuclease 
class III enzyme Dicer excises miRNAs from the pri-miRNA in the cytoplasm  and 
cleaves both strands to form a ∼22 nt length double- stranded microRNA duplex 
(Hutvagner et al. 2001). The two strands become separated and one strand is 
incorporated in to the RNA Induced Silencing Complex (RISC). The core component of 
RISC is an Argonaute homologue (in mammals, this is called eIF2c; four eIF2c 
isoforms are expressed and all four are associated with RISC, though only eIF2c2 has 
“slicer” activity directed against dsRNAs). In turn, microRNA-loaded RISC binds to 
target mRNAs and regulates their translation by one of several different mechanisms 
(Pillai et al. 2007). 
 
In contrast to the linear miRNA processing pathway that was initially thought to be 
universal for the biogenesis of all mature miRNAs (Figure 2.2) multiple discoveries led 
to the recognition of miRNA-specific differences that open a plethora of regulatory 
options to express and process individual miRNAs differentially. Drosha forms two 
different complexes a small microprocessor complex that contains only Drosha and 
DGCR8 and processes many pri-miRNAs, and a larger complex that contains RNA 
helicases, double-stranded RNA binding proteins, heterogeneous nuclear 
ribonucleoproteins and Ewing's sarcoma proteins (Gregory et al. 2004). The expression 
of several miRNAs were reduced in homozygous p68 -/- and p72 -/- (RNA helicases 
and part of large drosha complex) knockout mice, while, other miRNAs remained 
unaffected (Fukuda et al. 2007). 
LITRATURE REVIEW 23 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.2: Diagrammatic representation of the canonical pathway of microRNA 
processing (Winter et al. 2009). 
 
Individual miRNA can be also regulated by drosha mediated cleavage, for instance, the 
heterogeneous nuclear ribonucleoprotein A1 (hnRNP A1) binds specifically to pri-miR-
18a (Guil and Caceres 2007) and changes the hairpin conformation to create more 
favourable cleavage site for Drosha (Michlewski et al. 2008). As intron-derived 
miRNAs are released from their host transcripts after splicing, drosha-mediated 
processing of pri-miRNAs into pre-miRNAs is not always mandatory. If the intron 
resulting from the action of the splicing machinery and the lariat debranching enzyme 
has the appropriate size to form a hairpin resembling a pre-miRNA, it bypasses Drosha 
cleavage and is further processed in the cytoplasm by Dicer (Ruby et al. 2007). These 
miRNAs, called mirtrons, have been discovered in several species including mammals, 
D. melanogaster and C. elegans (Berezikov et al. 2007). The miRNA processing factors 
Drosha and DGCR8 are also regulated post-transcriptionally or post translationally. 
DGCR8 stabilizes Drosha through an interaction between its conserved carboxyl-
terminal domains with the middle domain of Drosha. On the other hand, Drosha cleaves 
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two hairpin structures in the 5' untranslated region and the coding sequence of the 
Dgcr8 mRNA leading to DGCR8 degradation resulting in a negative feedback loop 
reducing Dgcr8 expression when sufficient microprocessor activity is available (Yeom 
et al. 2006). The discovery that Drosha can directly cleave hairpin structures in mRNAs 
also points to the possibility that the two Drosha complexes in the cell regulate mRNAs 
independently of miRNAs. 
 
2.2.2.  Principles of target recognition by miRNAs and mode of action 
 
Animal miRNAs target transcripts most commonly through imperfect base pairing to 
the 3’ untranslated region (3’UTR). Base pairing between the 3’UTR of mRNA and the 
seed region of microRNA is critical for the mRNA and miRNA interaction. Moreover, 
3’- end pairing is suggested to stabilize miRNA - mRNA hybrid formation, especially 
when there is weak Watson and Crick complementarity in the seed region (Brodersen 
and Voinnet 2009). Despite these facts, experiments with artificial sensor constructs in 
human cells showed that miRNA-guided repression is equally efficient when sites are 
located in the 5' or 3' UTRs of reporter transcripts, thereby demonstrating that no 
mechanistic requirement confines miRNA action to 3' UTRs (Lytle et al. 2007). Two 
studies in human cells have identified functional miRNA target sites in the ORFs of 
DNMT3B (Duursma et al. 2008) and CDKN2A (Lal et al. 2008). In microarray studies 
that involved miRNA transfection in human cells, transcripts with potential miRNA 
target sites in ORFs were noticed in repressed gene sets, although they were not pursued 
in depth because they were thought to be rare, weak or of uncertain importance in vivo 
(Lim et al. 2005). 
 
Besides the complexity of the rule that govern miRNA- target mRNA interaction, 
studies have shown that a conserved seed ‘match’ consisting of bases 2-9 of the miRNA 
is a reliable predictor of interaction (Brennecke et al. 2005) while perfect base pair 
matching does not guarantee interaction between miRNA and target gene (Didiano and 
Hobert 2006) and wobble G:U base pairs are often tolerated in target sites (Vella et al. 
2004). Furthermore, Hon and Zhang (2007) have shown that the number and 
arrangement of miRNA recognition sites can influence the degree and specificity of 
miRNA-mediated gene repression. Taking these principles into account, it has become a 
well established fact that an individual miRNA is able to control the expression of more 
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than one target mRNAs (Lewis et al. 2005, Lim et al. 2005) and that each mRNA may 
be regulated by multiple miRNAs (Brennecke et al. 2005, Enright et al. 2003). 
 
Even if the requirements for microRNA-target gene interaction are fulfilled translation 
repression may not be possible unless the target site is accessible to the miRNAs. 
mRNA target site accessibility is influenced by the structure of RNA and its association 
with RNA binding proteins (RBPs) which consequently affect the extent of post 
transcriptional regulation by miRNAs (Brodersen and Voinnet 2009). The accessible 
mRNA target site can be regulated by the targeting miRNA loaded Argonaute (Ago) 
protein or regulation can be avoided if the target site participate in the secondary 
structure formation (Kertesz et al. 2007).   
 
Eukaryotic cells contain two general and conserved pathways for the degradation of 
bulk mRNA, both of which require an initial removal of the 3′ poly (A) tail in a process 
referred to as deadenylation (Parker and Song 2004). In one case, deadenylation is 
followed by 3′- to-5′ exonucleolytic degradation by the exosome, a multimeric complex 
with 3′- to-5′ exonuclease activity. Alternatively, after deadenylation, mRNAs can be 
decapped by the Dcp1/Dcp2 decapping enzymes and degraded 5′- to-3′ by the abundant 
5′- to-3′ exoribonuclease, Xrn1p (Valencia-Sanchez et al. 2006). Evidence suggests that 
following mRNA cleavage triggered by miRNAs, the 3′ fragment is degraded by major 
cellular 5′- to-3′ exonucleases. For instance, in Drosophila S2 cells in culture, Xrn1p is 
required for degradation of the 3′ cleavage product from RISC-mediated cleavage 
(Orban and Izaurralde 2005). 
 
Another way that miRNAs silence mRNAs is by interfering with their translation. 
Silencing by a miRNA is observed with either no change in the mRNA level, or with a 
significantly smaller decrease in mRNA levels than is observed for protein (Cimmino et 
al. 2005). This was first suggested by the observation that the lin-4 miRNA reduced the 
amount of lin-14 protein, without reducing the amount of the lin-14 mRNA (Lee et al. 
1993, Wightman et al. 1993). Never the less, another subsequent observation suggested 
that the lin-4 might also affect mRNA levels (Bagga et al. 2005). MicroRNAs also 
control post-transcriptional gene expression by directing endonuclease cleavage of the 
target mRNA. Such endonuclease cleavage activity was first demonstrated in cell 
cultures with exogenously provided dsRNAs (Hammond et al. 2000). It is observed that 
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some endogenous miRNAs in metazoans direct endolytic cleavage and it is generally 
favoured by perfect base-pairing between the miRNA and the mRNA, although some 
mismatches can be tolerated and still allow cleavage to occur (Yekta et al. 2004). 
However, studies in plants showed that extensive base-pairing between the miRNA and 
the mRNA is not always sufficient to induce cleavage, suggesting that there can be 
additional requirements for a RISC complex to catalyze endonucleolytic cleavage (Chen 
2004). 
 
The interaction between the miRNA and the target mRNA is complicated than it was 
thought. The observation in miR-122, a liver specific miRNA, showed that it binds to 
the 5’-non-coding region of the RNA HCV (hepatitis C virus) genome and induces the 
accumulation of viral RNAs and it seems that miR-122 can act on viral RNA replication 
rather than RNA translation or stability (Jopling et al. 2005). Another observation 
showed that miRNAs oscillate between repression and activation in the duration of a 
cell cycle, and they identified miR-369-3p in proliferating cells, which represses the 
translation of targets but switches to mediate activation process in cell-cycle arrest 
(G1/G0) (Vasudevan et al. 2007). miRNAs also appear to activate certain mRNA 
targets in stress conditions, such as hypoxia and nutrient deprivation (Leung and Sharp 
2007). Whether these up-regulation phenomena happen in special conditions or in 
ubiquitous regulatory mechanisms remains to be further illustrated. 
 
More than one-third of mRNAs in the mammalian genome are thought to be regulated 
by one or more miRNAs (Chaudhuri and Chatterjee 2007). Like the mRNAs, miRNAs 
themselves are co-ordinately modulated by different effectors. Experimental evidences 
demonstrated that miRNAs show developmental time and tissue specific regulation 
mechanisms although considerable amount of known miRNAs are expressed 
universally in various tissues and species (Biemar et al. 2005). It appears that precise 
regulation network exist to regulate the biogenesis and functions of miRNAs where the 
influence of cooperated multiple steps in miRNA biogenesis was reported (Kim 2005).  
 
Single nucleotide polymorphisms (SNPs), created by changes in DNA sequences of 
miRNA-coding genes or in miRNA-binding site in mRNAs, are able to affect the 
biogenesis and function of miRNA. Many miRNA polymorphisms are shown to be 
associated with diseases, because a gain-of-function of an miRNA polymorphism may 
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recruit or enhance the combination of the miRNA to the targets, thereby strengthen the 
regulation effects, such as tumour suppressor genes; on the contrary, a loss-of-function 
may result in losing control of the mRNAs especially those oncogenes and drug targets 
(Mishra et al. 2008). A common G/C polymorphism within the pre-miR-146a sequence 
decreased the generation of pre- and mature miR-146a and led to less efficient 
inhibition of target genes involved in the Toll-like receptor and cytokine signaling 
pathway, which contribute to the genetic predisposition to papillary thyroid carcinoma 
(Jazdzewski et al. 2008). On the other hand, SNPs in the target sites of mRNAs may 
result in the escape of inhibition or degradation by an miRNA (Chin et al. 2008). 
 
miRNA editing may represent a fine tuning process in miRNA biogenesis at different 
steps, resulting in variations of target mRNAs and providing another layer of regulatory 
controls within the complex network of RNA-mediated gene functions. RNA editing is 
a site-selective modification of RNA molecules at post-transcriptional level to yield a 
product differing from the DNA template. Approximately 16 % human pri-miRNAs are 
subject to A-to-I editing (Kawahara et al. 2008). A-to-I editing at specific positions of 
miR-142 and miR-151 blocks the Drosha/Dicer cleavage in the maturation of these 
miRNAs (Kawahara et al. 2007, Yang et al. 2006) indicating RNA editing displays a 
micro-regulatory role in controlling the miRNA processing machinery. In addition, 
edited miRNAs may silence a set of genes different from those targeted by the unedited 
miRNAs, extending the functional scope of miRNAs but increasing the complexity of 
analyses at the same time (Blow et al. 2006, Habig et al. 2007). Furthermore, RNA 
editing contributes to the diversity of miRNAs by generating different mature miRNAs 
from identical miRNA transcripts (Ohman 2007).  
 
Some microRNA genes are affected by epigenetic inactivation due to aberrant 
hypermethylation, which is characterized as early and frequent events in cancer 
development (Ando et al. 2009). The expression of miRNA genes located near CpG 
island, tend to be affected readily by methylation (Lodygin et al. 2008). Besides, it is 
reported that DNA methylation can affect the expression of transcription factors so that 
it may control the miRNA expression in an indirect manner (Han et al. 2007). 
 
More than, 45,000 miRNA target sites within human 3′ UTRs are conserved above 
background levels, and greater than 60% of human protein-coding genes have been 
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under selective pressure to maintain pairing to miRNAs (Friedman et al. 2009). It has 
been also known that considerable number of miRNAs is highly conserved among 
different organisms (Calin and Croce 2007) and experimental evidence supports the 
notion that miRNA is ancient regulatory mechanism evolved before the divergence of 
multicellular and unicellular organisms (Zhao et al. 2007). It is estimated that miRNAs 
constitute nearly 1% of all predicted genes in nematodes, flies and mammals (Lai et al. 
2003, Lim et al. 2003a, Lim et al. 2003b). In mammals, miRNAs are predicted to 
control the activity of more than 60% of all protein-coding genes (Friedman et al. 2009) 
and participate in the regulation of almost every cellular process investigated to date 
(Bushati and Cohen 2007, Ghildiyal and Zamore 2009) which include, developmental 
timing, cell differentiation, proliferation, apoptosis, tumorigenesis and host-pathogen 
interactions (Cho 2007, Liu 2008, Scaria et al. 2006).  
 
2.2.3.  MicroRNA involvement in early development 
 
Since the discovery of lin-4 and let-7 in C. elegans there is increasing evidence that 
miRNAs are involved in mammalian development, including proliferation and 
differentiation of embryonic stem (ES) cells, lineage commitment during 
embryogenesis, maturation of multiple tissues. The first demonstration of the 
essentiality miRNA in early embryogenesis of mammals has been reported by Bernstein 
et al. (2003) where the disruption of the global miRNA biogenesis by ablation of Dicer 
caused embryo death before gastrulation. Later studies have also shown that ES cells 
isolated from dicer knock out mice have a slower proliferation rate and impaired 
differentiation, indicating the involvement of miRNAs in the self renewal and 
pluripotency of ES cells (Laurent et al. 2008). In undifferentiated ES cells, there is high 
expression of miR-290 and low expression of miR-21 was reported and proposed that 
miR-290 the protein that inhibit the expression of Oct 4 while miR-21 causes the 
inhibition of Oct-4 as a target (Sun et al. 2010). miR-290 cluster is highly expressed in 
ES cells and it is proposed that miR-290 suppresses the proteins that inhibit the 
expression of Oct 4 (Sinkkonen et al. 2008). miR-1 and miR-133 are expressed in 
skeletal muscle cells while miR-1 promotes skeletal muscle differentiation during 
myogenesis and miR-133 enhances the proliferation of myoblasts (Chen et al. 2006). 
The expression of miR-143 was increased in adiposites during adipogenesis and the 
inhibition of miR-143 effectively suppresses the differentiation process by a reduction 
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in triglyceride accumulation and a decreased expression of adiposite genes (Esau et al. 
2004). 
 
Oocytes lacking Dicer, a gene required for microRNA processing and essential for 
mouse development, lack maternal microRNAs and fail to pass the first cell division 
(Murchison et al. 2007, Tang et al. 2007). In mouse zygote, maternally inherited 
microRNAs are abundant with dynamic expression profile and, notably, some are 
downregulated by as much as 95% between the one-and two-cell stages. Zygotic 
transcription of microRNAs begin from the two-cell stages (Tang et al. 2007). miR-
125a, an orthologue of C. elegans lin-4, is expressed in the two cell stage and its 
expression increases between the two cell and blastocyst stage. It is suggested that it 
may have a role in controlling early embryonic timing through the regulation of Ped 
gene (Byrne and Warner 2008). Furthermore, miR-93 is especially expressed in the 
trophectoderm and future primitive endoderm in a pattern complementary to Stat 3 gene 
which is important for early development (Foshay and Gallicano 2009, Takeda et al. 
1997). During ES cell differentiation, miR-93 has been observed to interact with and 
down regulate Stat3 mRNA (Takeda et al. 1997). In recent study, it has been shown that 
depletion of miR-21 in cultured granulosa cells induced apoptosis. In vivo apoptosis 
increased in LNA-21-treated ovaries, and ovulation rate decreased in LNA-21-treated 
ovaries, compared with their contralateral controls (Carletti et al. 2010). 
 
miRNAs, at least in X. levis, have a relevant role in Nodal signaling where miR-15 and 
miR-16 observed to inhibit Nodal signaling by reducing the expression of one of its 
receptors, Acvr2a. Over expression of miR-15 and miR-16 reduced Spemann’s 
organizer and head structures where as blockage of these miRNAs increased Spemann’s 
organizer and head structure. Moreover, miR-15 and miR-16 restored dorsal mesoderm 
induction in embryos in which Wnt/β-catenin signaling was suppressed (Martello et al. 
2007). In zebra fish, miR-430, a highly abundant miRNA that is required for the 
clearance of maternal mRNAs, has been shown to directly decrease the expression of 
squint (sqt) a member of Nodal family (Choi et al. 2007). The temporal expression of 
miRNAs during embryonic development was determined by microarray analysis.  Up to 
segmentation (12 hours post fertilization), most miRNAs could not be detected. Most 
miRNAs became visible 1 to 2 days after fertilization and showed strong expression 
when organogenesis is virtually completed (96 hpf). In adults, the majority of miRNAs 
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remained expressed. Further more, the expression of miRNAs in dissected organs of 
adult fish showed a high degree of tissue specificity at least for some miRNAs 
(Wienholds et al. 2005). 
 
2.2.4.  Implication of miRNAs in mammalian fertility 
 
Impaired uterine receptivity is one of the major reasons for the failure of assisted 
reproduction techniques and defects in implantation and trophoblast invasion are 
presently considered the major challenges for the successful establishment of pregnancy 
(Edwards 1995, Herrler et al. 2003). The identification of microRNA expression in the 
uterus and the functional analysis of individual miRNAs, have shed light on to the 
physiological changes that occur in the uterus in response to steroids and pregnancy. 
Studies have shown that deletion of Dicer1 resulted in the reduction of the mouse uterus 
length and diameter by one-half as compared the wild type females. In addition, the 
Dicer1fl/fl; Amhr2Cre/+ uterus was one-third the weight of wild-type uteri. Histology 
indicated a decreased smooth muscle layer and decreased presence of uterine glands 
(Hong et al. 2008). In another study, Dicer inactivation in mullerian duct mesenchyme – 
derived tissues of the reproductive tract of the mouse resulted in female infertility but 
mutant males were normal and fertile. The dicer mutant female oviducts were less 
coiled forming cyst at the isthmus with unfertilized degenerated oocytes indicating 
defect in embryo transit. Furthermore, blastocysts transferred directly to the mutant 
uterus did not result in pregnancy (Gonzalez and Behringer 2009). However, the 
identification of endogenous small interfering RNA that require Dicer for their synthesis 
and a Dicer dependant miRNA biogenic pathway confounds the notion that deletion of 
Dicer is equivalent with deletion of miRNAs. Thus, deletion of individual miRNAs 
could give much more specific results. 
 
Inline with this, miRNA microarray was performed on uteri from day 1 pregnant mice, 
during which the uterus is prereceptive to embryo implantation because estrogen is 
increased compared to uteri from day 4 pregnant mice, during which the uterus is 
receptive to embryo implantation because progesterone is increased. Two miRNA 
upregulated in the receptive stage, miR-101a and miR-199a*, are regulators of 
prostaglandin-endoperoxide synthase 2 (PTGS2). The expression of PTGS2 in the 
uterine luminal epithelium is necessary for embryo implantation. Thus, miR-101a and 
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miR-199a* may play a role in tightly regulating PTGS2 expression at the site of embryo 
implantation, thereby preventing unnecessary growth elsewhere in the uterus. 
Furthermore, PTGS2 expression is necessary for decidualization of the uterine stromal 
cells, and the expression profiles of miR-101a and PTGS2 are inversely correlated 
during decidualization. Therefore, miR-101a and miR-199a* are likely important 
regulators of PTGS2 during embryo implantation and the concurrent decidualization 
(Chakrabarty et al. 2007). 
 
In mice, miRNA microarray was used to examine differential expression of miRNAs in 
the mouse uterus between implantation sites and inter-implantation sites. Eight 
microRNAs were upregulated at implantation sites as compared with inter implantation 
sites, specifically miR-21 was highly expressed in subluminal stromal cells at 
implantation sites on day 5 of pregnancy (Hu et al. 2008). Furthermore, the authors 
showed that REC is the target gene of miR-21 and suggested miR-21 may play a key 
role during embryo implantation (Hu et al. 2008).  
 
Female mice with global miRNA deficiency as a consequence of germ line specific 
deletion of  Dicer I are sterile from several causes including defects in oocyte function 
where oocytes from these mice are observed to have disorganized meiotic spindles and 
elevated abundance of maternal mRNA transcripts that are normally degraded during 
meiotic maturation. Many of these maternally derived oocyte transcripts are predicted 
targets of oocyte - specific miRNAs. These experiments show that DicerI controls 
oocyte and early zygotic development by enhancing miRNA repression of maternally-
inherited cytoplasmic mRNAs. The sequential breakdown of maternally-derived 
cytoplasmic mRNAs in the oocyte appears to be vital to gamete production (Murchison 
et al. 2007, Tang et al. 2007). In human, morphologically similar blastocysts derived 
from patients with polycystic ovaries or male factor infertility exhibited a significant 
decrease in the expression of six microRNAs (has-let-7a, has-miR-19a, has-miR-19b, 
has-miR-24, has-miR-92, has-miR-93) in comparison with donor fertile control 
blastocysts. Hence, it appears that molecular signature of human embryo is not always 
reflective of morphology and this finding suggested that a possible role for embryonic 
microRNAs in the etiology of human infertility and potential subsequent implantation 
failure (McCallie et al. 2010). 
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It is reported that deletion of Dicer in mice has profound effects on uterine and 
oviductal development and function as well as ovarian function and oviductal defects 
are known to cause female infertility. Moreover, these mice exhibited reduced ovarian 
function as evidenced by decreased ovulation rate which was attributed to loss of 
miRNA with in the Amhr-2 expressing granulosa cells (Gonzalez and Behringer 2009, 
Nagaraja et al. 2008, Pastorelli et al. 2009). In another mouse model, female infertility 
was observed as a result of 80% reduction in Dicer expression. These female mice 
exhibited normal ovulation rates but the corpora lutea had reduced progesterone output 
and as a result the mice were unable to sustain pregnancies. These investigators went on 
to show that loss of Dicer decreased vascularisation of the corpora lutea and that 
exogenous administration of two miRNA (miR-17-5p and let-7b) could prevent this loss 
(Otsuka et al. 2008). 
 
2.2.5.  Role of miRNAs in immune system development 
 
Mammals have evolved complex genetic programmes that simultaneously regulate the 
development and function of hematopoietic cells, resulting in the capacity to activate 
specific responses against invading foreign pathogens while maintaining self-tolerance. 
From recent studies, miRNAs are emerging as major players in the molecular circuitry 
that controls the development and differentiation of haematopoietic lineages (Cobb et 
al. 2006). Knocking-out Dicer activity in early B-cell progenitors determined a block at 
the pro-B cell stage during the differentiation process leading to mature activated B-
cells. Gene-expression profiling revealed a miR-17-92 signature in the 3' UTRs of genes 
upregulated in Dicer-deficient pro-B cells; the proapoptotic molecule Bim, a top miR-
17-92 target, was also highly upregulated. Surprisingly, B cell development was 
partially rescued by ablation of Bim or transgenic expression of the prosurvival protein 
Bcl-2 (Koralov et al. 2008). The pioneer knockout of miR-155 in mice (the first mouse 
knockout for a single miRNA) revealed an essential role in the acquired immunity for 
this miRNA. In fact, despite miR-155 null mice developed normally, immune system 
analysis revealed that miR-155 depletion led to pleiotropic defects in the function of B 
cells, T cells and dendritic cells. These mice were unable to gain acquired immunity in 
response to vaccination, demonstrating that miR-155 is indispensable for normal 
adaptive immune responses (Rodriguez et al. 2007). 
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Another functional example derives from the study of Ventura et al. (2008) who 
demonstrated that the miR-17-92 cluster is involved in controlling B-lymphocyte 
proliferation. Deletion of this miRNA cluster was lethal in mice resulting in lung 
hypoplasia, ventricular sept defects and impairment of the pro-B to pre-B transition. 
Absence of miR-17-92 led to increased levels of the pro-apoptotic protein Bim and 
inhibited B cell development at the pro-B to pre-B transition. Furthermore, while 
ablation of miR-106b-25 or miR-106a-363 (the two paralogous clusters) had no obvious 
phenotypic consequences, compound mutant embryos lacking both miR-106b-25 and 
miR-17-92 died at mid-gestation. On the contrary, over-expression of miR-17-92 cluster 
in mice led to lymphoproliferative and autoimmune diseases that were associated with 
self-reactive antibody production (Ventura et al. 2008).  
 
MicroRNAs are implicated in a wide range of biological processes including 
development, differentiation, apoptosis and proliferation. miR-14 and batman were the 
first miRNAs to be associated with apoptotic function in Drosophila (Brennecke et al. 
2003, Xu et al. 2003) and an increasing number of studies have clearly shown the link 
and role of miRNAs in apoptosis especially in cancer development. Dicer, an 
endonuclease, is required for miRNA maturation; loss or inactivation of Dicer leads to 
decreased levels of miRNAs such as let-7a, miR-16, and miR-21 that are implicated in 
apoptosis (Ghodgaonkar et al. 2009). Both pro-apoptotic and anti-apoptotic genes are 
potentially regulated by miRNAs. Since miRNAs can regulate hundreds of gene targets 
at a given time, a single miRNA can function both as pro-apoptotic and/or anti-
apoptotic depending on the cellular context and the target gene. For instance, miR-21 
predominantly functions as an anti-apoptotic miRNA and is upregulated in many cancer 
cell types and it also exerts its pro-apoptotic function when it targets tumour suppressor 
genes. Moreover, the level of miR-21 is inversely correlated with TPM1 and PTEN 
expression and apoptosis in tongue squamous cell carcinomas (Li et al. 2009). miR-15 
and miR-16 regulate the anti-apoptotic factor BCL2 and are considered to be pro-
apoptotic microRNAs. These miRNAs induce apoptosis and negatively regulate cell 
growth and cell cycle when exogenously expressed in tumour cell lines (Cimmino et al. 
2005). 
 
Even though there are cases where a particular miRNA acts as pro-apoptotic and anti-
apoptotic, miR-17-92 were observed to target pro-apoptotic genes CDKN1A (p21) and 
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BIM in B-cell lymphoma (Inomata et al. 2009) and subsequently promote cell survival 
and proliferation. Up regulation of miR-106b-25 is detected in the majority of gastric 
cancer cases, where these miRNAs negatively regulate pro-apoptotic genes p21 and 
BCL2L11 protein expression in the TGFβ tumour suppressor pathway leading to 
tumour progression (Petrocca et al. 2008). miR-221 and miR-222 have been shown to 
regulate CDK1B (p27), a tumour suppressor gene that promotes apoptosis. These 
miRNAs behave as an anti apoptotic miRNAs by regulating CDK1B and their increase 
expression leads to cell proliferation and cell survival (Fornari et al. 2008). 
 
Hull et al. (2008) hypothesized that TGFβ mediates a swith from an initially ischaemic 
and inflammatory environment that causes tissue damage and necrosis, to a healing 
milieu that promotes cellular proliferation and tissue remodeling during endometriotic 
lesion development. Experimental evidences have shown that TGFβ-1 and -2  mRNA 
translation is repressed by miR-21 and miR-141(Burk et al. 2008, Lu et al. 2009) and 
these miRNAs are downregulated in endometriosis (Pan et al. 2007). Dysregulation of 
miR-1, miR-21, miR-141 and miR-194 may synergetically enhance TGFβ signaling in 
endometriotic lesions by increasing TGFβ expression and restraining TGIF’s. Besides, 
miR-1 and miR-194 mediated TGIF repression may have effects on retinoic acid 
signaling, promoting tissue remodeling, cell proliferation and invasiveness in 
endometriosis (Ohlsson Teague et al. 2009a). 
 
Interleukin -1 beta and tumour necrosis factor alpha (TNF-α) in pro-inflammatory 
condition of the endometrium activate nuclear factor κB (NFκB) and HIFIα signaling 
leading to enhanced COX-2 transcription. Cox-2 is a rate limiting enzyme in the pro-
inflammatory prostaglandin pathway that also demonstrates pro-angiogenic activity 
(Cao et al. 2005, Keenan et al. 1995, Wu et al. 2002). miR-199a*  and miR-16 are 
known to repress translation of COX-2, moreover miR-199a* targets IκB kinase β 
(IKBKB) which is co-factor required for NFκB activation (Chakrabarty et al. 2007, 
Chen et al. 2008). 
 
In study of various human cancers, tissue miRNA expression profiles identified both 
physiological and pathological conditions more accurately than mRNA abundance 
signatures (Lu et al. 2005). Potential miRNA biomarkers that display high sensitivity 
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and specificity have been identified for a variety of tumour types (Iorio et al. 2007). It is 
thus clear that cellular processes are regulated by miRNAs in a cell-lineage and disease 
dependant manner.   
 
2.2.6.  MicroRNA and uterine pathophysiology 
 
Different animal models have shown the role of microRNAs in normal physiological 
processes of uterine (Chakrabarty et al. 2007). A number of experimental procedures 
using animal models have also identified numerous transcripts associated with 
mammalian uterine disease and these transcripts encode for the proteins involved in 
broad signaling pathways. These pathways mediate inflammation, tissue remodeling, 
apoptosis, cellular proliferation, and angiogenesis and wound healing (Arimoto et al. 
2003, Hull et al. 2008, Matsuzaki et al. 2001). Many mRNA transcripts are 
differentially regulated in endometriotic lesions when compared with eutopic tissues 
(Arimoto et al. 2003, Hull et al. 2008), however, mismatch between the expression 
levels of transcriptomes and proteins associated with the endometriotic disease revealed 
the post-transcriptional regulatory role of miRNAs in endometriosis (Wren et al. 2007). 
 
miRNA regulation at least partly share the post-transcriptional gene regulation, as it has 
been indicated by studies that identified differentially expressed miRNAs in 
endometriotic tissues (Ohlsson Teague et al. 2009b, Pan and Chegini 2008). Ohlsson 
Teague et al. (2009a) proposed a model for microRNA regulation in endometriotic 
lesion development utilizing miRNA microarray studies of eutopic and ectopic 
endometrium and further supplementing experimentally confirmed mRNA targets of 
endometriosis associated miRNAs in other diseases, including epithelial, fibroblast and 
myoblast cell lineages. However, these cells constitute endometriotic lesions and 
participate in pathological processes, such as cell proliferation, migration and 
angiogenesis that are common to human endometriosis, cancer and many other diseases 
(Figure 2.3). 
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Figure 2.3: microRNA regulatory functions during human endometriosis lesion 
development. MicroRNA expression may play a role in these processes, regulating 
transcripts involved in hypoxia, inflammation, apoptosis, tissue repair, cellular 
proliferation, extracellular matrix remodeling and angiogenesis (Ohlsson Teague et al. 
2009a). 
 
2.2.6.1.  Inflammation 
 
Elevated levels of tumour necrosis factor alpha (TNF-α) and interleukin-1 beta (IL-1β) 
elicit inflammatory response in the endometrium (Keenan et al. 1995, Mori et al. 1991). 
Endometrial synthesis of prostaglandins is under the control of several cytokines 
including TNF- α and IL-1β, which can increase PGF2α secretion as it is observed 
cultured bovine endometrial stromal cells (Davidson et al. 1995, Skarzynski et al. 
2000). In addition COX-2  demonstrates a pro-angiogenic activity (Smith and Dewitt 
1996) and also participate in positive feed forward loop that enhances aromatase 
activity and local estradiol production there by promoting a proliferative local hormonal 
environment (Bulun et al. 2000). Cyclooxygenase-2 expression is posttranscriptionally 
regulated by mmu-miR-101a and mmu-miR-199a* and it is possible that whenever 
there is a situation that reduce the expression of these two microRNAs induce up-
regulation of COX-2 protein level that may promote an inflammatory environment 
(Chakrabarty et al. 2007). 
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2.2.6.2.  Cell growth, proliferation and apoptosis 
 
Cellular growth is critically regulated at two particular transitions of cell cycle that is 
G1-S and G2-M. Mammalian cell proliferation is regulated by D-type cyclins (D1, D2 
and D3) which are also known as G1 cyclines. The D-type cyclines accumulate during 
the G1 phase and their association with CDK4 or CDK6 is important to form 
holoenzymes that facilitate cell entry into S-phase. Retinoblastoma protein (RB) and its 
family members RBL1 and RBL2 are negative regulators of the D-cyclins. Inactivation 
of these regulators by phosphorylation, dependant on the cyclin/CDK complex activity, 
allows cell cycle progression through the G1 phase (Riley et al. 1994). By contrast, 
cyclins A and B are involved in progression from S to G2-M phase. A critical balance 
between the positive and negative cell cycle regulators is the key decision maker for cell 
division. Changes in the expression levels of D-type cyclins and CKls normally occur 
when quiescent cells are stimulated by mitogenic signals. MicroRNAs up-regulate cell 
cycle repressors that can lead to repression of cellular proliferation. The down 
regulation of microRNAs that target cell cycle repressors mRNA could lead to the 
accumulation of cell cycle inhibitor molecules, such as cyclin dependent kinase 
inhibitor 1A (CDKN1A/p21), CDKN1B and CDKN1C in endometrial cells (Hull et al. 
2008, Inomata et al. 2009, Matsuzaki et al. 2001).  
 
Moreover, cell proliferation is promoted by the cell cycle regulator insulin receptor 
substrate-1. The insulin receptor substrate-1 (IRS-1), a docking protein for both the type 
1 insulin-like growth factor receptor (IGF-IR) and the insulin receptor, is known to send 
a mitogenic, anti-apoptotic, and anti-differentiation signal (White 1998). miR-126 and 
miR-145 target this mitogen protein and may inhibit endometrial cell proliferation (Shi 
et al. 2007). In addition, miR-143 may suppress cell proliferation by repressing 
mitogene-activated protein kinase 7 (MAPK7) (Esau et al. 2004). On the other hand, 
apoptotic resistance is mediated by intracellular proteins such as B-cell/lymphoma 2 
(BCL2) that lead to enhanced survival of mammalian cells, and it has been observed 
that this gene promote survival of stressed endometrial cells in endometriosis 
(Meresman et al. 2000). As miR-15b/16 is confirmed to target BCL2 (Cimmino et al. 
2005) upregulation of the miRNAs could induce apoptosis.  
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2.2.6.3.  Angiogenesis 
 
As a tissue that exhibit rapid cyclical growth throughout the reproductive life of a cow, 
the endometrium is subject to normal physiological angiogenesis as well as pathological 
situations such as wound healing and tumour growth. Angiogenesis is defined as the 
process whereby new blood vessels are created from the pre-existing vasculature. This 
process involves a number of steps which include activation of endothelial cells (EC) 
with in the existing vessel, breakdown of basement membrane, migration of the EC 
towards a stimulus, proliferation of the EC, fusion of two sprouts to form a continuous 
line of EC, tube formation and replacement of blood flow (Klagsbrun and D'Amore 
1991). Variations on these steps have been also reported (Nagy et al. 1995, Vernon et al. 
1995). Since several angiogenesis related transcripts are confirmed targets of 
microRNAs. For instance, miR-126 enhances VEGF and fibroblast growth factor (FGF) 
signaling via repression of inhibitors of these pathways, leading to neoangiogenesis and 
the development of mature vasculature (Wang et al. 2008). miR-126 is an overlapping 
transcript with EGF-like-domain, multiple 7 (EGFL7) gene and both transcripts were 
up-regulated in ectopic versus eutopic endometrium (Ohlsson Teague et al. 2009b) 
indicating that they are co-transcribed (Figure 2.4). The effect of miR-126 was 
enhanced by EGFL7 by inducing endothelial cell migration during neovascularisation 
(Schmidt et al. 2007). 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: The intronic miR-126 and its host gene, EGF-like-domain, multiple 
7(Egfl7), promote angiogenesis (Ohlsson Teague et al. 2009a). 
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2.2.7.  Potential role of miRNAs in endometrial transcriptome dynamics and 
endometritis 
 
Postpartum uterine health in dairy cows is compromised due to persistent bacterial 
infection causing uterine disease. Uterine infection often is associated with 
Arcanobacterium pyogenes, Escherichia coli, Fusobacterium necrophorum and 
Prevotella melaninogenicus (Bonnett et al. 1991, Sheldon et al. 2003). Endometritis is 
one of the most commonly observed dairy cattle reproductive disorders that usually lead 
to reduced fertility (Knutti et al. 2000). Clinical endometritis is characterized by the 
presence of purulent (>50% pus) or mucopurulent (approximately 50% pus, 50% 
mucus) uterine exudates in the vagina, 21 days or more post partum with out systemic 
signs of illness (LeBlanc et al. 2002) while, subclinical endometritis is described as 
inflammation of the uterus with out clinical signs but characterized by increased number 
of polymorphonuclear neutrophils (PMN) in the endometrium (Sheldon et al. 2006) 
with threshold level of 5 % (Gilbert et al. 2005). The incidence of clinical and 
subclinical endometritis in dairy cattle was reported to be 53 % at 40–60 days post 
partum, and often found to be associated with delayed conception and increased culling 
(Gilbert et al. 2005). The higher fertilization rate (90%) reported in bovine (Dalton et al. 
2001, Pomar et al. 2005)  is usually followed by magnificent proportion of embryo loss 
between day 8 and 17 of pregnancy (Humblot 2001, Thatcher et al. 2001) indicating 
implantation and maintenance of pregnancy are critical phases after fertilization. 
 
Uterine bacterial infections are important because they disrupt not only the function of 
the uterus, but also the ovary and the overarching higher control centers in the 
hypothalamus and pituitary. The innate immune system is principally responsible for 
combating bacterial contamination of the uterus by a range of anatomic, physiological, 
phagocytic and inflammatory defenses. Neutrophils are the earliest and most important 
phagocytic cell to be recruited from the peripheral circulation to the uterine lumen, 
killing internalized bacteria and contributing to the formation of pus when the 
phagocytes die. However, the functional capacity of neutrophils is reduced after 
parturition in many cattle (Zerbe et al. 2000); and this may predispose to the 
establishment of uterine disease. Later, macrophages are likely to be important in the 
uterine immune response. Immune cells detect bacterial components such as endotoxin 
and peptidoglycan via toll-like receptors, which activate down-stream signaling to 
LITRATURE REVIEW 40 
stimulate the release of cytokines including tumour necrosis factor-alpha (TNFα), and 
interleukins (IL-1, IL-6, IL-8) (Beutler et al. 2003).  
 
Heat-killed E. coli or LPS provokes an inflammatory response by the endometrial cells, 
characterized by the increased expression of transcripts for tumour necrosis factor, nitric 
oxide synthase, and prostaglandin-endoperoxide synthase 2 (PTGS2, formerly COX-2) 
and the secretion of prostaglandins F2α (PGF) and PGE (Herath et al. 2006). Heat-killed 
E. coli, LPS, A. pyogenes pyolysin, BoHV-4, bacterial DNA, and lipids also influence 
endometrial cell prostaglandin secretion, particularly stimulating the secretion of PGE 
rather than PGF in cattle (Herath et al. 2009a). LPS-induced PGE secretion by 
endometrial cells is important for fertility because prostaglandins have multiple roles in 
endometrial function, and luteolysis is initiated by PGF from oxytocin-stimulated 
epithelial cells (Poyser 1995). In addition, PGE has an important role in the mammalian 
immune response, acting through prostaglandin E receptors 2 and 4 (PTGER2 and 
PTGER4) to control inflammation (Sugimoto and Narumiya 2007).  
 
Taken together, studies in mouse and invitro human uterine cell culture models have 
shown the implication of miRNAs in healthy as well as diseased condition of 
endometrium. Despite the suggestion of possible role of some transcripts in the 
development of subclinical endometritis in bovine, no attempt has been conducted to 
understand the involvement of miRNAs in bovine pre-implantation embryo 
development and uterine disorders. 
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3.  Part I: Identification and expression profiling of miRNAs during oocyte maturation 
 
Bovine oocyte maturation involves the resumption and completion of the first meiotic 
division from germinal vesicle (GV) stage to metaphase II (MII) with corresponding 
cytoplasmic maturation. Optimal storage and timely availability of mRNA during 
oocyte maturation and early embryo development are essential for oocyte quality and 
developmental competence. Fair et al. (2007) showed the differential expression of 
transcripts in invitro matured and immature bovine oocytes which underlines the tight 
temporal control of protein synthesis required for oocyte maturation and in preparation 
of subsequent fertilization and early embryo development. Like the mRNA, microRNA 
expression in mouse shows a dynamic change during oogenesis and large proportion of 
maternal genes are directly or indirectly under the control of miRNAs (Tang et al. 2007) 
and the turn over of substantial subset of maternal transcripts is induced by the binding 
of proteins and microRNAs to the 3’ untranslated region (UTR) of target mRNAs.  
 
Despite the fact that knowledge on the role of microRNAs in development in different 
species is increasingly building; discovery, expression profiling and specific functions 
of microRNAs during bovine early development remained to be little explored. Given 
the emerging roles of microRNAs in development, identifying the differentially 
expressed microRNAs during in vitro oocyte maturation is an important first step to 
investigate the function of miRNAs in the course of early bovine development. In this 
study, differentially expressed microRNAs during in vitro bovine oocyte maturation 
were generated with their matured and immature oocyte stage preference using miRNA 
microarray technology and quantitative RT-PCR. Moreover, new bovine miRNAs were 
identified using heterologous approach. Besides, as the function of a specific microRNA 
can be thought of as a product of the genes that it regulates; we retrieved the potential 
targets for some micro-RNAs and quantified using qRT-PCR.
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3.1.  Part I: Materials and methods  
 
3.1.1.  Materials 
 
During the laboratory analysis, a diverse list of laboratory experiments, chemicals, 
growth media and solutions were used. Besides, during the entire study period a broad 
list of data bases and soft wares were used. 
 
3.1.1.1.  List of laboratory equipments used during the study 
 
Equipments Manufacturer 
Laminar flow chamber  Heraeus, Germany 
UV Transilluminator (Uvi-tec) Uni Equip, Martinsried, Germany 
ABI PRISM® 7000 SDS  Applied Bio systems 
Millipore apparatus Millipore Corporation, USA 
Carbon dioxide incubator (MCO-17AI) Sanyo, Japan 
Inverted fluorescence microscope DM 
IRB 
Leica, Germany 
Stereomicroscope SMZ 645 Nikon, Japan 
Centrifuge Hermel, Wehing 
Electrophoresis chamber BoRad, Munich 
My Cycler Thermal cycler  Bio-RadLaboratories, CA, USA 
SHKE6000-8CE refrigerated Stackable 
Shaker 
Thermoscinentific, IWA, USA 
CEQTM 8000 Genetic Analysis BeckmanCoulter,Krefeld, Germany 
Ultra low freezer (-80 ° C) Labotect GmbH, Gottingen, Germany 
Centrifuges (small, medium, large) Heraeus, Hanau, Germany 
MAXQ6000 shacking incubator  Thermo scientific, Germany 
Carbon dioxide incubator (MCO-17AI) Sanyo, Japan 
Hybridization chamber GFL, Dülmen, Germany 
Hybridization cassette (TeleChem International, Inc., Sunnyvale, 
CA). 
Nanodrop 8000 Spectrophotometer  Thermo Fisher Scientific, DE, USA 
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Axon GenePix 4000B scanner Axon Instruments, Foster City, CA 
Four well dishes 
Thermo Fisher Scientific, Nunc, Roskilde, 
Denmark 
Rigid thin wall 96 X 0.2 ml skirted  
microplates for real-time PCR 
STARLAB GmbH (Ahrensburg) 
 
3.1.1.2. List of chemicals,  competent cells and kits 
 
Chemicals and competent cells Manufacturer/Supplier 
Fetal Bovine serum (FBS) Sigma-Aldrich Chemie GmbH, Munich, Germany 
10x PCR buffer                                      Promega, WI, USA 
2x rapid ligation buffer Promega, WI, USA 
Fetal Calf serum (FCS) Sigma-Aldrich Chemie GmbH, Munich, Germany 
E. coli competent cells Stratagene, Amsterdam, The Netherlands 
5x First-Stand buffer Invitrogen Life Technologies, Karlsruhe 
Agar-Agar Roth, Karlsruhe, Germany 
Agarose                                                        Sigma-Aldrich Chemie GmbH, Munich 
Ligase cocktail System Bioscience (SBI), Mountain View, CA 
Control RNA System Bioscience (SBI), Mountain View, CA 
RNase-free Water System Bioscience (SBI), Mountain View, CA 
3’ adaptor System Bioscience (SBI), Mountain View, CA 
3’adaptor primer System Bioscience (SBI), Mountain View, CA 
5’ adaptor System Bioscience (SBI), Mountain View, CA 
5’ adaptor primer System Bioscience (SBI), Mountain View, CA 
Chloroform Roth , Karlsruhe, Germany 
Dimethyl sulfoxide (DMSO) Roth , Karlsruhe, Germany 
dNTPs Roth , Karlsruhe, Germany 
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DTT Invitrogen Life Technologies, Karlsruhe, Germany 
Dye terminator cycle 
sequencing s(DTCS) 
Beckman Coulter, Krefeld, Germany 
Ethanol Roth, Karlsruhe, Germany 
Ethidium bromide Roth, Karlsruhe, Germany 
ExoSAP-IT USB, Ohio, USA 
Hy5TM  fluorescent label Exiqon, Vedbaek, Denmark 
Hy3TM  fluorescent label Exiqon, Vedbaek, Denmark 
Labeling enzyme Exiqon, Vedbaek, Denmark 
Glycogen for sequencing Beckman Coulter, Krefeld, Germany 
Reverse transcriptase System Bioscience (SBI), Mountain View, CA 
5x Reverse transcriptase buffer System Bioscience (SBI), Mountain View, CA 
QIAzol lysis reagent Qiagen, Hilden, Germany 
Buffer RWT Qiagen, Hilden, Germany 
Buffer RPE Qiagen, Hilden, Germany 
Hybridization buffer Exiqon, Vedbaek, Denmark 
20x Salt buffer Exiqon, Vedbaek, Denmark 
10 % Detergent solution Exiqon, Vedbaek, Denmark 
Isopropyl -D-thiogalactoside 
(IPTG) 
Roth, Karlsruhe, Germany 
Igepal Roth, Karlsruhe, Germany 
Isopropyl β-D-thiogalactoside 
(IPTG) 
Roth, Karlsruhe, Germany 
L-Glutamine Sigma-Aldrich, Germany 
Magnesium chloride Sigma-Aldrich Chemie GmbH, Munich, Germany 
ROX  Bio-Rad, Hercules, CA 
Mineral oil Sigma-Aldrich Chemie GmbH, Munich, Germany 
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BCB Sigma-Alderich, Taufenkirchen, Germany 
Oligonucleotide primers MWG Biotech, Eberberg, Germany 
Pepton Roth , Karlsruhe, Germany 
Penicillin Sigma-Aldrich Chemie GmbH, Taufkirchen 
pGEM®-T vector Promega, WI, USA 
Phenol red solution (5% in D-
PBS) 
Sigma-Aldrich Chemie GmbH , Munich 
Potassium chloride Sigma-Aldrich Chemie GmbH, Munich, Germany 
DNA size ladder Bio-Rad laboratories, Munich, Germany 
Random primer Promega, WI, USA 
Ribo-nuclease inhibitor 
(RNasin) 
Promega, WI, USA 
FSH Sigma-Aldrich Chemie GmbH, Munich, Germany 
RQ1 RNase-free DNase Promega, WI, USA 
RNasin Promega, WI, USA 
Sample loading solution (SLS) Beckman Coulter, Krefeld, Germany 
Sequagel XR Sequencing Gel Beckman Coulter, Krefeld, Germany 
Sodium acetate Roth , Karlsruhe, Germany 
Sodium chloride Roth , Karlsruhe, Germany 
Sodium dodecyl sulfate (SDS) Sigma-Aldrich Inc, MO, USA 
Sodium hydrogen sulphate Sigma-Aldrich Inc, MO, USA 
Sodium lactate solution (60%) Sigma-Aldrich Inc, MO, USA 
Sodium pyruvate Sigma-Aldrich Inc, MO, USA 
Streptomycin sulphate Sigma-Aldrich Inc, MO, USA 
Superscript II reverse 
transcriptase 
Invitrogen,  CA, USA 
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iTaq SYBR Green Supermix 
with ROX  
Bio-Rad laboratories, Munich, Germany 
T4 DNA ligase Promega, WI, USA 
Taq DNA polymerase Sigma-Aldrich Inc, MO, USA 
Tris Roth ,Karlsruhe, Germany 
Triton X-100 Roche Diagnostics GmbH, Mannheim, Germany 
Resuspension solution Sigma –Aldrich Chemie GmbH, Munich, Germany 
Lysis solution  Sigma –Aldrich Chemie GmbH, Munich, Germany 
Neutralization solution Sigma –Aldrich Chemie GmbH, Munich, Germany 
Column preparation solution Sigma –Aldrich Chemie GmbH, Munich, Germany 
Optional wash solution Sigma –Aldrich Chemie GmbH, Munich, Germany 
Wash solution concentrate Sigma –Aldrich Chemie GmbH, Munich, Germany 
Elution solution Sigma –Aldrich Chemie GmbH, Munich, Germany 
X-Gal (5-bromo-4-chloro-3-
indolylbeta-D-
galactopyranoside) 
Roth, Karlsruhe,  Germany 
miRCURYTM LNA Array 
microarray kit 
Exiqon, Vedbaek, Denmark 
miRCURYTM  LNA Array 
labeling kit 
Exiqon, Vedbaek, Denmark 
miRNeasy Mini kit Qiagen, Hilden, Germany 
Global microRNA 
amplification kit 
System Bioscience, Mountain View, CA 
A T7 based in vitro 
transcription kit 
Epicentre Technologies, Oldendorf, Germany 
mirVana qRT-PCR kit Ambion, Austin, TX 
QIAquick PCR Purification Quigen, Hiden, Germany 
GenEluteTM Plasmid Miniprep 
Kit 
Sigma–Aldrich Chemie GmbH, Munich, Germany 
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3.1.1.3.  Growth media and solutions 
 
CR1-aa culture medium (50 ml) Hemi-calcium lactate 0.0273 g 
 Streptomycin sulphate 0.0039 g 
 Penicillin G 0.0019 g 
 Sodium chloride 0.3156 g 
 Potassium chloride 0.0112 g 
 Sodium hydrogen carbonate 0.1050 g 
 Sodium pyruvate 0.0022 g 
 L-Glutamine 0.0073 g 
 Phenol red solution (5% in D-PBS) 100 µl 
 Sodium hydrogen carbonate 0.080 g 
Modified parker medium HEPES 0.140 g 
 Sodium pyruvate 0.025 g 
 L-Glutamin 0.010 g 
 Gentamicin 500 µl 
 Medium 199 99 ml 
 Hemi calcium lactate 0.06 g 
 added to water 110 ml 
Capacitation medium (50 ml) Sodium chloride 0.2900 g 
 Potassium chloride  0.0115 g 
 Sodium hydrogen carbonate  0.1050 g 
 Sodium dihydrogene phosphate 0.0017 g 
 Hepes 0.1190 g 
 Magnesium chloride dihydrate 0.0115 
 Calcium chloride dihydrate 0.0145 g 
 Sodium lactate solution (60 %) 184 µl 
 Phenol red solution (5 % in D-PBS) 100.0 µl   
 Water up to  50.0 ml 
Fertilization medium Sodium chloride 0.3300 g 
 Potasium chloride 0.0117 g 
 Sodium hydrogen carbonate  0.1050 g 
 Sodium dihydrogen phosphate 0.0021 g 
 Penicillin 0.0032 g  
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 Magnesium chloride hexahydrate  0.0050 g 
 Calcium chloride dihydrate  0.0150 g 
 Sodium lactate solution (60%) 93.0 µl 
 Phenol red solution (5 % in D-PBS) 100.0 µl 
 Water up to  50.0 ml 
LB-agar Sodium chloride 8.0 g 
 Peptone 8.0 g 
 Yeast extract 4.0 g 
 Agar-Agar 12.0 g 
 Sodium hydroxide (40 mg/ml) 480.0µl  
 ddH2O added to 800.0 ml 
LB-broth Sodium chloride 8.0 g 
 Peptone 8.0 g 
 Yeast extract 4.0 g 
 Sodium hydroxide (40 mg/ml) 480.0 µl 
 ddH2O added to 800.0 ml 
BSA (3%) Bovine serum albumin 0.15 g 
 added to PBS+PVA 5 ml 
DEPC-treated water (1000 ml) DEPC 1 ml 
 added to water  1000 ml 
Lysis buffer (100 µl) Igepal (0.8%) 0.8 µl 
 RNasin 5 µl 
 DTT 5 µl 
 added to water 100 µl 
TAE (50x) buffer, pH 8.0 Tris  242.0 mg0  
 Acetic acid   57.1 ml  
 EDTA (0.5 M) 100.0 ml00 
 ddH2O added to 1000.0 ml 
TE (1x) buffer Tris (1 M) 10.0 ml 
 EDTA (0.5 M) 2.0 ml 
X-gal ddH2O added to 1000.0 ml 
 X-gal 50.0 mg 
(16%) Para formaldehyde (10 ml) N, N’-dimethylformamide 1.0 ml 
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 Para formaldehyde  1.6 g 
 added to water  10 ml 
PBS + PVA (50 ml) Polyvinyl alcohol (PVA) 
PBS added to 
300 mg 
50 ml 
Permeabilizing solution (10 ml) Triton X-100 5 µl 
 Glycine + PBS added  10 ml 
Physiological saline solution  Sodium chloride 9 g 
 added to water 1000 ml 
Agarose loading buffer Bromophenol blue 0.0625 g 
 Xylencyanol 0.0625 g 
 Glycerol 7.5 ml 
 ddH2O added to 25 ml 
dNTP solution dATP (100 mM) 10.0 µl 
 dCTP (100 mM) 10.0 µl 
 dGTP (100 mM) 10.0 µl 
 dTTP (100 mM) 10.0 µl 
 ddH2O added to 400.0 µl 
Wash buffer A 20x Salt buffer  20 ml 
 10 % Detergent solution  4 ml 
 Nuclease free water 176 ml 
Wash buffer B 20x Salt buffer 10 ml 
 Nuclease free water 190 ml 
Wash buffer C 20x Salt buffer 2 ml 
 Nuclease free water 198 ml 
IPTG solution IPTG 1.2 g 
 ddH2O added to 10.0 µl 
3M Sodium Acetate, pH 5.2 Sodium Acetate  123.1 g 
 ddH2O added to 500 ml 
1M EDTA, pH 8.0 EDTA 37.3 g 
 ddH2O added to 1000 ml 
Phenol Chloroform  Phenol : Chloroform 1 : 1 (v/v) 
0.2% Triton-X100: Triton 2 ml 
 10x PBS : added to 1,000.0ml 
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0.3% BSA in PBS BSA 3 g 
 10x PBS : added to 1,000.0 ml 
3% BSA in PBS BSA 30g 
 10x PBS : added to 1,000.0 ml 
 
3.1.1.4.  List of soft wares and data bases used during the study 
 
Soft wares and data bases Source of soft wares and data bases 
miRBase v.10 http//microrna.sanger.ac.uk/ 
Significance 
Analysis for Microarray (SAM) 
(http://www-stat.stanford.edu/;tibs/SAM/) 
GPRocessor 2.0a software (http://bioinformatics.med.yale.edu/softwarelist) 
GenePix Pro (ver. 4.0) Axon Instruments, Foster City, CA 
Entrez Gene http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene 
EndNote X1 Thomoson 
Primer Express ® software Applied Biosystems, Foster city, CA, USA 
BLAST program http://blast.ncbi.nlm.nih.gov/Blast.cgi 
Prism for windows (ver.5.0) Graph Pad software, Inc. 
NCBI http://www.ncbi.nlm.nih.gov 
Weight to molar quantity 
converter 
http://www.molbiol.ru/eng/scripts/01_07.html 
miTarget http://cbit.snu.ac.kr/~miTarget/ 
Manupulate and display  
DNA sequence 
http://www.vivo.colostate.edu/molkit/manip/ 
Alibee - multiple alignment 
http://www.genebee.msu.su/services/malign_reduc
ed.html 
ENSEMBL  http://www.ensembl.org). 
Patrocles database  www.patrocles.org 
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3.1.2.  Methods 
 
3.1.2.1.  Heterologous approach 
 
As most microRNAs are evolutionarily conserved across related species and the bovine 
microRNAs discovered and registered in the miRBase release 8.0 at The Wellcome 
Trust Sanger Institute are too small, we used microarray slides spotted with miRNA 
probes from human, mouse and rat. For this, miRCURY TM array (Exiqon, Vedbaek, 
Denmark) that consists of control probes, mismatch probes and 454 capture probes was 
used to hybridize total RNA containing microRNA isolated from immature and invitro 
matured oocytes. After sequentially washing and scanning, we used species-specific 
GenePix® Array Lists (GAL) files of human, mouse and rat alternatively to figure out 
the differentially expressed microRNAs. As we alternatively analysed the array data 
using the three gal files, we detected the same number of miRNAs. The number of 
known miRNAs varies with species and hence a specific probe could belong to a known 
miRNA at least in one or all of the three gal files. We systematically assessed each 
differentially expressed miRNA in each data set (human, mouse and rat) and observed 
that a given capture probe was designed to serve for all the three species specific gal 
files by exploiting the inter species sequence conservation feature of miRNAs. 
Therefore, we deduced those miRNAs that are differentially expressed and known at 
least in one of the three species gal files and not included in the miRBase v.10 under 
bovine microRNAs as bovine miRNA not known before. 
 
3.1.2.2.  Oocyte collection, in vitro maturation, sperm capacitation and IVF 
 
Bovine ovaries were obtained from a local slaughter house and transported to the 
laboratory in a thermoflask containing 0.9% saline solution. The cumulus-oocyte 
complexes (COCs) were aspirated from follicles (2–8mm in diameter) with an 18-gauge 
needle and COCs with multiple layers of cumulus cells were selected for this 
experiment. Part of these oocytes was used as immature oocytes, while the others 
allowed to mature. To get matured oocytes, selected oocytes were washed in maturation 
medium (MPM, modified parker medium) (MPM) supplemented with 15% estrus cow 
serum (OCS), 0.5 mM L-glutamine, 0.2 mM pyruvate, 50 mg/ml gentamycin sulfate, 
and 10 µl/ml FSH (Folltropin, Vetrepharm, Canada) before set into culture. The COCs 
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were cultured in groups of 50 in 400 ml of maturation medium under mineral oil in 
four-well dishes (Nunc, Roskilde, Denmark). Maturation was performed for 24 hr at 
39°C under a humidified atmosphere of 5% CO2 in air. Both immature and matured 
oocytes were snap frozen after removal of the surrounding cumulus cells. 
 
Two sperm straws were thawed at a temperature of 39 °C for 8 seconds in a water bath, 
and separated by means of the ´swim up´ technique (Parrish et al. 1988). The matured 
oocytes in groups of 50 were transferred to fertilization medium and inseminated with 
spermatozoa at a concentration of 1x106 cells/ml. Fertilization was initiated during 
coincubation of spermatozoa and matured oocytes for 20 hrs under the same condition 
as used for maturation (Parrish et al. 1988). 
 
3.1.2.3.  In vitro culture and embryo collection 
 
Cumulus free zygotes were washed and transferred to CR1aa culture media (Rosenkrans 
and First 1994) supplemented with essential and non essential amino acids. Further 
culture in culture medium was performed in the same incubator and under the same 
conditions as used for maturation and fertilization. Cattle oocytes and embryos were 
collected from the culture at specific time points after maturation or fertilization. 
Matured oocytes were collected at 24 hr after maturation, while 2-cell, 4-cell, 8-cell, 
morula, and blastocyst stage embryos were collected from the culture at 28, 48, 70, 120 
and 168 hr of post-insemination (hpi) respectively. The oocytes and embryos collected 
were washed once with PBS and snap-frozen in cryotubes containing lysis buffer 0.8% 
Igepal (Sigma, Taufkirchen, Germany), 40 U RNasin (Promega, Mannheim, Germany), 
and 5 mM dithiothreitol (DTT) (Promega). Until RNA isolation, all frozen oocytes and 
embryos were stored at -80 oC.  
 
3.1.2.4.  Brilliant cresyl blue (BCB) staining of COCs 
 
The procedure of BCB staining was done as described in previous studies (Alm et al. 
2005, Bhojwani et al. 2007). Briefly, immature and matured oocyte complexes (COC) 
were subjected to 26 µM BCB (B-5388, Sigma-Alderich, Taufenkirchen, Germany) 
diluted in mDPBS for 90 min at 38.5 °C in humidified air atmosphere. After washing, 
the stained COCs were examined under stereomicroscope and categorized into two 
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groups according to their cytoplasm coloration: oocytes with any degree of blue 
coloration in the cytoplasm (BCB+) (n = 300) and oocytes without visual blue 
coloration (BCB-) (n = 300). From each group the denuded oocytes and corresponding 
cumulus cells were snap frozen and stored in -80°C.  
 
3.1.2.5.  Total RNA isolation, miRNA amplification and invitrotranscription 
 
Total RNA containing microRNAs was isolated from three independent pools of 
immature and in vitro matured oocytes (each containing 100 oocytes) using miRNeasy 
mini kit (Qiagen, Hilden, Germany) following manufacturer’s protocol. RNA isolation 
was performed at three time points in whole experiment. First, RNA isolation was 
performed from three independent pools of immature and invitro matured oocytes each 
containing 100 oocytes to be used for miRNA array hybridization. Secondly, three 
independent pools of oocytes (IO and MO) and cumulus cells from BCB+ and BCB- 
groups were used for RNA isolation to test some of the candidates’ expression in fully 
grown (BCB+) and growing (BCB-) oocytes. At last RNA isolation was also performed 
from three independent pools of pre-implantation stage embryos that includes matured 
oocytes (n = 400), 2-cell (n = 100), 4-cell (n = 80), 8-cell (40), morula (20) and 
blastocysts (10) to profile the expression of some candidate miRNAs in early 
developmental stages. 
 
The need of microgram amount of total RNA for microRNA microarray analysis led us 
to amplify low yield of RNA (nanogram range) obtained from both immature and 
matured oocytes. Total microRNA was then linearly amplified using global microRNA 
amplification kit (System Bioscience, CA, USA) and amplification was performed 
according to manufacturer’s procedure. Briefly, prior to adaptor ligation, 100 ng of total 
RNA from three pools of immature and matured oocytes was incubated at 65°C for 5 
min. 3’ adaptor ligation was performed in a 10 µl reaction with 2 µl RNase free water, 5 
µl ligase buffer (warmed to 37°C before use), 0.5 µl 3’ adaptor, 2µl total RNA and 0.5 
µl ligase cocktail added together. The reaction was incubated at 37 °C for 1 hour and 
then kept on ice until the RT-step. For the first strand cDNA synthesis, primarily, 4.0 µl 
RNase free water, 0.5 µl 3’ adaptor primer and 1 µl ligation were added together and 
incubated at 65°C for 1 min and at 42°C for 5 min. After incubation the reactions were 
kept on ice. Then after, a master mix was prepared by adding 2.0 µl of 5X reverse 
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transcriptase buffer, 1 µl dNTP mix, 0.5 µl 5’ adaptors, 0.5 µl Dithiothreitol (DTT) and 
0.5 µl reverse transcriptase. From this mix, 4.5 µl was added to the previous one and 
incubated for 5 min at 42 °C and for 10 min at 95 °C. Second strand cDNA synthesis 
and amplification was done by adding 67 µl RNase free water, 10 µl 10X PCR buffer, 2 
µl dNTP mix, 4 µl 3’ adaptor primer, 4 µl 5’adaptor primer and 3 µl PCR polymerase. 
The cycling conditions were, initial denaturation at 95 °C for 2 min , 38 cycles of 
denaturing at 95°C for 20 seconds, annealing at 55°C for 15 sec and extension 72 °C for 
15 sec followed by final extension of 72°C for 30 sec and hold at 15°C. The amplified 
cDNA was purified using QIAquick nucleotide removal kit (Qiagen, Hilden, Germany) 
as suggested by the manufacturer and after subsequent washing the cDNA was eluted 
with 30 µl elution buffer. 
 
A T7 based invitro transcription kit (Epicentre technologies, Oldendorf, Germany) was 
used according to manufacturer’s instruction to invitro transcribe the amplified cDNA 
in to RNA. Briefly, 2 µl of 10X reaction buffer, 6 µl dNTP (100 mM each of ATP, 
CTP, GTP and UTP), 2 µl of DTT and 2 µl of T7 RNA polymerase were added to 8 µl 
of purified cDNA, mixed well and incubated at 37 ˚C for 2 hrs. At the end of 
incubation, 1 µl of DNase I (Qiagen, Hilden, Germany) has been added and incubated at 
37 ˚C for 15 minutes to degenerate the DNA. Then the amplified RNA (aRNA) was 
purified using miRNeasy Mini kit (Qiagen, Hilden, Germany) according to the 
manufacturer’s recommendations. Finally, the aRNA was eluted with 30 µl RNase free 
water from which 8 µl was taken to estimate the yield and purity of aRNA by UV 
absorbance reading at A260/280 using Ultrospec™ 2100 pro UV/Visible 
Spectrophotometer (Amersham Bioscience, Freiburg, Germany). 
 
In order to validate if the amplified pool of microRNA was representative of the initial 
population, we took the starting total RNA for amplification from the same sample of 
non-amplified total RNA and quantified five microRNAs (miR-127, mir-145, miR-206, 
mir-130b, miR-208) and 5S using qRT-PCR. 
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3.1.2.6.  miRNA labeling and hybridization 
 
Three independent pools amplified miRNAs from both immature and matured oocytes 
each with 8 µg amount were used for labelling and subsequent hybridization. 
MicroRNA labeling was done using miRCURYTM locked nucleic acids (LNA) array 
(Exiqon, Vedbaek, Denmark) labeling kit where miRNA from immature oocytes were 
labeled with Hy5TM fluorescent label and miRNA from matured oocytes with Hy3TM 
fluorescent label. Labeling was performed in a two step protocol, where by, a 
fluorescent label was attached enzymatically to the 3’- end of the miRNAs. Then, this 
was followed by an enzyme inactivation step after which the sample was ready for 
hybridization. Synthetic small RNA oligonucleotides designed to hybridize to 
miRCURYTM array labeling control capture probes were spiked into a miRNA sample 
to serve as a positive labeling control. 
 
The labeled RNAs from immature and matured oocytes were hybridized in three 
independent slides with capture probes using miRCURYTM locked nucleic acids (LNA) 
array (Exiqon, Vedbaek, Denmark) that consist of 454 capture probes for human, mouse 
and rat miRNAs as registered and annotated in the miRBase release 8.0 at The 
Wellcome Trust Sanger Institute. Briefly, 10 µl of completely dissolved 2x 
hybridization buffer was added to the labeled samples. After mixing by vortexing and 
brief spinning, the samples were incubated at 95°C for 3-5 min. Then, the labelled 
targets were centrifuged at maximum speed for two min. The slides were placed in the 
slide chamber and target samples were added over the spotted area. The arrays were 
covered with glass cover slips and fixed well in the hybridization cassette (TeleChem 
International, Inc, CA, USA). Hybridization was done by incubating the casset in a 
hybridization chamber (GFL, Dülmen, Germany) at 60 °C for 16 hours. 
 
The microarray slides were washed with wash buffer A (20ml of 20X salt buffer, 4ml of 
10% detergent solution and 176 ml nuclease free water) for 1 min and briefly immersed 
in wash buffer B (10ml of 20X salt buffer and 190 ml nuclease free water) to avoid 
transfer of detergent to the next wash step. After subsequently washing the slides with 
wash buffer B in new coupling jar (at room temperature), washing with buffer C (2ml 
20X salt buffer and 198 ml of nuclease free water) was performed by plunging gently 
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for two min at room temperature. Finally, slides were dried by centrifugation for 2 min 
at 2000 rpm. 
 
3.1.2.7.  MicroRNA array scanning and data analysis 
 
The miRNA array slides were scanned using Axon GenePix 4000B scanner (Axon 
Instruments, Foster City, CA, USA). The GenePix® Pro 4.0 software (Axon 
Instruments, CA, USA) was used to process the images, find spots, integrate the 
alternative GAL files and finally to create reports of spot intensity data. The LOWESS 
normalization of microarray data was performed using GPRocessor 2.0a software 
(http://bioinformatics.med.yale.edu/softwarelist). The normalized data was then 
calculated for the replicates to obtain one value per clone. For microarray data analysis 
the Hy5/Hy3 ratios were log2 transformed and submitted to SAM (Significance 
Analysis for Microarray), a free software developed at Stanford University (http://www-
stat.stanford.edu/;tibs/SAM/). We finally took a threshold level of ≥ 1.5 fold changes as 
a cut off value and significant level of p ≤ 0.05 to screen differentially expressed 
miRNAs. 
 
3.1.2.8.  MicroRNA qRT-PCR for microarray validation 
 
To validate the results of the microarray, individual miRNAs were quantified in three 
independent miRNA samples of immature and matured oocytes using mirVana qRT-
PCR kit (Ambion, Austin, USA), which is designed to detect mature miRNA sequences 
in a two-step process according to manufacturer’s protocol. In the first, RT-primer was 
used to reverse transcribe and in the second the RT-product was used as template for 
quantification using miRNA specific PCR primers. Each qRT-PCR primer set includes 
a primer for reverse transcription and a PCR primer pair optimized for sensitive 
amplification of specific miRNAs which preferentially detects mature miRNA. Primer 
set that amplifies 5S rRNA was used as internal control to normalize miRNA content 
among different experimental samples. Three biological replicates were used for the 
qRT-PCR to quantify the expression level of the miRNAs in question.  
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The relative abundance of miRNAs was calculated using a comparative threshold cycle 
(ct) method. Where, Relative abundance =2-∆∆ct 
∆ct = average ct target miRNA – average ct of normalize∗ 
∆∆ct = ∆ct target miRNA - ∆ct of the calibrator∗∗ 
Expression level (fold change) = 2-∆∆ct 
∗ 5S was used as internal control to normalize each target microRNA expression  
∗∗ the one with the highest ∆ct value among the groups was used as a calibrator 
 
3.1.2.9.  Retrieving miRNA targets and chromosomal location 
 
The potential targets for all microRNAs discovered and annotated so far are predicted 
and found in the miRBase. We selected three microRNAs that showed consistent 
pattern of expression in microarray and qRT-PCR platform and retrieved their potential 
targets. With the aim of generating supplemental evidence for the predicted microRNA 
targets, we quantified the expression of some target genes (IGF2BP3, SMARCC1, 
MAP3K11, ADAMTSL2, MET and SNAPIN) and compared their expression with the 
targeting miRNAs. 
 
We also traced the chromosomal location of microRNAs that were found to be 
differentially regulated during bovine oocyte maturation from ENSEMBL 
(http://www.ensembl.org). As limited number of bovine microRNAs annotated in the 
miRBase, we used chromosomal location of human, mouse and rat to get an insight 
about bovine miRNA genomic location. 
 
3.1.2.10.  Total RNA isolation and cDNA synthesis for analysis of target genes 
 
A total of three pools each containing 100 oocytes both in immature and matured 
oocytes were used for total RNA isolation using miRNeasy mini kit (Qiagen, Hilden, 
Germany) as described before. The RNA was then reverse transcribed to cDNA using 
superscript II reverse transcriptase (Invitrogen). Briefly, 10 µl of total RNA from each 
sample, 1 µl of random primer and 1µl of oligo (dT) 23 were mixed and incubated at 70 
°C for 3 min and then the samples were kept on ice for 2 min. The RNA samples were 
reverse transcribed in a 20µl reaction volume containing 4 µl 5x first strand buffer, 2µl 
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DTT, 1µl dNTP, 0.3µl RNasin and 0.7 µl of RT enzyme. The cDNA was then used for 
the quantitative real time PCR to quantify the target genes (IGF2BP3, SMARCC1, 
MAP3K11, ADAMTSL2, MET and SNAPIN) using sequence specific primers. 
 
3.1.2.11.  Real-time quantitative PCR for target genes 
 
Quantification of IGF2BP3, SMARCCA1, SNAPIN, MAP3K11, ADAMTSL2, MET 
and GAPDH (endogenous control) mRNAs in each pool of cDNA samples from 
immature and matured oocytes were assessed by quantitative PCR. The ABI Prism 7000 
apparatus (Applied Biosystems, Foster City, USA) was used to perform the quantitative 
analysis using iTaqTM SYBR® Green Supermix with ROX (Bio-Rad, CA, USA). 
Quantification of all transcripts was done in comparison with GAPDH as an 
endogenous control and was run in separate wells. The primer sequences (Table 1) were 
designed for PCR amplification according to the bovine cDNA sequences using Primer 
Express software v 2.0 (Applied Biosystems, Foster City, USA). Standard curves were 
generated for all target genes and the endogenous control using serial dilution of 
plasmid DNA (101-109 molecules). All PCRs were performed in a 20 µl reaction 
volume containing 10µl iTaq SYBR® Green; optimal levels of forward and reverse 
primers and 2µl of oocyte cDNA samples. During each PCR reaction, samples from the 
same cDNA source were run in duplicate to control the reproducibility of the results. A 
universal thermal cycling parameter with initial denaturation step at 95°C for 3 min, 40 
cycles of PCR cycling at 95°C for 15 sec and 60°C for 45 sec was used to run the PCR. 
Finally, quantitative analysis was done using the relative standard curve method in 
which the ratio of the quantity of target genes to that of the endogenous control 
(GAPDH) with in the same sample was calculated and expressed as relative levels of 
mRNA expression.  
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Table 1: List of primers used for qRT-PCR quantification of target genes with 
corresponding sequences, product length and annealing temperatures. 
 
 
S.N. Primer sequences  Product 
length  
Annealing 
temperature 
1 ADMTSL2 F:CAGATCGTGGAGCGGAAGA 
ADMTSL2 R:TTGCCATTTTGATTCCACACC 
232 56 °C 
2 IGF2BP3 F:TGAGGACCAGGCAACTTTCG 
IGF2BP3 R:AAGCCAATTTCTGGCATCATG 
225 56°C 
3 MET F:TGGATTCCCACCCTGTGTCT 
MET R:GAGCATTCCTCCAATCGCAC 
213 56°C 
4 MAP3K11F:CAAAGGCAGCGATGTCTGG 
MAP3K11R:TGAAGGATGGAGGCGAAGTC 
221 56°C 
5 SMARCC1F:GGCCAAGCTAGTCTTTATGGGAA 
SMARCC1R:CGCCTGTCGTGACTGTTTCTT 
219 54°C 
6 SNAPIN F:CCACCGAACTGTGCCGTAT 
SNAPIN R:TCTCCTTCGGGCTGTTTCC 
178 55°C 
7 GAPDH F:AATGAAAGGGCCATCACCATC 
GAPDH R:GTGGTTCACGCCCATCACA 
240 57°C 
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3.2.  Part I: Results  
 
To ascertain if the amplified pool of microRNA was representative of the initial 
population, we conducted qRT-PCR analysis of five microRNAs (miR-127, mir-145, 
miR-206, mir-130b, miR-208) and 5S in amplified and non-amplified total RNA 
containing microRNAs in both immature and matured oocytes. Here, we found out that 
all the microRNAs investigated and the 5S were detected and maintained similar trend 
of expression in immature and matured oocytes when compared between non-amplified 
and amplified samples. This could subsequently testify the representativeness of the 
amplified microRNA species in immature and matured oocytes after amplification 
(Figure 3.5). 
 
Figure 3.5: Relative expression level of five microRNAs and 5S in non-amplified RNA 
from immature (IO) and matured (MO) (a) and amplified RNA from immature and 
matured oocytes analysed using qRT-PCR (IO: immature oocytes, Mo: matured 
oocytes, Non-amp: non – amplified, Amp: amplified). 
 
3.2.1.  MicroRNA detection during bovine oocyte maturation 
 
Here we used a heterologous array with microRNA capture probes that are perfectly 
matched for all human, mouse and rat miRNAs as registered and annotated in the 
miRBase release 8.0 at The Wellcome Trust Sanger Institute to analyse conserved 
miRNAs in bovine oocytes. Analysis of the data using each of the three species specific 
gal files showed the differential expression (≥1.5 fold changes) of 59 micoRNAs out of 
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the total of 454 multi-species capture probes. Among the microRNAs that showed 
altered expression during oocyte maturation, 31 microRNAs showed relative 
preferential expression in immature oocytes (Table 2) where as the remaining 28 were 
more abundant in matured ones (Table 3). The expression of seven microRNAs (miR-
496, miR-297, miR-292-3P, miR-99a, miR-410, miR-145 and miR-515-5p) in matured 
and two microRNAs (miR-512-5p and miR-214) in immature showed ≥ 2 fold higher 
abundance in relative terms. miR-496 (5.2 fold change) and miR-512-5p (2.3 fold 
change) revealed the maximum fold change up regulation in matured and immature 
oocytes respectively. 
 
Expression profiling of bovine microRNAs using human, mouse and rat probes during 
oocyte maturation led us to identify 32 microRNAs which are not so far identified and 
annotated in bovine. As most microRNAs show high degree of cross-species sequence 
conservation, miRCURYTM LNA slides were spotted with multi-species miRNA 
capture probes (human, mouse and rat) in such a way that alternative application of the 
respective gal files help to investigate the expression of all target miRNAs for the 
existing probes. For instance, probe ID 11020 stands for hsa-miR-22, mmu-miR-22 and 
rno-miR-22 as the nucleotide sequence for this microRNA remain the same in all the 
three species and hence analysis of microarray image data with GenePix® 6.0 species-
specific array list results in the detection of inherently similar number of microRNAs.  
 
After the analysis of the hybridized image data, we systematically compared the three 
(human, mouse and rat) differentially expressed miRNA data sets to screen those 
microRNAs that are not identified in bovine so far but correspond to a known miRNA 
in any of the three species having the same probe ID. This comparative approach 
enabled us to identify and deduce orthologous microRNAs that are not so far identified 
in bovine but identified and annotated in either human, mouse or rat. By then, only 117 
microRNAs have been identified and annotated for bovine in the miRBase v.10. Our 
result revealed the presence and expression of 32 bovine microRNAs not identified 
before. Among these, 18 were abundant at higher level in immature oocytes (Table 4) 
and the remaining 14 were more enriched in matured oocytes (Table 5). 
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Table 2: The list of miRNAs highly abundant in immature oocytes compared to their 
matured counterparts with their corresponding chromosomal location and fold change. 
microRNA Chromosomal location Fold change 
miR-512-5p 19q13.42 (H) 2.28 
miR-214 Chr.16 (B) 2.02 
miR-200c Chr.5 (B) 1.90 
miR-298 2H3 (M) 1.87 
miR-208 14q11.2 (H) 1.87 
miR-469 5F (M) 1.86 
miR-375 2q35(H) 1.84 
miR-541 12 F2 (M) 1.79 
miR-127 Chr.21 (B) 1.78 
miR-381 14q32.31 (M) 1.78 
miR-25 Chr.25 (B) 1.77 
miR-372 19q13.42(H) 1.76 
miR-207 4A5 (M) 1.70 
miR-124a Chr.8 (B) 1.69 
miR-545 Chr.X (B) 1.67 
miR-433-5p 12F2 (M) 1.67 
miR-468 6 D1 (M) 1.63 
miR-29b Chr.16 (B) 1.63 
miR-382 14q32.31(H) 1.62 
miR-130b 22q11.21(H) 1.61 
miR-378 5q32 (H) 1.61 
miR-125a Chr.18 (B) 1.60 
miR-192 Chr.29 (B) 1.58 
miR-138 Chr. 18(B) 1.58 
miR-519e* 19q13.42 (H) 1.56 
miR-470 XA6 (M) 1.55 
miR-98 Chr.X (B) 1.55 
miR-542-5p X q26.3 (H) 1.53 
miR-339 7p22.3 (H) 1.53 
miR-547 X A6 (M) 1.52 
miR-10a Chr. 19 (B) 1.51 
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Table 3: The list of miRNAs highly abundant in matured oocytes compared to their 
immature counterparts with their corresponding chromosomal location and fold change. 
microRNA Chromosomal location Fold change 
miR-496 14q32.31(H) 5.19 
miR-297 10 q 32.1(R) 3.35 
miR-292-3p 7A1(M) 3.16 
miR-99a Chr.1 (B) 2.37 
miR-145 Chr.7 (B) 2.16 
miR-515-5p 19 q13.42(H) 2.05 
miR-410 14q32.31(H) 2.03 
miR-206 6p12.2 (H) 1.91 
miR-423 Chr.19 (B) 1.85 
miR-188 X p11.22 (H) 1.82 
miR-22 17p13.3 (H) 1.75 
miR-34c Chr.15 (B) 1.75 
miR-181c Chr.7 (B) 1.73 
miR-467a 2 A1(M) 1.72 
miR-190 15q22.2 (H) 1.71 
miR-153 12F2(M) 1.70 
let 7d 9q22.32 (H) 1.68 
miR-122a 18q21.31(H) 1.65 
miR-182* 7q32.2 (H) 1.62 
miR-140* 8D2 (M) 1.60 
miR-365 Chr.25 (B) 1.60 
miR-128a 2q21.3(H) 1.56 
miR-380-5p Chr.21 (B) 1.54 
miR-518b 19q13.42 (H) 1.53 
miR-519e 19q13.42 (H) 1.53 
miR-484 Chr.25 (B) 1.52 
miR-128b 3p22.3 (H) 1.50 
miR-223 Xq12 (H) 1.50 
The letter in parenthesis for the chromosomal location indicate the species for which the 
map was done (H= human, M=mouse, R=rat, B= Bovine). 
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Table 4: MicroRNAs that are highly abundant in immature oocytes and not known so 
far in bovine but known orthologous microRNAs in either human, mouse or rat. 
 
Among the bovine microRNAs identified as a result of heterologous approach (not 
identified in bovine before), six microRNAs (miR-512-5p, miR-372, miR-515-5p, miR-
182*, miR-518b, miR-519e) are only known in human and another six (miR-469, miR-
470, miR433-5p, miR-468, miR-547 and miR-467a) are also known only in mouse. 
However, miR-297 was found to be differentially expressed in bovine oocytes and its 
identification and assessment of expression in bovine was possible as result of rat 
miRNA capture probe. The remaining ten microRNAs were identified in all the three 
species, four microRNAs in human and mouse and five microRNAs in mouse and rat 
(Figure 3.6). 
 
 
Probe ID Human Mouse Rat 
11145 hsa-miR-512-5p No-known-mmu-target No-known-rno-target 
11220 No-known-hsa-target mmu-miR-298 rno-miR-298 
11255 No-known-hsa-target mmu-miR-469 No-known-rno-target 
14306 hsa-miR-381 mmu-miR-381 rno-miR-381 
11208 No-known-hsa-target mmu-miR-207 rno-miR-207 
5730 hsa-miR-208 mmu-miR-208 rno-miR-208 
11088 hsa-miR-375 mmu-miR-375 No-known-rno-target 
11084 hsa-miR-372 No-known-mmu-target No-known-rno-target 
14290 No-known-hsa-target mmu-miR-541 rno-miR-541 
10936 hsa-miR-130b mmu-miR-130b rno-miR-130b 
11092 hsa-miR-378 mmu-miR-378 rno-mir-378 
11097 hsa-miR-382 mmu-miR-382 rno-miR-382 
11256 No-known-hsa-target mmu-miR-470 No-known-rno-target 
11245 No-known-hsa-target mmu-miR-433-5p No-known-rno-target 
11068 hsa-miR-339 mmu-miR-339 rno-miR-339 
11254 No-known-hsa-target mmu-miR-468 No-known-rno-target 
14291 No-known-hsa-target mmu-miR-542-5p rno-miR-542-5p 
13784 No-known-hsa-target mmu-miR-547 No-known-rno-target 
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Figure 3.6: The distribution of species specific microRNA capture probes resulted in the 
detection of oocyte microRNAs which are not identified before in bovine. 
 
Moreover, we assessed these newly detected bovine microRNAs for single nucleotide 
polymorphism (SNP) from Patrocles database (www.patrocles.org). Out of the 32 
miRNAs, only four miRNAs were observed to have single nucleotide polymorphism in 
human (miR-339 with G/A and miR-223 with -/C) and mouse (miR-206 with A/G and 
miR-468 with T/C). 
 
Table 5: Bovine microRNAs (highly abundant in matured oocytes) which have no 
known targets in bovine but with known orthologous microRNAs at least in one of the 
three species (human, mouse and rat) 
Probe ID Human Mouse  Rat 
11128 hsa-miR-496 mmu-miR-496 No-known-rno-target 
11262 No-known-hsa-target No-known-mmu-target rno-mir-297 
11215 No-known-hsa-target mmu-miR-292-3p rno-mir-292-3p 
11102 hsa-miR-410 mmu-miR-410 No-known-rno-target 
11149 hsa-miR-515-5p No-known-mmu-target No-known-rno-target 
11007 hsa-miR-206 mmu-miR-206 rno-miR-206 
10961 hsa-miR-153 mmu-miR-153 rno-miR-153 
10981 hsa-miR-188 mmu-miR-188 No-known-rno-target 
10976 hsa-miR-182* No-known-mmu-target No-known-rno-target 
11156 hsa-miR-518b No-known-mmu-target No-known-rno-target 
11164 hsa-miR-519e No-known-mmu-target No-known-rno-target 
11024 hsa-miR-223 mmu-miR-223 rno-miR-223 
11253 No-known-hsa-target mmu-miR-467a No-known-rno-target 
10984 hsa-miR-190 mmu-miR-190 rno-miR-190 
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3.2.2.  MicroRNA array validation 
 
The result from the qRT-PCR analysis revealed that miR-25, miR-125a, miR-130b, 
miR-208 miR-127 and 200c were more abundant in immature as compared to their 
matured counterparts. On the other hand, real time PCR analysis has validated the 
expression of miR-206 and miR-145 to be higher in matured as compared to the 
immature ones. Interestingly, the magnitude of expression for five microRNAs (miR-
25, miR-125a, miR-130b, miR-145 and miR-200c) in both microarray and qRT-PCR 
platforms was found to be comparable. However, miR-208 revealed a much higher 
abundance in immature relative to the matured ones (4.72 fold change) in qRT-PCR as 
compared to 1.9 fold change in microarray. Despite the detection of expression in both 
microarray and qRT-PCR platforms, we observed a discordant expression pattern for 
miR-122a, miR-382 and miR-375. Comparison of the magnitude of increased 
expression in immature oocytes (among the microRNAs profiled using qRT-PCR and 
confirmed the array result) showed that miR-208 was the most abundant, while miR-
125a was the least. We found out that miR-206 and miR-145 (among the miRNAs 
validated the array result) were more abundant in matured oocytes relative to the 
immature ones (Figure 3.7a). Furthermore, the specificity of the product was reaffirmed 
by loading the qRT-PCR product on agarose gel (Figure 3.7b). 
 
Figure 3.7: qRT-PCR quantification of eight miRNAs (miR-25, miR-125a, miR-130b, 
miR-208, miR-206, miR-127, miR-145 and miR-200c) in immature and matured 
oocytes (a).The qRT-PCR product was loaded on 3 % agarose gel with 50 bp molecular 
marker and confirmed the specificity of the product (b). 
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3.2.3.  MicroRNA expression profiling across pre-implantation embryo stages 
 
With the aim of searching for more comprehensive and wider dimension of information 
on the expression profile of some microRNAs that validated the array result, we 
investigated the expression pattern of five microRNAs (miR-125a, miR-25, miR-127, 
miR-208 and miR-145) in bovine pre-implantation developmental stages (oocyte, 2-cell, 
4-cell, 8-cell, 16-cell, morula and blastocyst). The result revealed that all the five 
microRNAs have a variable trend of expression from oocyte to blastocyst stage (Figure 
3.8a-f). miR-125a has the lowest expression level in oocyte and the maximum at 4-cell 
stage with a slight decline until blastocyst. miR-25, however, revealed opposite trend of 
expression as that of miR-125a , which showed the lowest expression level at 8-cell 
stage with decreasing trend from oocyte to 8-cell and increasing trend from 8-cell to 
blastocyst. Moreover, miR-127 and miR-145 have the maximum expression level at 8-
cell stage with relatively lower expression level in pre-and post 8-cell stages and miR-
208 revealed an increasing trend of expression through pre-implantation developmental 
stages with relatively decreased level at blastocyst. 
 
Figure 3.8: The expression profile of miR-125a (a), miR-25 (b), miR-208 (c), miR-127 
(d) and miR-145 (e) in bovine pre-implantation developmental stages analysed using 
qRT-PCR. 
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3.2.4.  MicroRNA expression profiling in BCB+ and BCB- immature and matured 
COCs 
 
As BCB staining enables us to differentiate between fully grown and growing oocytes, 
here we aimed to investigate the expression of some microRNAs during oocyte growth 
(Figure 3.9a & b). For this, we conducted qRT-PCR analysis for four microRNAs (miR-
125a, miR-127, miR-145 and miR-208) in BCB+ (fully grown oocytes with low 
G6PDH activity) and BCB-(growing oocytes with high G6PDH activity) oocytes. Our 
result in BCB+ and BCB- immature oocytes seem to indicate that the expression level 
of all microRNAs investigated was higher in BCB- immature oocyte as compared to 
their BCB+ counterparts. Similarly, we investigated the expression level of the same 
microRNAs in BCB+ and BCB- matured oocytes. Our result showed that the expression 
of miR-125a and miR-127 was higher in BCB- while the expression of miR-145 and 
miR-208 was higher in BCB+ matured oocytes. 
 
Figure 3.9: The relative expression level of miR-125a, miR-127, miR-145 and miR-208 
in BCB- and BCB+ immature (a) and matured (b) oocyte stages. 
 
As bovine oocyte maturation is strongly influenced by cumulus cells expansion and 
subsequent communication between the cumulus and the oocyte, we investigated the 
relative abundance of miR-125a, miR-127, miR-145 and miR-208 in the cumulus cells 
denuded from BCB+ and BCB- immature and matured COCs (Figure 10a & b). 
Interestingly, the result in BCB stained immature cumulus cells revealed that the 
expression levels of miR-125a, miR-127, miR-145 and miR-208 were higher in BCB- 
immature cumulus cells as compared to their BCB+ counterparts. However, in BCB 
stained matured cumulus cells only miR-127 and miR-145 showed higher relative 
expression level in BCB- matured cumulus cells as compared to the BCB+, while, a 
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similar expression level in both BCB- and BCB+ matured cumulus cells was observed 
for miR-125a and miR-208. 
Figure 3.10: The relative expression level of miR-125a, miR-127, miR-145 and miR-
208 in cumulus cells derived from BCB-and BCB+ immature (a) and matured (b) 
oocytes (ICC: cumulus cells derived from immature COC, MCC: cumulus cells derived 
from matured COC). 
 
3.2.5.  Predicted targets for some miRNAs  
 
With the aim of functional characterization, we retrieved for the mRNA targets of five 
selected miRNAs which are predicted using MIRANDA algorithm and made available 
at http//microrna.sanger.ac.uk/. Even though, there are too many potential target genes 
predicted for a particular microRNA, we selected some targets to present in this study 
based on the score and their relevance to the biological process. Given miR-25, miR-
125a, miR-130b, miR-208 and miR-206 showed consistent differential expression 
pattern between microarray and qRT-PCR, we filtered the corresponding target hits on 
the basis of their score, free energy and evolutionary conservation in the MIRANDA 
prediction as well as their potential relevance during mammalian oocyte maturation. 
Among the microRNAs that we selected to trace their targets, miR-25 and miR-125a 
were primarily identified in bovine (Coutinho et al. 2007) and target bovine mRNA 
search was possible, however, miR-130b, miR-208 and miR-206 were not previously 
identified in bovine and target bovine mRNA search using MIRANDA from the 
miRBase was not possible. Hence, their targets were retrieved from their human 
homolog.  
 
Some miR-125a target genes like Tripartite motif–containing protein 71 (Lin-41 
homolog) (TRIM71), Argonaute 2 (EIF2C2), Aminopeptidase (LOC407138), 5-
hydroxy tryptamine 6 receptor (HTR6), Potassium voltage gated channel subfamily H 
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member 6 (KCNH6), Mitotic spindle assembly check point protein MAD1 (MAD1L1), 
ADAMTS like 2 (ADAMTSL2) are known to be expressed in the process of 
mammalian oogenesis.  
 
Some of the targets for miR-130b includes hepatocyte growth factor receptor precursor 
(MET), low-density lipoprotein receptor-related protein 2 precursor (LRP2), potassium 
voltage-gated channel subfamily A member 1 (KCNA1), trinucleotide repeat-containing 
gene 6A protein (TNRC6A), proactivator polypeptide precursor (PSAP), relaxin 
receptor 2 (RXFP2), condensin complex subunit 1 (NCAPD2), growth arrest and DNA-
damage-inducible protein GADD45 alpha (GADD45A). 
 
The chromosomal locations for differentially expressed microRNAs during bovine 
oocyte maturation were presented in table 1 and 2. The search for chromosomal 
locations of these microRNAs in human mouse and rat showed the distribution miRNAs 
in most of the chromosomes. 
 
3.2.6.  Relative abundance of miRNAs and their target mRNAs 
 
Despite, nearly all microRNA targets were predicted by bioinformatics analysis, only a 
hand full of microRNA targets are experimentally validated. Moreover, it appears more 
important and complete to study microRNAs with their targets so as to investigate their 
subsequent role in diverse cellular processes. We then quantified six genes (targets for 
some selected microRNAs) with the intention to compare the expression pattern of the 
microRNA and the corresponding targets in immature and matured oocytes (Figure 
3.11).  
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Figure 3.11: The expression profile of six target genes in immature and matured oocytes 
as revealed by real time PCR. Among the six genes quantified, only SMARCC1 showed 
statistically significant (P< 0.05) expression level between immature and matured 
oocytes. 
 
We selected three microRNAs and six target genes (two targets for each microRNA) 
namely; insulin like growth factor 2 mRNA binding protein 3 (IGF2BP3) and 
SWI/SNF-related matrix – associated actin dependent regulator of chromatin subfamily 
C member 1(SMARCC1) as potential targets for miR-208, hepatocyte growth factor 
receptor precursor (MET) and SNARE-associated protein snapin (SNAPIN) as targets 
for miR-130b, mitogen activated protein kinase kinase kinase 11 (MAP3K11) and 
ADAMTS-like 2 (ADAMTSL2) as targets for miR-125a. As we utilized the data base 
of mRNA target prediction for human, alignment of the microRNAs and corresponding 
targets of bovine mRNA (3’ UTR region) confirmed that these genes harbor 
complementary sequences with their targeting miRNAs as it was observed in human 
(Figure 3.12). The result revealed that the expression pattern of the three microRNAs in 
both immature and matured oocytes is in a reciprocal manner with their corresponding 
targets. The microRNAs showed higher expression in immature as compared to matured 
where as the targets showed higher expression in matured as compared to the immature. 
PART I: RESULTS 72 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.12: The alignment of target genes and targeting microRNAs: MET 3´ UTR and 
miR-130b (a), SNAPIN 3´ UTR and miR-130b (b), IGF2BP3 3´UTR and miR-208 (c), 
SMARCC1 3´ UTR and miR-208 (d), ADAMTSL2 3´ UTR and miR-125a (e), 
MAP3K11 3´ UTR and miR-125a (f). 
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3.2.7.  miR-99a and miR-100 repress expression of bovine tribbles homologue 2 
(TRB2) 
 
3.2.7.1. TRB2 is a predicted target for miR-99a and miR-100 
 
miR-99a and miR-100 are family of miRNAs that differ in a single nucleotide and are 
predicted to target bovine tribbles homologue 2 (TRB2). miR-99a is observed to be 
differentially regulated at GV stage oocyte as compared to MII stage oocyte while miR-
100 is differentially expressed in companion cumulus cells at both immature and 
matured stages. Exceptionally, TRB2 is predicted to be targeted by only four 
microRNAs (miR-99a, miR-100, miR-487a and miR-350) (Figure 3.13). Among these 
four miRNAs miR-99a, miR-100 and miR-487a are identified in bovine, where as, miR-
350 is discovered only in Mus musculus. Experimental evidences showed that Bovine 
tribbles homologue 2 is a widely conserved gene evidenced to regulate cell cycle 
negatively. From this preliminary information, we hypothesised that miR-99a and miR-
100 might involve in the promotion of cell cycle by repressing TRB2 protein which 
interact and negatively regulate CDC25C, a phosphatase protein that dephosphorylate 
maturation promoting factor and regulate G2/M transition. 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.13: Bioinformatic prediction of miR-99a, miR-100, miR-487a and miR-350 
binding sites on the 3’UTR of Bovine tribbles homologue 2 (TRB2). 
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3.2.7.2.  miR-99a and miR-100 have markedly higher expression in cumulus cells 
 
The expression profile of miR-99a, miR-100, miR-387a and miR-350 was conducted in 
immature and matured oocytes and their corresponding cumulus cells using qRT- PCR. 
Quantification of miR-99a, miR-100 and miR-387a was performed using primers 
designed for the quantification of their human orthologues. However, quantification of 
miR-350 in bovine cumulus cells and oocyte samples using the human orthologue 
primer showed unspecific amplification and removed from the analysis. 
 
Interestingly, miR-99a and miR-100 which are family of microRNAs showed a 
markedly higher expression in cumulus cells as compared to oocytes at both immature 
and matured stages. However, miR-487a revealed a higher expression at GV stage 
oocyte as compared to the matured one (Figure 3.14). 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3.14: The expression profile of miR-99a, miR-100 and miR-487a in bovine 
oocytes and their companion cumulus cells at immature and matured stages. The 
analysis was conducted using qRT-PCR and the data was normalized with the mean 
value of three internal controls (U6, SNORD 44 and SNORD 48). (IO = Immature 
oocyte, MO = Matured oocyte, ICC = Immature cumulus cells, MCC = matured 
cumulus cells). 
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3.2.7.3.  Inverse expression pattern of TRB2 with targeting microRNAs  
 
We analysed the expression pattern of tribbles homologue 2 (TRB2) mRNA in oocytes 
and corresponding cumulus cells using qRT-PCR and semi-quantitative PCR. GAPDH 
was used as an internal control. We observed a striking inverse expression pattern 
between TRB2 mRNA expression and the expression of miR-99a and miR-100. We 
quantified the expression level of both the targeting miRNA and target genes from the 
same sample. The expression analysis of TRB2 using qRT-PCR revealed markedly 
higher expression level in oocytes as compared to their companion cumulus cells both at 
GV and MII stages and this is the exact opposite pattern with the targeting miRNAs 
(miR-99a and miR-100) (Figure 3.15a). The semi-quantitative PCR analysis has 
confirmed the fact that TRB2 mRNA is expressed in much higher level in oocytes as 
compared to the cumulus cells (Figure 3.15b). TRB2 showed markedly lower band 
intensity in cumulus cells as compared to the oocytes. Here, we are confident that the 
expression data quality is not compromised by comparing oocytes and somatic cells as 
the internal control (GAPDH) showed a stable expression with markedly variable 
expression of TRB2. Besides, the mRNA of TRB2 showed a comparable expression 
level in immature and matured oocyte where as a much higher expression in immature 
cumulus cells as compared to the matured one.  
       
 
 
 
 
 
 
 
 
Figure 3.15: The mRNA expression profile of Tribbles homologue 2 (TRB2) in bovine 
oocytes and their companion cumulus cells. The expression analysis was conducted 
using qRT-PCR (A) and semi-quantitative PCR(B). (IO = Immature oocyte, MO = 
Matured oocyte, ICC = Immature cumulus cells, MCC = matured cumulus cells)
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3.2.7.4.  miR-99a and miR-100 directly target the 3’- UTR of TRB2 
 
To confirm that miR-99a and miR-100 directly bind and repress the expression of TRB2 
transcript, we used a luciferase reporter assay system. We cloned the binding site of 
miR-99a and 100 down stream of the luciferase reporter gene into the pmirGLO vector. 
After we checked the cloning of the right sequence in the correct orientation by 
sequencing, we conducted transfection into cumulus cells in four treatment groups 
namely, cells transfected with pmirGLO vector, cells transfected with pmiRGLO vector 
construct containing miR-99a and 100 target site, cells co-transfected with construct 
vector and mimic, cells co-transfected with mismatch construct vector and mimic. 
Exogenous miR- 99a resulted in 48 % luciferase activity reduction as compared to those 
cells transfected with construct vector. Overexpression of miR-99a in the negative 
control (three nucleotide mismatches in the seed region) showed a slight reduction of 
luciferase activity but not statistically different from the positive control group (Figure 
3.16a).  
 
The direct interaction between miR-100 and TRB2 3’ UTR and subsequent effect of 
translation repression was assessed using same procedure and treatment groups as it was 
used for miR-99a (Figure 16b). Co-transfection of miR-100 mimic and pmirGLO vector 
cloned with miR-100 target site into cumulus cells revealed a pronounced luciferase 
activity reduction (73%). The precision and conclusiveness of the result has been 
supported by slight reduction of the miR-100 mimic in the negative control group. 
Moreover, miR-487a is one of the three bovine miRNAs that target bovine tribbles 
homologue 2 (TRB2) and target validation using luciferase reporter assay. The result 
from the luciferase assay experiment showed that miR-487a showed a modest luciferase 
activity reduction (29%) indicating minimal role of this miRNA in the regulation of the 
target TRB2 gene (Figure 3.16c). Hence, these data show that miR-99a and miR-100 
directly target the 3’ UTR of TRB2 mRNA. 
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Figure 3.16: Validation of miRNA-target interaction using luciferase reporter assay. 
The mean firefly / renilla ratio observed in four treatment groups (pmirGLO vector 
transfected, construct vector transfected, construct vector + mimic transfected and 
mismatch vector + mimic) showing a marked reduction in firefly/renilla ratio in miR-
99a mimic co-transfected group (A). A pronounced firefly/renilla ratio was also 
observed in miR-100 and construct vector co-transfected group (B). A modest reduction 
of luciferase activity was observed in miR-487a mimic and pmirGLO construct vector 
co-transfected group (C). Treatment groups with a star (*) indicate significant 
difference (P< 0.05) between them. 
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3.3.  Part I: Discussion  
 
3.3.1.  Identification of new miRNAs using heterologous approach 
 
The use of a heterologous microRNA microarray platform (human, mouse and rat) to 
analyse the expression profile of bovine microRNAs during invitro oocyte maturation 
enabled us to detect 400 miRNAs out of 454 probes. This reaffirms the fact that most 
microRNA sequences are conserved across related animal species (Griffiths-Jones et al. 
2006, Niwa and Slack 2007) and assures the validity of the approach we used for 
miRNA identification and expression analysis. Some miRNAs differ from each other by 
only a single nucleotide which imposes ambiguity on the accurate detection and 
expression profiling. To circumvent this problem we used locked nucleic acid (LNA)-
modified capture probes designed in such a way that it could produce uniform, high-
affinity hybridizations, yielding highly accurate signals able to discriminate between 
single nucleotide differences and, hence, between closely related miRNA family 
members (Castoldi et al. 2006). We, therefore, exploited the strong mismatch 
discriminatory feature of the LNA capture probes on one side (Castoldi et al. 2006) and 
the cross species conservation of miRNAs (Bentwich et al. 2005) on the other to asses 
the expression profile as well as identify those miRNAs differentially expressed during 
bovine oocyte maturation. The nomenclature of miRNAs also takes the cross species 
conservation features into account and orthologous miRNAs only differ in the first three 
letters indicating the same microRNA sequence but found in different species (Griffiths-
Jones et al. 2006). Hence, it appears reasonable to deduce those miRNAs differentially 
expressed in the course of oocyte maturation and not known before in bovine are 
essentially new miRNAs. 
 
3.3.2.  Expression analysis of miRNAs during oocyte maturation, fully grown and 
growing oocytes and pre-implantation embryos 
 
The results of this study showed a differential miRNA expression pattern during bovine 
oocyte maturation which is in agreement with the report by Tang et al. (2007) where 
they showed a dynamic change of miRNA during mouse oogenesis. With this regard, 
our data indicated that bovine oocyte maturation involves a wave of expression of some 
classes of miRNAs suggesting their possible role during oocyte maturation. The qRT-
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PCR for miR-200c, miR-145, miR-127, miR-25, miR-125a, miR-130b, miR-208 and 
miR-206 revealed a similar expression pattern with the microarray result for the same 
microRNAs but a bit different magnitude of expression which can be explained by 
differential sensitivity of the two techniques. 
 
The findings of the qRT-PCR analysis for five microRNAs (miR-125a, miR-25, miR-
127, miR-208 and miR-145) across pre-implantation embryo developmental stages 
(oocyte, 2-cell, 4-cell, 8-cell, 16-cell, morula and blastocyst) suggests the possible role 
of microRNAs in bovine pre-implantation embryo development. The expression profile 
of miR-125a showed an increase in 4-cell and 8-cell followed by a decline during 
morula and blastocyst. This tends to be different from the findings observed in mice 
(Byrne and Warner 2008) where, miR-125a expression increases during pre-
implantation embryo development. The progressive decrease in the expression of miR-
25 from oocyte to 8-cell and subsequent increase from 8-cell to blastocyst, that we 
observed, is in agreement with the findings of Tang et al. (2007) in which they showed 
the down regulation of total amount of microRNAs by 60% between the one cell and 
two cell stages of mouse embryonic development. The increased expression level of 
miR-127 and miR-145 at 8-cell stage with increasing pre-8-cell stages and decreasing 
post 8-cell stages during pre-implantation embryo development might indicate their 
maternal origin and their potential involvement in maternal transcript turn over and 
maternal-to-zygotic transition as it was observed for miR-430 in zebra fish (Giraldez et 
al. 2006). 
 
The differential expression of miRNAs between immature and matured oocytes may 
indicate their natural turnover or their involvement in the process of oocyte maturation. 
In order to investigate the expression of some candidate miRNAs during oocyte growth, 
we used independent model involving the use of brilliant cresyl blue (BCB). Previous 
findings demonstrated that brilliant cresyl blue (BCB) can be used for the selection of 
competent oocytes of cattle (Alm et al. 2005, Bhojwani et al. 2007, Pujol et al. 2004). 
Our data on the expression profile of four microRNAs (miR-125a, miR-127, miR-145 
and miR-208) in growing (BCB-) and fully grown (BCB+) immature oocytes and 
corresponding cumulus cells showed increased expression of all microRNAs in BCB- as 
compared to BCB+ ones. This is in accordance with their expression pattern between 
immature and matured oocytes except for miR-145. This suggests that the increased 
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expression of these microRNAs might correlate with decreased rate of mRNA and 
protein accumulation as microRNAs could degrade their target mRNA or inhibit 
translation. 
 
Stable over expression of miR-200c in A549 cells leads to reduced expression of 
transcription factor 8 and increased expression of E-cadhrin (Hurteau et al. 2007) 
indicating transcription factor 8 to be a target for miR-200c. Our result revealed the 
preferential expression of miR-200c in immature oocyte as compared to matured ones 
which is in agreement with the notion that during mouse preimplantation development, 
the components of the E-cadherin-catenin complex are derived from both maternal and 
zygotic gene activity and increasingly accumulated in a non-functional form ready to be 
used for compaction and the formation of trophectoderm cell layer (Ohsugi et al. 1996). 
Hence, increased expression of miR-200c in immature oocytes in this study may have 
led to decreased expression of transcription factor 8 and subsequent accumulation of E-
cadherin at germinal vesicle stage in non-functional form. 
 
We also observed that miR-145 showed one of the most altered expressions during 
oocyte maturation with matured stage preferential abundance. It was confirmed that 
miR-145 targets the insulin receptor substrate-1 (Shi et al. 2007) known to send 
unambiguous mitogenic, anti-apoptotic and anti-differentiation signal when activated by 
insulin like growth factor receptor (White 1998). The elevated expression level of miR-
145 in immature oocytes in our study might be to regulate the expression of insulin 
receptor substrate-1 during oocyte maturation. 
 
Recent reports show that microRNAs may be associated with fragile sites and cancer 
associated genomic regions. Huppi et al. (2008) reported the identification of miRNAs 
in genomically unstable region of human chromosome 8q24, while, Sevignani et al. 
(2007) showed significant association between the chromosomal location of 
microRNAs and those of mouse cancer susceptibility loci that influence the 
development of solid tumors. 
 
The role of miRNAs as posttranscriptional regulators is well documented (Ambros 
2004, Bagga et al. 2005, Bartel 2004). Many studies suggested that posttranscriptional 
down regulation of mRNAs by partially complementary miRNAs was entirely 
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attributed to decreased translation (Lee et al. 1993, Moss et al. 1997) but other studies 
have shown these miRNAs reduce cellular concentration of their mRNA targets (Bagga 
et al. 2005, Wu et al. 2006). This shows that microRNA expression and their 
corresponding targets abundance could be an inversely related cellular phenomenon and 
measuring the expression profile of the microRNA and the predicted target in the same 
sample could give an additional evidence for the miRNA target relation. The differential 
expression of miRNAs in immature or matured stage may fine tune their corresponding 
target genes in which their expression need to be maintained at a certain threshold level. 
 
The quantitative RT-PCR results showed a reciprocal expression pattern between the 
miRNA and the targets in bovine oocytes which is in agreement with (Tian et al. 2008) 
that showed reciprocal expression of a microRNA and a predicted target within a 
physiological context and suggested the presence and relevance of a microRNA–target 
pair. Moreover, alignment of the 3´ UTR of the target gene and the targeting microRNA 
revealed base complementarity especially between the miRNA seed region and the 
target mRNA (Figure 3.12) which may suggest the regulatory mechanism of the 
miRNA on the relative abundance of the target mRNA. Schulman et al. (2005) also 
reported reciprocal expression of lin-41 and the microRNAs let-7 and miR-125 during 
mouse embryogenesis. Despite the fact that the reciprocal expression of miRNAs and 
predicted targets imply the microRNA-target pair, we couldn’t rule out the involvement 
of other miRNAs in expression regulation of the target as multiple miRNAs could have 
binding sites on single target (Kuzin et al. 2007). 
 
Su et al. (2007) showed the selective destruction of transcripts during the maturation of 
mouse oocyte (GV to MII transition) in which transcripts involved in processes that are 
associated with meiotic arrest at the GV stage and the progression of oocyte maturation 
such as oxidative phosphorylation, energy production and protein synthesis and 
metabolism were dramatically degraded while transcripts involved in protein kinase 
pathway were the most prominent among the stable transcripts. miR-430 accelerates the 
clearance of several hundred target messenger RNAs suggesting this miRNA facilitates 
the deadenylation and clearance of maternal mRNAs during early zebra fish 
embryogenesis (Giraldez et al. 2006). Hence, it is plausible to suggest the up regulation 
of some miRNAs in matured oocytes might correlate with the maternal transcript 
turnover to effect the maternal-zygotic transition as it was observed in other species. 
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3.3.3.  Potential role of miR-99a and miR-100 in bovine cumulus cells proliferation 
 
With the intention of shift from expression profiling to investigation of specific 
microRNA functions in cumulus oocyte complex, we selected miR-99a and miR-100 
that belong to miR-99 family. The bioinformatic prediction of target genes for these 
microRNAs revealed that a range of genes with extremely diverse role could be affected 
by miR-99 family. Of special interest, bta-miR-99a and bta-miR-100 target tribbles 
homolog 2 (TRB2) and only bta-miR-487a was also shown to co-target TRB2. Hence, 
our data on these three miRNAs (bta-miR-99a, bta-miR-100 and bta-miR-487a) and 
TRB2 3’ UTR interaction is more informative since the confounding effect as a result of 
too many microRNA targeting a single transcript is avoided. 
 
An obvious hurdle to the understanding of microRNA function is identifying the target 
genes they regulate. Experiments indicate that animal miRNAs generally display only 
limited pairing to their targets and seven contiguous base pairs between the target 3’ 
UTR and miRNA ‘seed’ region is supposed to be suffice for regulation (Brennecke et 
al. 2005, Doench and Sharp 2004, Lai et al. 2005). The contiguous base pairs between 
the TRB2 UTR and the 5’ end of miR-99a and miR-100, substantial base pairing at the 
3’ end and conservation across multiple species (Lewis et al. 2005, Xie et al. 2005) 
suggest the regulatory importance of these microRNAs. 
 
TRB2 and targeting microRNAs (bta-miR-99a and bta-miR-100) showed a striking 
spatial shift in expression in germ cell (oocyte) and companion cumulus cells in exact 
reciprocal manner. This consolidates the rationale that animal microRNA could reduce 
the expression of their target mRNA when they appear in the same cells or tissue (Lim 
et al. 2005). It seems also apparent that the higher expression of miR-99a and miR-100 
in oocyte tend to keep lower expression of TRB2 and this might help the oocyte to 
trigger the G2/M transition and subsequently mature. On the contrary, markedly higher 
expression of miR-99a and miR-100 and the lower expression of TRB2 in cumulus cells 
support the idea that cumulus cell proliferation is promoted (Mata et al. 2000, Seher and 
Leptin 2000) during oocyte maturation. This might be attained by deregulating the cell 
cycle negative regulator TRB2 protein through miR-99a and miR-100 mediated 
posttranscriptional regulatory process. 
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Next, we wanted to confirm if bovine tribbles homologue 2 (TRB2) is a physiological 
target for miR-99a, miR-100 and miR-487a and subsequently used the luciferase assay 
technique. As miRNAs constitute a prominent class of regulatory genes in animals, 
posttranscriptional regulatory mechanisms that are mediated by these small RNAs are 
ubiquitous (Lagos-Quintana et al. 2001, Lewis et al. 2005). For this purpose, we co-
transfected invitro cultured cumulus cells with target site cloned pmiRGLO vector and 
microRNA mimic. microRNA mimic is small, chemically modified double-stranded 
RNA molecule that mimic endogenous mature miRNA molecule which is incorporated 
into RNA-induced silencing complex up on transfection into the cells. The introduction 
of miR-99a and miR-100 into cumulus cells resulted in 48% and 73% luciferase 
reporter protein reduction, respectively, suggesting that these miRNAs are potent 
regulators of TRB2. The mild repressive ability observed for miR-487a confirms the 
fact that miRNA vary in the extent of their target genes regulation which is attributed to 
the variation of the molecular architecher in the 3’ UTR (Brennecke et al. 2005).   
 
Taken together, this data suggests that miR-99a and miR-100 may promote bovine 
cumulus cells proliferation by down regulating the negative regulator of cell cycle, 
bovine tribbles homologue 2 (TRB2). 
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4.  Part II: MicroRNA regulated noble molecular signature underlying bovine 
subclinical endometritis  
 
In vivo and in vitro animal model studies have shown the need for regulation of specific 
uterine genes both at transcriptional and translational levels (Achache and Revel 2006, 
Horcajadas et al. 2007, Makker and Singh 2006). MicroRNAs (~ 22nt length) have 
emerged as key regulators of posttranscriptional gene expression by interacting with the 
3’ UTR of target mRNAs and subsequently influencing the translation or stability of 
transcripts. Animal miRNAs are known to regulate diverse biological functions and 
evidenced to have central roles in the development of some diseases and biological 
disorders where their aberrant expression has been associated with establishment and 
progression of various disorders in mammalian uterine (Pan and Chegini 2008). 
 
In cattle, a significantly higher expression of L-PGDS, IL-1α and IL-1-RN has been 
reported in the endometrium of cows with subclinical or clinical endometritis compared 
with healthy. Besides, a two fold lower cPGES mRNA expression was observed in 
subclinical endometritis as compared to the healthy ones (Gabler et al. 2009). 
Differential expression of 48 miRNAs in the human endometrium has been reported 
suggesting the importance of endometrial microenvironment on the regulation of 
microRNAs (Pan et al. 2007). Furthermore, miR-21 was confirmed to target Reck gene 
suggesting its key role during embryo implantation (Hu et al. 2008). Qian et al. (2009) 
showed the involvement of hsa-miR-222 in differentiation of endometrial stromal cells 
in to decidual cells invitro. Abnormalities of decidualization in human result in many 
pregnancy disorders such as recurrent miscarriages and infertility (Gellersen and 
Brosens 2003). 
 
Despite the fact that experiments evidenced the negative impact of subclinical 
endometritis on dairy cattle fertility (LeBlanc et al. 2002; Gilbert et al. 2005), our 
knowledge regarding molecular mechanism underlying bovine subclinical endometritis 
was significantly limited. Therefore in this experiment, we aimed to investigate the 
underlying molecular mechanism potentially affected by subclinical endometritis from 
microRNA perspectives. Thus, we hypothesized that aberrant expression of miRNAs 
and dysregulation of their respective molecular networks and pathways could be 
triggered by subclinical endometritis. Hence, we identified aberrantly expressed 
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miRNAs in uterine cytobrush samples taken from cows with subclinical endometritis as 
compared to the healthy ones. Then after, we screened high ranking target genes for the 
23 miRNAs from miRBase and used Ingenuity Pathway Analysis (IPA) to figure out the 
molecular networks, biological functions and canonical pathways that these miRNAs 
potentially regulate. Further more, to substantiate the miRNA target gene interaction 
beyond bioinformatic prediction, we validated some miRNAs and key target genes that 
control top networks using luciferase assay technique. 
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4. 1.  Part II: Materials and methods  
 
4.1.1.  Materials 
 
4.1.1.1.  Laboratory equipments used during the study 
 
Equipment Manufacturer 
Laminar flow chamber  Heraeus, Geramny 
UV Transilluminator (Uvi-tec) Uni Equip, Martinsried, Germany 
ABI PRISM® 7000 SDS  Applied Bio systems 
Millipore apparatus Millipore  Corporation, USA 
Carbon dioxide incubator (MCO-17AI) Sanyo, Japan 
Inverted fluorescence microscope DM IRB Leica, Germany 
Stereomicroscope SMZ 645 Nikon, Japan 
Centrifuge Hermel, Wehing 
Electrophoresis chamber BoRad, Munich 
My Cycler Thermal cycler  Bio-RadLaboratories, CA, USA 
SHKE6000-8CE refrigerated Stackable 
Shaker 
Thermoscinentific, IWA, USA 
CEQTM 8000 Genetic Analysis BeckmanCoulter,Krefeld, Germany 
Ultra low freezer (-80 °C) Labotect GmbH, Göttingen, Germany 
Centrifuges (small, medium, large) Heraeus, Hanau, Germany 
MAXQ6000 shacking incubator  Thermo scientific, Germany 
Carbon dioxide incubator (MCO-17AI) Sanyo, Japan 
Nanodrop 8000 Spectrophotometer  Thermo Fisher Scientific, DE, USA 
Axon GenePix 4000B scanner Axon Instruments, Foster City, CA 
Rigid thin wall 96 X 0.2 ml skirted  
microplates for real-time PCR 
STARLAB GmbH (Ahrensburg) 
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4.1.1.2.  List of chemicals, competent cells and kits 
 
Chemicals and competent cells Manufacturer/Supplier 
pmirGLO Dual-Luciferase miRNA target 
expression vector 
Promega, Madison, Wisconsin, USA 
Attractene transfection reagent QIAGEN Gmbh, Hilden, Germany 
Restriction endonuclease New England Biolabs, Inc., U.S.A 
Hemacolor staining set Merck, Darmstadt, Germany 
DNase I Qiagen, Hilden, Germany 
Cytobrush Medscand Inc., Malmö, Sweden 
10x PCR buffer Promega, WI, USA 
2x rapid ligation buffer Promega, WI, USA 
2-Mercaptoethanol Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
E. coli competent cells Stratagene, Amsterdam, The 
Netherlands 
5x First-Stand buffer Invitrogen Life Technologies, 
Karlsruhe 
Acetic acid Roth, Karlsruhe, Germany 
Agar-Agar Roth, Karlsruhe, Germany 
Agarose Sigma-Aldrich Chemie GmbH, Munich 
Ampicillin Roth , Karlsruhe 
BME (essential amino acids) Gibco BRL, life technologies, 
Karlsruhe 
Boric acid Roth , Karlsruhe, Germany 
Bovine serum ablbumin (BSA) Promega, Mannheim, Germany 
Calcium chloride 
Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
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Chloroform Roth , Karlsruhe, Germany 
Dimethyl sulfoxide (DMSO) Roth , Karlsruhe, Germany 
dNTPs Roth , Karlsruhe, Germany 
DTT 
Invitrogen Life Technologies, 
Karlsruhe, Germany 
Dye terminator cycle sequencing (DTCS) Beckman Coulter, Krefeld, Germany 
Ethanol Roth, Karlsruhe, Germany 
Ethidium bromide Roth, Karlsruhe, Germany 
ExoSAP-IT USB, Ohio, USA 
Ethylenediaminetetra acetic acid  Roth , Karlsruhe, Germany 
Formaldehyde 
Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
QuantiTect SYBR Green PCR Buffer QIAGEN, Austin, USA 
Glycogen for sequencing Beckman Coulter, Krefeld, Germany 
Hemi-calcium lactate Promega, WI, USA 
Hydrochloric acid Roth, Karlsruhe 
Hepes Sigma-Aldrich Chemie GmbH, Munich 
Hydroxylamine Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
dNTP mix, including dUTP QIAGEN, Austin, USA 
SYBR Green I QIAGEN, Austin, USA 
Igepal Roth, Karlsruhe, Germany 
ROX  QIAGEN, Austin, USA 
L-Glutamine Sigma-Aldrich, Germany 
Magnesium chloride Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
MEM (non essential amino acids) Gico BRL, life technologies, Karlsruhe 
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Mineral oil 
Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Oligonucleotide primers MWG Biotech, Eberberg, Germany 
Pepton Roth , Karlsruhe, Germany 
Penicillin Sigma-Aldrich Chemie GmbH, 
Taufkirchen 
5x miRNA RT Buffer SABiosciences, Frederick, MD, USA 
Phenol red solution (5% in D-PBS) Sigma-Aldrich Chemie GmbH , 
Munich 
Potassium chloride 
Sigma-Aldrich Chemie GmbH, 
Munich, Germany 
Random primer Promega, WI, USA 
2x RT2 SYBR Green PCR master mix SABiosciences, Frederick, MD, USA 
RNA later Sigma-Aldrich, MI, USA 
RQ1 RNase-free DNase Promega, WI, USA 
RNasin Promega, WI, USA 
Sample loading solution (SLS) Beckman Coulter, Krefeld, Germany 
Sequagel XR Sequencing Gel Beckman Coulter, Krefeld, Germany 
Sodium acetate Roth , Karlsruhe, Germany 
Sodium chloride Roth , Karlsruhe, Germany 
Sodium dodecyl sulfate (SDS) Sigma-Aldrich Inc, MO, USA 
Sodium hydrogen sulphate Sigma-Aldrich Inc, MO, USA 
Sodium lactate solution (60%) Sigma-Aldrich Inc, MO, USA 
Sodium pyruvate Sigma-Aldrich Inc, MO, USA 
Streptomycin sulphate Sigma-Aldrich Inc, MO, USA 
Superscript II reverse transcriptase Invitrogen, CA, USA 
miRNA RT Primer & ERC Mix SABiosciences, Frederick, MD, USA 
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T4 DNA ligase Promega, WI, USA 
Taq DNA polymerase Sigma-Aldrich Inc, MO, USA 
Tris Roth ,Karlsruhe, Germany 
Triton X-100 Roche Diagnostics GmbH, Mannheim, 
Germany 
Yeast extract Roth, Karlsruhe, Germany 
QIAzol lysis reagent Qiagen, Hilden, Germany 
Buffer RWT Qiagen, Hilden, Germany 
Buffer RPE Qiagen, Hilden, Germany 
miRNeasy mini kit Qiagen, Hiden, Germany 
RT2 miRNA first Strand kit  SABiosciences, Frederick, MD, USA 
Genome wide RT2 miRNA PCR array kit SABiosciences, Frederick, MD, USA 
miScript SYBR Green PCR Kit  QIAGEN, Austin, USA 
miScript Reverse Transcription Kit  QIAGEN, Austin, USA 
GenEluteTM Plasmid Miniprep Kit 
Sigma–Aldrich Chemie GmbH, 
Munich, Germany 
Dual – Luciferase Reporter Assay kit  Promega, WI, USA 
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4.1.1.3.  Media and solutions 
 
LB-agar Sodium chloride 8.0 g 
 Peptone 8.0 g 
 Yeast extract 4.0 g 
 Agar-Agar 12.0 g 
 Sodium hydroxide (40 mg/ml) 480.0 µl 
 ddH2O added to 800.0 ml 
LB-broth Sodium chloride 8.0 g 
 Peptone 8.0 g 
 Yeast extract 4.0 g 
 Sodium hydroxide (40 mg/ml) 480.0 µl  
 ddH2O added to 800.0 ml 
Dulbecco’s Modified Eagle 
Medium (D-MEM) 
DMEM 1x 425 ml 
 Sodium pyruvate  5 ml 
 MEM 5 ml 
 L-glutamine 5 ml 
 Penicillin- Streptomycin 5 ml 
 Amphotericin 5 ml 
 Merkaptoethanol 5 µl 
BSA (3%) Bovine serum albumin 0.15 g 
 added to PBS+PVA 5 ml 
DEPC-treated water (1000 ml) DEPC 1 ml 
 added to water  1000 ml 
Lysis buffer (100 µl) Igepal (0.8%) 0.8 µl 
 RNasin 5 µl 
 DTT 5 µl 
 added to water 100 µl 
TAE (50x) buffer, pH 8.0 Tris  242.0 mg0  
 Acetic acid   57.1 ml  
 EDTA (0.5 M) 100.0 ml00 
 ddH2O added to 1000.0 ml 
TE (1x) buffer Tris (1 M) 10.0 ml 
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 EDTA (0.5 M) 2.0 ml 
X-gal ddH2O added to 1000.0 ml 
 X-gal 50.0 mg 
(16%) Para formaldehyde (10 ml) N, N’-dimethylformamide 1.0 ml 
 Para formaldehyde  1.6 g 
 added to water  10 ml 
PBS + PVA (50 ml) Polyvinyl alcohol (PVA) 
PBS added to 
300 mg 
50 ml 
Permeabilizing solution (10 ml) Triton X-100 5 µl 
 Glycine + PBS added  10 ml 
Physiological saline solution  Sodium chloride 9 g 
 added to water 1000 ml 
Agarose loading buffer Bromophenol blue 0.0625 g 
 Xylencyanol 0.0625 g 
 Glycerol 7.5 ml 
 ddH2O added to 25 ml 
dNTP solution dATP (100 mM) 10.0 µl 
 dCTP (100 mM) 10.0 µl 
 dGTP (100 mM) 10.0 µl 
 dTTP (100 mM) 10.0 µl 
 ddH2O added to 400.0 µl 
IPTG solution IPTG 1.2 g 
 ddH2O added to 10.0 µl 
3M Sodium Acetate, pH 5.2 Sodium Acetate  123.1 g 
 ddH2O added to 500 ml 
1M EDTA, pH 8.0 EDTA 37.3 g 
 ddH2O added to 1000 ml 
Phenol Chloroform  Phenol : Chloroform 1 : 1 (v/v) 
0.2% Triton-X100: Triton 2 ml 
 10x PBS : added to 1,000.0ml 
0.3% BSA in PBS BSA 3 g 
 10x PBS : added to 1,000.0 ml 
3% BSA in PBS BSA 30g 
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 10x PBS : added to 1,000.0 ml 
 
4.1.1.4.  Data bases and softwares used during the study 
 
Soft wares and data bases Source of soft wares and data bases 
miRBase v.14 http//microrna.sanger.ac.uk/ 
Entrez Gene http://www.ncbi.nlm.nih.gov/sites/entrez?db=gene 
EndNote X1 Thomoson 
Primer Express ® 
software 
Applied Biosystems, Foster city, CA, USA 
BLAST program http://blast.ncbi.nlm.nih.gov/Blast.cgi 
Prism for windows 
(ver.5.0) Graph Pad software, Inc. 
NCBI http://www.ncbi.nlm.nih.gov 
Weight to molar quantity 
converter 
http://www.molbiol.ru/eng/scripts/01_07.html 
miTarget http://cbit.snu.ac.kr/~miTarget/ 
Manupulate and display  
DNA sequence 
http://www.vivo.colostate.edu/molkit/manip/ 
Alibee - multiple 
alignment 
http://www.genebee.msu.su/services/malign_reduced.html 
ENSEMBL  http://www.ensembl.org). 
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4.1.2.  Methods 
 
4.1.2.1.  Endometrial cytobrush samples collection and cytology 
 
For the investigation of the miRNA expression in the endometrium of cows with 
subclinical endometritis and healthy, endometrial cytobrush samples were collected 
from lactating cows using the cytobrush technique at day 7 of estrous cycle. Cytobrush 
samples were collected from cows at the second parity and 60-80 days postpartum. 
Briefly, a brush (Gynobrush, Heinz Herenz, Hamburg, and Germany) with 20 mm 
length and 6 mm diameter, screwed on a 70-cm long rod, protected by a metallic 
catheter was inserted via the cervix into the uterine body. Cells were collected by 
rotating the cytobrush in a clockwise direction while in contact with the uterine wall. 
Here, two cytobrush samples were collected from each animal: for cytological analysis 
and miRNA expression study. Cytological analysis was done by rolling the cell-
containing cytobrush on a clean glass microscope slide. The slides were immediately 
fixed on farm and stained (LT-SYS®, Labor und Technik, Berlin, Germany) in the 
laboratory. A total of 300 cells were counted under a microscope (× 400 magnifications) 
to determine the proportion of PMN. On the basis of PMN proportion in the endometrial 
samples, cows were categorized in to two groups. Healthy group included 0 % PMN 
where as cows with subclinical endometritis included ≥ 5% PMN count as described by 
Gilbert et al.(2005). The other cytobrush sample for each cow was immediately 
transferred into reaction tubes filled with 500 µl RNA later (Sigma, Deisenhofen, 
Germany) and transported to the laboratory. Finally, samples were stored at -20 °C until 
miRNA extraction.  
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4.1.2.2.  Total RNA isolation 
 
Total RNA containing microRNAs was isolated from uterine cytobrush samples from 
healthy (n = 6) and cows with sub-clinical (n = 6) using miRNeasy mini kit (Qiagen, 
Hilden, Germany) following manufacturer’s protocol. Briefly, cytobrush samples were 
thawed at room temperature and the RNA later was removed from the cells. Then after, 
cells were lysed by adding 700 µl QIAzol lysis reagent. After adding 140 µl chloroform 
samples were thoroughly mixed and centrifuged for 15 min at 12000xg at 4°C. The 
upper aqueous phase was collected to a new collection tube and 525 µl ethanol was 
added. Total RNA containing microRNA was bound on column by centrifuging at ≥ 
8000xg for 15 sec. at room temperature. On-column DNA digestion was subsequently 
done using DNAse I (Qiagen, Hilden, Germany) to remove any DNA contamination. 
After subsequent washing with washing buffers, total RNA was eluted with 30 µl 
elution buffer. 
 
4.1.2.3.  First strand cDNA synthesis and quantitative PCR (qPCR) assay 
 
From the total RNA, fractionation of small RNAs and large RNA was done using RT2 
qPCR-Grade miRNA isolation kit (SABiosciences, Frederick, MD). In all RNA 
samples, the fractionated small miRNAs and large RNAs were checked for their 
concentration and integrity (based on 260/280 nm measurement) using Nanodrop 8000 
instrument (peqLab Biotechnologies GmbH, Erlangen, Germany). Equal amount of 
RNAs from both healthy (PMN = 0) and cows with subclinical endometritis (PMN ≥ 5) 
groups were used for first strand cDNA synthesis using RT2 miRNA first Strand kit 
(SABiosciences, Frederick, MD) following manufacturer’s protocol. Briefly, 50 ng of 
small RNA was incubated with a mix containing 2 µl of 5x miRNA RT buffer, 1 µl 
miRNA RT primer, 1 µl DTT (100 mM) and miRNA enzyme mix in a 10 µl reaction 
volume. Reaction incubation was done at 37 °C for 2 hrs followed by heating at 95 °C 
for 5 min to inactivate the reverse transcriptase. The resulting cDNA samples were 
diluted before use as template for miRNA qPCR assay. 
 
Expression profiling of miRNAs in endometrial cytobrush samples from healthy and 
subclinical dairy cows was conducted using 96-well Genome wide RT2 miRNA PCR 
array (SABioscience, Frederic, MD) following manufacturers protocol. The 96-well 
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whole Genome RT2 miRNA qPCR array is designed to quantify a total of 352 well 
characterized human microRNAs in four different sets of 96-well plates each containing 
88 miRNAs, four housekeeping small RNAs (SNORD44, SNORD47, SNORD48 and 
U6) and RT negative controls. Prior to real time PCR profiling, 90 µl DNase/RNase-
free water was added to each of the 10 µl first strand cDNA product from each 
biological replicates of endometrial cytobrush samples from healthy and sub-clinical 
dairy cows. A PCR master mix was prepared using the 100 µl diluted cDNA template, 
1275 µl 2x RT2 SYBR Green PCR master mix and 1175 µl DNase/RNase-free water. 
Twenty four micro liter of this mix was distributed to each well of the 96-well plate 
containing sequence specific miRNA primer sets and the respective controls. Following 
brief centrifugation, the plate was loaded onto ABI prism 7000 real time PCR apparatus 
and run with a thermal program of initial heating at 95 °C for 10 min followed by 40 
cycles of 95 °C for 15 sec and 60 °C for 1 min. The specificity of amplification was 
controlled using a melting curve generated at the end of the PCR protocol. 
 
The expression of microRNAs in clinical and healthy cytobrush samples was then 
analysed using ∆∆CT method from the PCR array data analysis web portal 
(http//www.sabiosciences.com/pcrarraydataanalysis.php). A 96-well template was used 
for each four set separately and the final result has been combined. 
 
Prior to miRNA and their corresponding target interaction validation, we ascertained the 
expression of those target genes (MAPK14, NOS2, JUN, IKBKB, INSR, SP1, ID3) in 
bovine endometrium samples collected across estrous cycle using semi quantitative RT-
PCR. Glyceraldehyde 3- phosphate dehydrogenase (GAPDH) was quantified from the 
same sample and used as a reference gene (Table 6). 
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4.1.2.4.  Ingenuity path way analysis (IPA) 
 
With the aim of tracing the molecular networks and biological functions that the 
aberrantly expressed microRNAs involve, we filtered the miRBase microcosm 
predicted target genes according to their score, free energy and evolutionary 
conservation. The high ranking target genes with known gene identifiers (Known 
symbols) were uploaded into the web-based pathways analysis tool IPA (Ingenuity 
Systems, www. Ingenuity.com) to identify molecular networks and biological functions 
underlying bovine endometritis as described previously (Li and Capuco 2008). This 
web-based entry tools allows for the mapping of gene expression data into relevant 
pathways based on their functional annotation and known molecular interactions. The 
knowledge coming from published, peer reviewed scientific publications is stored in the 
Ingenuity Pathway Knowledge Base (IPKB), and is continuously updated. A molecular 
network of direct or indirect physical, transcriptional and enzymatic interactions 
between mammalian orthologs was computed from the knowledge base. High ranking 
target genes for the differentially regulated microRNAs were imported and the system 
compares the list of genes with IPKB and produce relevant networks, biological 
functions and canonical pathways as out put. 
 
Each gene identifier was mapped to its corresponding gene object in the Ingenuity Path 
Way Knowledge Base. Networks of focus genes were then algorithmically generated 
based on their connectivity and assign a score. The score is a numerical value used to 
rank networks according to how relevant they are to the genes in the input data set and it 
takes into account the number of focus genes in the network and the size of the network 
to approximate the relevance of the network to the original list of focus genes. 
 
A functional analysis of a network then identified the biological functions and/or 
diseases that were most significant to the genes in the network. Canonical pathways 
were identified from the IPA library of canonical pathways based on two parameters: 
(1) a ratio of the number of genes from the data set that map to the pathway divided by 
the total number of genes that map the canonical path way and (2) a P value calculated 
using Fisher’s exact test determining the probability that the association between the 
genes in the data set and the canonical pathway is due to chance alone. 
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Table 6: List of primers with their sequences and annealing temperature that were used 
for semi-quantitative PCR analysis of target genes. 
Gene name Sequence Annealing 
temperature (°C) 
MAPK14 F-GTGGTACAGGGCTCCTGAGATC 
R- TGGCTTGGCATCCTGTTAATG 
TD: 60-56 
NOS2 F-CAACAACGGCAACATCAGGTC 
R- CTAGAGGCAACACGTCGAAGC 
TD: 58-56 
JUN F-AGAGGAAGCGCATGAGGAAC 
R-CTGCGTTAGCATGAGTTGGC 
63 
IKBKB F- AGTGCGAGTGATTTATACGCAGC 
R-GTTCATACTGTCCGGGCTTCC 
57 
INSR F-GCCTGCGTCACTTTACTGGC 
R-CAATCAGACCGTTGGGTTCC 
TD: 57-55 
SP1 F-ACACCTACGGGCACACTTGC 
R-TTATTCTGGTGGGTCTTGATAATGC 
TD: 57-55 
ID3 F-TGACTTCCCCAAACCCCTG 
R- ACCCCGTACACCTCCACACA 
TD: 56-54 
TD = touchdown PCR 
 
4.1.2.5.  Plasmid construction and transient transfection 
 
After identifying the aberrantly expressed miRNAs, we used their respective 
bioinformatically predicted high ranking targets for the IPA analysis. Bioinformatic 
prediction of target mRNA and miRNA interactions is not by itself a solid evidence 
unless confirmed by further laboratory experiments. As central genes in the network 
(from the IPA analysis) are key genes that control the entire network and subsequent 
biological functions, we decided to experimentally verify whether the central genes in 
the top networks (IKBKB, JUN, ID3, Sp1, INSR, NOS2 and MAPK14) are in vivo 
targets of miRNAs (miR-423-3p, miR-196b, miR-24-3p, miR-27a-3p, miR-503). To 
attain this, we amplified miRNA binding site(s) from the 3’UTR of the central genes 
from genomic DNA by PCR using sequence specific primers indicated in Table 7. The 
amplified PCR products were then cloned into pmirGLO Dual-Luciferase miRNA 
target expression vector (Promega, Madison, Wisconsin, USA) digested by NheI and 
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SalI restriction enzymes. Cloning of the right sequence was confirmed by sequencing 
from the construct plasmid vector. As negative controls, we used synthesized oligos that 
harbor the miRNA target recognition site with three nucleotide mismatches at the seed 
region (Table 8). Furthermore, the negative controls were designed in such a way that 
when annealed and ligated into the pmirGLO vector result in the miRNA target region 
in the correct 5´ to 3´ orientation. The overhangs created at the ends of the annealed 
oligonucleotides were made complementary to those generated by restriction enzyme 
digestion of the pmirGLO Vector. 
 
Table 7: List of primers used to amplify binding sites of miRNAs in the 3’ UTR of 
target genes. 
Gene name Primer sequence Annealing 
temperature (°C) 
MAPK14 F -CTAGTGTGGGAGGGTAAAACATGATG 
R- TCGACGTCTACTCCGGATTCACACG 
60 
NOS2 F - CTAGGGAACTTAATGATGGCACCCA 
R - TCGAGAGTGGCGTGACAGCGC 
TD: 62-59 
JUN F- CTAGCAAGTTGCGAGAGGGAAACAG 
R -TCGAATCCTTTCTGGAATTTTCAGAAACA 
TD: 61-57 
IKBKB F- CTAGACCCCTCCTGCTCTCCAAAG 
R- TCGACCGTGCTGTCCTTCTGTTACAC 
62 
INSR F - CTAGGTGGCCTTTTGCTTGGTCTTC 
R - TCGACCTTAGCGGTTTCTCCTCTGG 
61 
SP1 F - CTAGGCTGGGAGGAGGAAGGAGAC 
R-  TCGATGGAGATGTTCAAAAGAGGAAGTG 
TD: 64-60 
ID3 F - CTAGCCTCCAGAACGCAGGTGC 
R - TCGACATCGCATGGTTACAGAAAGTCAC 
61 
TD = touchdown PCR 
 
Bovine cumulus cells were co-transfected with miRNA target sites cloned pmirGLO 
vector and miRNA mimic using attractene transfection reagent (QIAGEN Gmbh, 
Hilden, Germany) in a 24 well plate in four treatment groups (pmirGLO vector, 
pmirGLO – 3’UTR reporter vector, pmirGLO – 3’UTR reporter vector + mimic, 
pmirGLO – mismatch reporter vector) according to manufacturer’s protocol. Briefly, 
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0.4 µg of pmirGLO vector and mimic was diluted in a medium with out serum and 
proteins, to a total volume of 60 µl. After adding 1.5 µl of attractane transfection 
reagent and short centrifugation, the solution was kept at room temperature for 10-15 
minutes to allow transfection complex formation. In the mean time, cells from the 
monolayer were harvested by trysinization and suspended in culture medium containing 
serum and antibiotics. Then after, cells were seeded in a 24-well plate at the density of 
0.4 - 1.6 x105 in 500 µl medium. Next, transfection complexes in the respective 
treatment groups were added to each well and the cells with transfection complexes 
were incubated at 37 °C with 5 % CO2 for 48 hours. Cell extracts were prepared 48 
hours after transfection and the luciferase activity of firefly and Renilla was measured 
with the Dual-Luciferase Reporter Assay System (Promega). 
  
Table 8: Oligo nucleotide sequences with three nucleotide mismatches in the miRNA 
target site. The sense and anti sense nucleotide sequences were company synthesized 
and annealed to have a double strand DNA fragment and subsequently cloned into a 
pmirGLO vector to be used as a negative control. 
 
miRNA target 
mismatch 
Nucleotide sequence 
miR-423-3p Sense 5’-CTAGCTAGCGGCCGC TAGTACTGAGGGGCCTCAGAGGCGCTG-3’  
Antisense 5’-TCGACAGCGCCTCTGAGGCCCCTCAGTACTAGCGGCCGCTAG-3’ 
miR-196b Sense 5´-CTAGCTAGCGGCCGCTAGTCCCAACAACAGGAAACTTGGAG-3’ 
Antisense 5’- TCGACTCCAAGTTTCCTGTTGTTGGGACTAGCGGCCGCTAG-3’ 
miR-24 Sense 5’ – CTAGCTAGCGGCCGCTAGTCTGTTCCTGCTGAACTGCGGAG-3’ 
Antisense 5’ – TCGACTCCGCAGTTCAGCAGGAACAGACTAGCGGCCGCTAG-3’ 
miR-503 Sense 5’- CTAGCTAGCGGCCGCTAGTCTGCAGAACTGTTCCCGGTCGAG-3’ 
Antisense 5’- TCGACTCGACCGGGAACAGTTCTGCAGACTAGCGGCCGCTAG-3’ 
miR-27a Sense 5’- CTAGCTAGCGGCCGCTAGTGCGGAACTTAGCCAGTCTCAG-3’ 
Antisense 5’- TCGACTGAGACTGGCTAAGTTCCGCACTAGCGGCCGCTAG-3’ 
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4.1.2.6.  Quantification of selected miRNAs during estrous cycle 
 
Total RNA containing small RNAs was purified from endometrial epithelium samples 
collected at different time points of estrus cycle (day 0, day 3, day 7, day 14) and three 
pregnant cows. Samples were collected after slaughtering the cows and the three 
pregnant cows were at day 50 pregnancy. cDNA synthesis from equal amount (690 ng) 
of total RNA containing small RNAs was performed using miScript Reverse 
Transcription Kit (QIAGEN, Austin, USA) according to manufacturer’s protocol. 
Following cDNA synthesis, quantitative real time PCR analysis in three biological 
replicates for six selected miRNAs was conducted using miScript SYBR Green PCR 
Kit (QIAGEN, Austin, USA) following manufacturer’s procedure.  
 
The relative abundance of miRNAs at different time points of estrous cycle and 
pregnancy group was calculated using a comparative threshold cycle (ct) method. The 
data was normalized by geometric mean of multiple endogenous controls. 
Where, Relative abundance =2-∆∆ct 
∆ct = average ct target miRNA – average ct of endogenous controls∗ 
∆∆ct = ∆ct target miRNA - ∆ct of the calibrator∗∗ 
Expression level (fold change) = 2-∆∆ct 
∗ geometric mean of endogenous controls (U6, SNORD44 and SNORD 48) was used to 
normalize each target microRNA expression at different time points of estrous. 
∗∗ the one with the highest ∆ct value among the groups was used as a calibrator 
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4.3.  Part II: Results  
 
4.3.1.  Altered expression of microRNAs in cows with subclinical endometritis 
 
Out of a total of 352 microRNAs in which their expression was assessed, we found 23 
microRNAs to be differentially expressed in cytobrush samples taken from cows with 
subclinical endometritis as compared to their healthy counterparts. Among the 
differentially expressed microRNAs 15 were upregulated and 8 were downregulated in 
cows with subclinical endometrititis. miR-423-3p exceptionally showed higher (1341 
fold change) expression level where as, miR-215 showed a higher fold change down 
regulation in cows with subclinical endometritis. Among the differentially expressed 
miRNAs, 12 were found to be intergenic where as five miRNAs (miR-25, miR-423-3p, 
miR-98, miR-339-5p and miR-215) were intronic and the other five (miR-511, miR-
643, miR-619, miR-503 and miR-210) were not yet identified in bovine. However, 
miR-194 was observed to have both intergenic and intronic genomic location. We 
detected two miRNA clusters; miR-27a and miR-24 clusters on bovine chromosome 7 
and were highly expressed in cows with subclinical endometritis where as miR-362-3p 
and miR-502-5p were miRNA clusters on bovine X chromosome and were found to be 
downregulated in cows with subclinical endometritis (Table 9). 
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Table 9: List of differentially regulated microRNAs in cows with subclinical 
endometritis as compared to the healthy counterparts. 
microRNA P-value Fold Change Genomic location 
miR-16 0.0488 4 Intergenic (Chr.12) 
miR-21 0.0186 2 Intergenic (Chr.19) 
miR-126 0.0599 5 Intergenic (Chr.11) 
miR-27a 0.0265 2 Intergenic (Chr.7) 
miR-24 0.0370 2 Intergenic (Chr.7) 
miR-424 0.0135 4 Intergenic (Unknown) 
miR-25 0.0251 2 ENSBTAT00000003728 (Chr.25) 
miR-223 0.0314 16 Intergenic (Chr. X) 
miR-196b 0.0435 6 Intergenic (Chr.4) 
miR-194 0.0184 2 Intergenic (Chr. 29) 
ENSBTAT00000061457 (Un.) 
miR-125a-5p 0.0209 2 Intergenic (Chr. 18) 
miR-423-3p 0.0677 1341 ENSBTAT00000025760  (Chr. 19) 
miR-210 0.0012 -3 Not known 
miR-196a 0.0311 3 Intergenic (Chr.5 & 19) 
miR-503 0.0679 5 Not known 
miR-98 0.0046 3 ENSBTAT00000008060 (Chr. X) 
miR-339-5p 0.0714 -3 ENSBTAT00000043431  (Chr.25) 
miR-362-3p 0.0445 -2 Intergenic (Chr. X) 
miR-215 0.0591 -47 ENSBTAT00000061457 
(Unknown) 
miR-502-5p 0.0420 -5 Intergenic (Chr. X) 
miR-619 0.0189 -9 Not known 
miR-643 0.0183 -9 Not known 
miR-511 0.0324 -6 Not known 
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4.3.2.  Molecular networks and biological functions that are possibly affected by 
endometritis 
 
The identification of aberrantly expressed miRNAs in cows with subclinical 
endometritis led us to hypothesize that tracing target genes for the miss expressed 
miRNAs and subsequently identifying pathways and biological functions that these 
target genes are enriched with, will help us to understand the underlying molecular 
mechanisms potentially induced and/or affected by subclinical endometritis. To test this 
hypothesis, we filtered the high ranking predicted target genes (680) for the aberrantly 
expressed miRNAs (23) and uploaded into the Ingenuity Pathway Analysis (IPA). The 
result indicated molecular networks, biological functions and the molecular pathways 
that these target genes potentially constitute in the context of subclinical endometritis in 
bovine. The IPA identified 28 significant molecular networks with a score greater than 
10 (10-10 chance that the gene in the network associated solely due to random events) 
underlying the biological functions which we exemplified top five networks and 
corresponding miRNAs that target genes with central position in the network. The first 
molecular network (score = 42) converged on nuclear factor kappa B (NF-kB) a key 
transcription factor that mediates gene expression and represent gene expression, 
haematological system development and function, cellular development. The second 
molecular network (score = 33) constituted by the 680 target genes has B cell 
lymphoma 2 (Bcl2), mitogen-activated protein kinase 14 (MAPK14), nitric oxide 
synthase 2 (NOS2) and interleukin 12 complex (IL12) at the central positions mediating 
cell death. The third network (score = 32) represents connective tissue development and 
function, nervous system development and function, skeletal and muscular system 
development and function with Jun as a focus gene. Cell signaling, amino acid 
metabolism, post translational modification (score = 31) and cell cycle, connective 
tissue development and function, cancer (score = 31) represent the fourth and the fifth 
networks respectively (Figure 4.17). 
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Figure 4.17: Top three molecular networks enriched by the 680 genes that are predicted 
targets of the 23 aberrantly expressed miRNAs in subclinical endometritis as compared 
to healthy ones. A molecular network from the IPA analysis converged to NF-KB that 
controls gene expression (A), gene network that mediates cell death (B) and molecular 
network that dictates connective tissue development and function (C). In the graphical 
representation of a network, genes or gene products are represented as nodes, and the 
biological relationship between two nodes is represented as a line. Nodes are displayed 
using various shapes that represent the functional class of the gene product. 
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The target genes were significantly enriched for diverse biological functions known to 
be fundamental for uterine dynamism and receptivity, organ development and 
reproductive organ diseases. This includes: cellular growth and proliferation, cell cycle, 
gene expression, cellular movement, cellular development, organ morphology, cell 
death, organismal development, haematopoiesis, cell morphology, cellular function and 
maintenance, cell mediated immune response, embryonic development, reproductive 
system development and function, connective tissue development and function and 
reproductive system disease (Figure 4. 18). 
 
Figure 4.18: A list of top biological functions in which the aberrantly expressed miRNA 
target genes are enriched.  
 
4.3.3.  Canonical pathways 
 
The canonical pathway analysis was generated using the IPA to understand whether the 
23 dysregulated miRNAs in subclinical endometritis and their corresponding target 
genes are significantly correlated to previously defined signaling or metabolic 
pathways. We identified pathways in which the 680 target genes for the 23 aberrantly 
expressed miRNAs are significantly correlated to canonical pathways library in the IPA 
as compared to randomly selected genes from the reference gene list (IKB). The 
analysis generated pathways known to induce female reproductive abnormalities, 
cellular proliferation and immune response that includes; aryl hydrocarbon receptor 
signaling, cell cycle : G1/S check point regulation, PTEN signaling, P53 signaling, Myc 
mediated apoptosis signaling, RhoA signaling, cyanoamino acid metabolism, cell cycle 
regulation by BTG family proteins, regulation of actin-based mobility by Rho, CCR5 
signaling in macrophages, cytotoxic T-lymphocyte mediated apoptosis of target cells, 
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melanoma signaling, TGF-β signaling , ILK signaling, JAK/Stat signaling, Wnt/β 
catenin signaling and IL-8 signaling (Figure 4.19).  
 
 
Figure 4.19: Top selected canonical pathways that were found to be most significant to 
the target gene list. 
 
4.3.4.  Interaction between center genes and targeting microRNA 
 
The IPA identified biological functions and /or diseases that were most significant to the 
genes in the network. With this line, the genes with central position in the network have 
critical role in dictating the underlying biological functions. Hence, scrutinizing the 
interaction of the aberrantly expressed miRNAs and the central genes of the network 
enabled us to exemplify and elucidate the magnitude of regulation exerted by the 
aberrantly expressed miRNAs. The bioinformatic analysis of some of the aberrantly 
expressed miRNAs and 3’ UTR of bovine mRNA (centre genes for the top networks) 
showed stringent and repetitive miRNA recognition sites (Figure 4.20). miR-423-3p has 
recognition sites in IKBKB, JUN, INSR, MAPK14 and ID3 3’UTR of the respective 
mRNA. miR-196b appears to regulate four central genes (IKBKB, INSR, MAPK14 and 
NOS2) where as miR-24-3p seems to exert a stronger posttranscriptional regulation on 
INSR as it harbors three recognition sites. Further more, miR-24-3p seems to extend its 
regulatory effect on IKBKB, SP1, MAPK14 and NOS2. miR-27a-3p has recognition 
sites on SP1, MAPK14 and ID3 while MAPK14 and JUN posses double recognition 
sites for miR-503. 
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Figure 4.20: The frequency and position of interaction between aberrantly expressed 
miRNAs and 3’UTR of target genes with central position in the top five gene networks.  
 
Moreover, the expression analysis of genes with central position of the top five gene 
networks (ID3, INSR, NOS2, SP1, IKBKB, MAPK14 and JUN), in which their 
interaction with their respective targeting miRNAs was validated using luciferase 
reporter assay, was conducted in endometrial cytobrush samples (taken at different time 
points of estrous cycle) using semi quantitative polymerase chain reaction method. The 
result revealed that all the seven genes are expressed during estrous cycle (Figure 4.21). 
 
 
 
 
 
 
 
 
Figure 4.21: The semi-quantitative expression analysis of genes with central position in 
the top networks (ID3, INSR, NOS2, SP1, IKBKB, MAPK14 and JUN) and internal 
control (GAPDH) in endometrial samples at different time points of estrous. 
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4.3.5.  Validation of miRNA–center genes interactions using luciferase assay 
 
Next, to verify if bioinformatically predicted miRNA target sites are real physiological 
targets, we cloned 3’ UTR containing target sites at the down stream of the firefly 
luciferase gene (luc2) in the pmirGLO dual-luciferase miRNA target expression vector 
and quantitatively evaluated the reduction in firefly luciferase expression that indicates 
the binding and translation repression of endogenous or the introduced miRNAs to the 
cloned miRNA target sequence. The bioinformatic analysis indicated that a particular 
miRNA could target multiple key genes of the networks and a single miRNA could 
have a repetitive target sites on a particular 3’ UTR (Figure 4.20). As validation for all 
target sites is too much to handle, we selected seven representative target sites for five 
miRNAs. Prior to luciferase activity assay, we ascertained the expression of the target 
genes in bovine endometrial epithelium samples using semi quantitative PCR. The 
interaction of the miRNAs and the 3’UTR revealed by bioinformatic analysis usually 
lacks the expression pattern of both miRNA and target gene in time and space. Thus, it 
seems quit apparent to unravel the expression of the miRNA and predicted target genes 
in the endometrial epithelium as in most cases miRNAs repress the expression of their 
target genes. 
 
To directly asses the impact of miR-503 on IKBKB and JUN, we cloned 599 and 655 
bp of the 3’ UTR into firefly luciferase (pmirGLO vector) respectively. IKBKB 3’ UTR 
was found to harbor miR-503 target site at 483 position while JUN 3’ UTR has 
recognition site for this miRNA at 406 position after the stop codon. We performed 
transfection in four treatment groups (pmirGLO vector, pmirGLO – IKBKB 3’UTR 
reporter vector, pmirGLO – IKBKB 3’UTR reporter vector + mimic, pmirGLO – 
mismatch reporter vector + mimic). Co-transfection of the construct vector (pmirGLO - 
IKBKB 3’UTR reporter vector) and miR-503 mimic in cumulus cells reduced luciferase 
activity by 46% as compared to those groups transfected with only construct vector. 
Here, the level of luciferase reduction is solely attributed to the exogenously introduced 
miR-503 mimic as the endogenous effect is ruled out by systematic inclusion of 
transfection only construct vector in the treatment groups (Figure 4.22A & B). On the 
other hand, exogenous miR-503 introduction resulted in 33% luciferase activity 
reduction in cumulus cells transfected with pmirGLO vector with JUN 3’UTR and miR-
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503 mimic as compared to control miR-negative (pmirGLO-JUN 3’ UTR vector) 
transfected cells (Figure 4.22C & D).  
Figure 4.22: Luciferase activity assay for miR-503 - IKBKB 3’ UTR and miR-503 – Jun 
3’ UTR interactions. The alignment of miR-503 with IKBKB and JUN (A & C) 
indicating the binding site that was cloned in the pmirGLO expression vector. 
Transfection of intact pmirGLO vector, construct cloned with IKBKB and JUN 3’ UTR  
with miR-503 mimic in four treatment groups (B & D). Treatment groups with a star (*) 
indicate significant difference (P< 0.05) between them. 
 
To confirm that miR-27a-3p can bind and cause translational repression to the 3’ UTR 
of Inhibitor of DNA binding 3, dominant negative helix- loop-helix protein (ID3) and 
SP1 transcription factor (SP1), we cloned 449 and 779 base pairs of 3’ UTR, 
respectively into pmirGLO dual-luciferase miRNA target expression vector. Besides, 
miR-27a-3p was observed to have two binding sites in SP1 3’ UTR (position 1052 and 
1679) and one binding site in ID3 3’ UTR at position 177 from the stop codon. 
Transfection was performed in four treatment groups as described previously. As shown 
in figure 4.23, the intensity of luciferase fluorescence was markedly reduced (63%) in 
the group (pmirGLO-SP1 3’ UTR reporter vector + miR-27a-3p mimic) as compared to 
the control group (pmirGLO-SP1 3’ UTR reporter vector). miR-27a -3p mimic has 
shown no effect on the luciferase activity in the miR-27a-3p mismatch cloned vector 
(pmirGLO-SP1 3’UTR mismatch + miR-27a-3p mimic). Similarly, we conducted 
transfection experiment for ID3 and observed a pronounced luciferase activity reduction 
(52%) in the group (pmirGLO - ID3 3’ UTR reporter vector + miR-27a-3p mimic)  
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compared to the control (pmirGLO-ID3 3’UTR reporter vector) with no miR-27a-3p 
effect on the luciferase activity in the negative control group (pmirGLO-ID3 3’UTR 
mismatch + miR-27a-3p mimic). These facts indicate that miR-27a-3p could bind to the 
3’UTR of both SP1 and ID3 mRNA and mediate posttranscriptional gene expression 
repression. Furthermore, the data substantiates the bioinformatic prediction that SP1 and 
ID3 are direct targets of miR-27a-3p. 
 
 
Figure 4.23: The base complementarity between miR-27a-3p versus ID3 and SP1 where 
multiple miR-27a-3p binding sites on SP1 and single binding site on ID3 were cloned 
into the pmirGLO expression vector (A & C). The mean firefly / renilla ratio observed 
in four treatment groups (pmirGLO vector transfected, Construct vector transfected,  
Construct vector + mimic transfected and mismatch vector + mimic) showing reduced  
firefly/renilla ratio in construct vector and miR-27a-3p mimic co-transfected group (B 
& D). Treatment groups with a star (*) indicate significant difference (P< 0.05) between 
them. 
 
We next examined whether the multiple miR-24a-3p binding sites with in the 3’ UTR of 
Insulin receptor (INSR) form miR-24a-3p - INSR 3’UTR duplex and mediate 
translational repression. Here, we cloned 500 base pairs of INSR 3’ UTR that harbor 
three binding sites of miR-24-3p into pmirGLO dual-luciferase miRNA target 
expression vector and transfected into cumulus cells in four treatment groups as 
described previously. Interestingly, co-transfection of miR-24-3p mimic and pmirGLO - 
INSR 3’ UTR reporter vector into cumulus cells markedly reduced the Luciferase/ 
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Renilla ratio by 55% when compared to pmirGLO - INSR 3’ UTR reporter vector only 
cloned group. Mismatches in the miR-24-3p binding sites considerably avoided 
translational repression by miR-24-3p mimic (Figure 4.24). Taken together these 
findings show that the multiple miR-24-3p binding sites on INSR 3’UTR could cause a 
pronounced protein expression reduction possibly by allowing miR-24-3p - INSR 
3’UTR duplex formation. Thus, INSR appears to be a plausible physiological target of 
miR-24-3p. 
 
Figure 4.24: The response of luciferase reporter protein cloned with INSR 3’ UTR 
following co-transfection in cumulus cells in four treatment groups (A). The Watson 
and Crick complimentarity between INSR 3’UTR and miR-24-3p. All the three target 
sites were cloned in to pmirGLO expression vector (B). Treatment groups with a star (*) 
indicate significant difference (P< 0.05) between them. 
 
We cloned 325 and 764 base pair fragments of NOS2 and MAPK14 3’UTRs into 
pmirGLO expression vector, downstream of the luciferase gene. Upon co-transfection 
of miR-196b and miR-423-3p mimics and corresponding constructs (pmirGLO vector  
cloned with the target sites) into cumulus cells, we observed repressed luciferase protein 
expression compared to the control (wt target site cloned construct in the absence of 
miRNA mimic) in both experiments (Figure 4.25). Unlike the other miRNAs analyzed, 
we observed a mild protein repression effect for both miR-196b (25%) and miR-423-3p 
(37%) on NOS2 and MAPK14 3’ UTRs respectively. Co-transfection of mismatch 
target site cloned vector with corresponding mimic didn’t significantly reduce luciferase 
activity showing specificity of the protein repression effect to the introduced miRNA 
mimics. 
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Figure 4.25: Target validation for miR-196b–NOS2 and miR-423-3p–MAPK14 using 
luciferase reporter assay. The Watson and Crick complimentarity between miR-196b 
and NOS2 3’UTR (A) and miR-423-3p–MAPK14 (C). Transfection of pmirGLO 
vector, pmirGLO vector cloned with NOS2 3’ UTR containing miR-196b target site, 
construct vector + miR-196b mimic in four treatment groups (B) similar transfection 
procedure was performed to validate the interaction between miR-423-3p and MAPK14 
3’ UTR (D). Treatment groups with a star (*) indicate significant difference (P< 0.05) 
between them. 
 
4.3.6.  Expression profile for miRNAs during estrous cycle of healthy animals 
 
With the intension of investigating the temporal expression pattern of the differentially 
regulated miRNAs, we quantified the expression of six miRNAs (miR-24, miR-215, 
miR-27a, miR-223, miR-619, miR-423) in endometrial epithelium samples using qRT-
PCR at four time points of estrous cycle (day 0, day 3, day 7, day 14) including 
pregnant animals. U6, SNORD44 & SNORD48 were quantified during estrous cycle 
and pregnant animals. The geometric mean ct value of the three internal controls was 
observed to be stable across estrous cycle and used to normalize the miRNA real time 
data (Figure 4.26). miR-24 and miR-223 showed a similar expression pattern where we 
observed a magnificent increase during pregnancy with lower and constant expression 
pattern during estrous cycle. miR-619 and miR-423-3p also showed a similar expression 
pattern with a progressive increase from the beginning to the end of estrous cycle 
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followed by decline during pregnancy. miR-619 exceptionally showed a pronounced 
decrease in expression level in the pregnant animal endometrial epithelium. The last 
group of miRNAs (miR-215 and miR-27a) revealed more or less similar pattern of 
expression with a slight increase at day3 of estrous cycle and subsequent decline at day 
7 and day 14 and finally followed by a marked increase at pregnancy (Figure 4.27). 
 
 
 
 
 
 
Figure 4.26: The mean ct values of internal controls across estrous cycle and pregnant 
group. The geometric mean of the internal controls (U6, SNORD44 and SNORD48) 
showed stable expression pattern across the groups that are compared and was used to 
normalize the qRT-PCR data for miRNAs. 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.27: The expression pattern of six miRNAs during estrous cycle (day 0, day 3, 
day 7, day 14) and in pregnant cows.miR-223 and miR-24-3p showed more or less 
constantly lower expression during estrous cycle and a marked rise during pregnancy 
while the expression of miR-215 and miR-27a-3p showed a variable pattern which is 
lower at day 0 and day 7. The expression of miR-619 linearly increased during estrous 
cycle (day3-day14) and a pronounced decrease during pregnancy. miR-423-3p showed 
more or less similar expression at different time points of estrous cycle as well as 
pregnant animals. 
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4.4.  Part II: Discussion 
 
4.4.1.  Endometrial miRNA detection 
 
We used whole genome human microRNA PCR array platform which represent 352 
microRNAs in a four set of 96- Well plate to assess the miRNA abundance in 
endometrium of cows with subclinical endometritis and healthy ones. As there is no 
ready to use bovine array, we used human RT2 PCR array and interestingly resulted in a 
strong signal detection with minimal negative calls. This is mainly attributed to the 
cross species conservation feature of miRNAs between human and bovine as it has been 
observed in wide range of species (Bentwich et al. 2005). To complement this evidence, 
we aligned the human miRNAs from the array used with the currently known bovine 
counterparts and we observed 100 % conservation in most cases. The real time based 
RT2 PCR array combines the principles of qRT-PCR and microarray which enabled us 
asses the expression of large number of bovine miRNAs at a time with out 
compromising accuracy as we have tried to use appropriate data analysis and 
normalization procedures. 
 
4.4.2.  Aberrant expression of microRNAs in the endometrium of cows with subclinical 
endometritis and implication of their genomic location 
 
Although so far there is no solid evidence linking aberrant miRNA expression to sub-
clinical endometritis, microRNAs are implicated in a number of diseases in human. 
Studies have shown altered expression of mRNA transcripts in endometriotic lesions 
when compared with eutopic tissues (Ohlsson Teague et al. 2009a) while, 22 miRNAs 
were found to be differentially expressed in seven paired ectopic versus eutopic 
peritoneal endometrial tissues from woman with rAFS stage II-IV endometriosis 
(Ohlsson Teague et al. 2009b). In our study we identified 23 differentially expressed 
miRNAs in cows with subclinical endometritis as compared to the healthy ones 
suggesting the aberrantly expressed miRNAs might have a role in the patho - 
physiology of subclinical endometritis. 
 
The genomic location of six differentially expressed miRNAs (miR-25, miR-194, miR-
423-3p, miR-98, miR-339-5p and miR-215) were observed to be intronic (with in the 
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introns of protein coding genes) and several studies showed that intronic miRNAs are 
co-expressed with host genes (Baskerville and Bartel 2005, Lagos-Quintana et al. 2001, 
Wang and Lee 2009) implying that both derived from a common transcript (Rodriguez 
et al. 2004) or the intronic miRNAs and their host genes may share common regulatory 
elements, such as common promoters (Kim and Nam 2006). miR-126, upregulated in 
cows with subclinical endometritis, in human it is located with in the intron 7 of EGFL7 
which is highly expressed in endothelial cells and vascularised tissues was found to 
control an important step in vasculogenesis (Fitch et al. 2004, Parker et al. 2004). On 
the other hand, miR-196 is genomically located in the intergenic regions in the Hox 
clusters of vertebrates and known to direct the cleavage of HoxB8 mRNA in mouse 
embryos and also regulates the expression of HoxC8, HoxD8, and HoxA7 (Yekta et al. 
2004). The intronic location of the aberrantly expressed miRNAs in cows with 
subclinical endometritis indicates the possible miss expression of host genes co-
expressed with this class of miRNAs. 
 
Similar expression pattern was observed for miRNA clusters where miR-27a and miR-
24 showed high expression, where as miR-362-3p and miR-502-5p showed a lower 
expression in cows with subclinical endometritis as compared to healthy counterparts. 
This is consistent with the fact that proximally paired miRNA genes located up to 50 kb 
apart are frequently co-expressed (Baskerville and Bartel 2005). 
 
4.4.3.  Molecular networks and biological functions potentially regulated by aberrantly 
expressed miRNAs 
 
Altered expression of miRNAs and improper repression of their targets can have diverse 
effects as these genes may involve in different molecular networks and biological 
functions. Assignment of the target genes to different functional groups depending on 
the signaling pathways that they have been mapped to, gives us important insight to the 
uterine functions that are potentially affected by the incidence of subclinical 
endometritis. This highlights a clue for the association of incidence of endometritis with 
reduced conception rate from miRNA perspective. Based on our data, the most 
significant biological functions generated from the IPA such as cellular growth and 
proliferation, cell cycle, gene expression, cellular movement and cell death strikingly 
overlap with array of cellular activities that are intrinsic to the uterus during estrous 
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cycle and pregnancy (Bigsby and Cunha 1986, Kurita et al. 1998). It is well established 
fact that successful pregnancy out come is affected by the quality of the embryo as well 
as endometrial function (Christiansen et al. 2006, Rai and Regan 2006). Several studies 
attempted to examine the effect of embryo and endometrium on implantation at cellular 
and molecular levels (Barnea 2001, Savaris et al. 2008, Strowitzki et al. 2006). The 
mammalian uterus is a dynamic physiological system in which cellular proliferation, 
differentiation, apoptosis occur in a temporal and cell-specific manner during pregnancy 
(Das 2009). Recently, Germeyer et al. (2010) found out that inadequate endometrial 
growth marked by reduced cell proliferation in endometrium could contribute to 
reproductive failure. Moreover, defective cell growth as a result of aberrantly expressed 
genes controlling cell cycle is likely to contribute to implantation failure (Lee et al. 
2007). In another study, a positive association between pregnancy rate and endometrial 
volume and /or thickness has been shown (Raga et al. 1999) which is likely dependent 
on the rate of cell proliferation at specific reproductive stages. In spite of the 
identification of miRNA-regulated biological functions intrinsic to cellular activities in 
the uterine, the canonical pathway analysis from the IPA showed pathways which are 
essential for successful pregnancy in mammals. Aryl hydrocarbon signaling pathway, 
the most significant pathway generated from the IPA, is evidenced to involve in the 
normal function of the endometrium, possibly by modulating cellular proliferation in 
response to hormones, by regulating the expression of upstream genes involved in the 
function of the endometrium, and/or by controlling uterine secretary function (reviewed 
in Hernandez-Ochoa et al. 2009). 
 
Besides, some of the key genes that have been shown to have central positions in the top 
five networks are implicated in bovine endometritis. Li et al. (2005) reported higher 
expression of NOS2 mRNA in endometrial biopsies from cows with subclinical 
endometritis, while Kim et al. (2005) demonstrated the interaction of IKBKB with 
NOS2 in endothelial cells that activation of IKBKB plays a critical and novel role to 
mediate the deleterious effect of high glucose on the insulin mediated activation of 
eNOS. Zhao et al. (2007a) showed the expression of INSR in the endometrial carcinoma 
cells and incubation with insulin stimulated a dose and time dependent proliferation and 
the apoptosis rate of carcinoma cells was decreased gradually with increasing 
concentration of insulin. Moreover, Takano et al. (2007) showed INSR as one of the 
most upregulated FOXO1 dependent transcriptional target and decidua–specific 
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transcriptome in human endometrium. Sp1 is one of the transcription factors that have 
been shown to be regulated by progesterone receptor in human endometrial 
adenocarcenoma cells (Gao et al. 2001). Cheng et al. (2006) revealed the expression of 
HSD17B2 in endometrial epithelial cells where estrogen inactivation is regulated by 
SP1 and SP3 which are down stream target of progesterone-dependent paracrine signals 
originating from endometrial stromal cells. 
 
NF-kB plays a crucial role in immune and inflammatory responses through the 
regulation of genes encoding inflammatory cytokines, adhesion molecules, chemokines,  
growth factors and inducible enzymes such as cyclo-oxygenase 2 (COX2) and inducible 
nitric oxide synthase (iNOS) (Baldwin 2001, Barnes and Karin 1997, Chen et al. 1999). 
Pro-inflammatory mediators (TNF-α, IL-1β, IL-6 and NOS2) affect embryonic 
development by acting either on the oocyte, developing embryo or endometrium. 
Bovine oocyte in vitro matured with TNF-α showed reduced blastocyst rate, while 
addition of TNF-α increased the proportion of blastomeres that were apoptotic (Soto et 
al. 2003). IL-6 blocks follicle stimulating hormone-induced estradiol secretion from 
bovine granulosa cells (Alpizar and Spicer 1994) and TNF - α is cytotoxic to bovine 
luteal cells (Petroff et al. 2001). Studies have shown that endometrial expression of 
prostaglandin F2α is under the control of several cytokines including TNF - α that 
increase PGF2α from cultured bovine stromal endometrial cells (Skarzynski et al. 2000)  
and IL-1β that induce PGF2α from endometrial stromal and epithelial cells (Davidson 
et al. 1995). Prostaglandin F2α has been reported to have a negative effect on embryo 
development in cattle where removal of the corpus luteum reduced the embryotoxic 
effects of PGF2α suggesting that PGF2α induces secretion of the embryotoxic molecule 
of luteal origin (Buford et al. 1996). Furthermore, pro-inflammatory cytokines like IL-
1β exert effects on endometrial tissue that interfere with endometrial receptivity and 
subsequent embryo development by reducing proliferation of endometrial stromal cells 
(Davidson et al. 1995). Elevated expression of NOS2 mRNA was observed in infertile 
cattle as a result of persistent endometritis (Herath et al. 2009b) where as IL-1α and IL-
RN were highly expressed in subclinical endometritis (Gabler et al. 2009). Thus, it is 
more likely that dysregulation of uterine miRNAs during subclinical endometritis result 
in the up regulation and translocation of NF-kB leading to expression of cytokines that 
could induce endometrial PGF2α release and subsequent pre-mature corpus luteum 
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regression. The ultimate negative effect of pro-inflammatory mediators on endometrial 
receptivity, oocyte maturation and blastocyst development could cause non-receptive 
endometrium, developmentally incompetent oocyte and/or blastocyst which is 
associated with frequent embryo loss and extended calving interval. Hence, at least 
partly, this explains the molecular mechanism that operates behind the association of 
subclinical endometritis with reduced reproductive performance in bovine. 
 
4.4.4.  Validation of some aberrantly expressed miRNAs and target genes 
 
Luciferase assay method have been widely used (Ben-Ami et al. 2009, Le et al. 2009, 
Silber et al. 2008, Yao et al. 2010) and it is becoming the standard and preferred means 
for the experimental validation of gene regulation by miRNAs in mammalian cells. In 
our study, we used pmirGLO expression vector which is designed to quantitatively 
evaluate miRNA activity by the insertion of miRNA target sites downstream of the 
firefly luciferase gene. To make the assay method as efficient as possible and increase 
experimental confidence, we incorporated control samples into the experimental design 
where we designed our experiment in four treatment groups (pmirGLO vector, 
pmirGLO – 3’UTR reporter vector, pmirGLO – 3’UTR reporter vector + mimic, 
pmirGLO – mismatch reporter vector). The basis of this experiment lies on the over 
expression (exogenous introduction of miRNA mimic) of the miRNA in question 
despite the possible expression of same miRNAs in the cells. However, comparison of 
firefly/renilla ratio in the construct group with no insert reveals the effect of endogenous 
miRNA while comparison of the construct group with construct + mimic could tell the 
exogenous miRNA effect systematically avoiding the confounding effect of endogenous 
miRNA. In the negative control group, introduction of three mismatches in the seed 
region and co-transfection with target miRNA showed no significant reduction in 
luciferase activity highlighting the specificity of luciferase reduction to the miRNA 
analysed and abrogating the possibility of global luciferase reduction effect from 
miRNA mimic introduction. 
 
The magnitude of luciferase assay reduction and the possible regulation of target genes 
by targeting miRNAs are observed to be variable for different miRNAs and target 
genes. We observed the maximum luciferase activity reduction (63%) for miR-27a-3p-
Sp1 3’UTR interaction followed by miR-27a-3p – ID3 mRNA interaction (52%) while 
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the minimum was for miR-196b-NOS2 interaction (25%). The differential repressive 
power of the miRNAs considered in this study might be attributed to the variation in the 
molecular architecture of target genes’ 3’ UTR which subsequently affected the miRNA 
- mRNA interaction. Besides the complexity of the rule that govern miRNA- target 
mRNA interaction, studies have shown that a conserved seed ‘match’ consisting of 
bases 2-9 of the miRNA is a reliable predictor of interaction (Brennecke et al. 2005) 
while perfect base pair matching does not guarantee interaction between miRNA and 
target gene (Didiano and Hobert 2006) and wobble G:U base pairs are often tolerated in 
target sites (Vella et al. 2004). Furthermore, Hon and Zhang (2007) have shown that the 
number and arrangement of miRNA recognition sites can influence the degree and 
specificity of miRNA-mediated gene repression. In agreement with this, Sp1 3’UTR 
harbors three miR-27a-target sites with comfortable seed region and 3’ end 
complimentarily, that may caused the pronounced repression of reporter gene protein 
following transfection by miR-27a mimic. Moreover, ID3 has the shortest 3’UTR (481 
nt) when compared with the genes (mRNA) considered in this study and this may be the 
reason for the boost in repression as it is confirmed that shorter size 3’UTR induce 
higher repression as compared to the larger ones (Hon and Zhang 2007). Interestingly, 
NOS2 and MAPK14 showed less stringent complementarity with the seed region of 
miR-196b and miR-423-3p, respectively and this in agreement with the fundamental 
principles of miRNA- target gene interaction (Brennecke et al. 2005). Taken together, 
the data substantiates the primary information from bioinformatic prediction that the 
miRNAs we have studied mediate reporter gene protein repression in variable 
magnitude suggesting the genes are physiological targets for the miRNAs considered. 
Thus, the data enabled us to deduce a convincing link between the aberrantly expressed 
miRNAs and target genes which keep our attempt to trace subclinical endometritis 
induced miRNA miss expression and potential dysregulation of molecular pathways and 
functions straight and reasonable. 
 
Collectively, this data suggests that incidence of subclinical endometritis induces altered 
expression of uterine miRNAs which at least partly regulate genes that involve in 
uterine cell proliferation, cell cycle, differentiation, apoptosis and gene expression. 
Extensive studies showed the need for tight regulation of cellular processes in the 
mammalian uterine in which deviations could compromise fertility. To articulate the 
link, miss expression of miRNAs could cause dysregulation of the fundamental cellular 
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processes of the uterus that negatively affect uterine receptivity and result in reduced 
fertility. It is more likely that these abnormal molecular mechanisms are informative of 
the mechanism that functions behind the correlation of subclinical endometritis with 
reduced conception rate.
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5.  Conclusion and future prospects 
 
In conclusion, our data showed the temporal expression of a certain class of microRNAs 
in the course of bovine oocyte maturation with a possible role during early embryonic 
development. The heterologous approach also enabled us to detect and profile 
microRNAs which are not so far identified in bovine. Moreover, miR-99a and miR-100 
which are expressed in a reciprocal manner with their predicted target, bovine 
homologue tribbles 2 (TRB2), in bovine oocytes and companion cumulus cells could 
bind the 3’ UTR of TRB2 mRNA and mediate posttranscriptional gene expression 
repression. This suggests that miR-99a and miR-100 promote cumulus cell proliferation 
by repressing the TRB2 protein which is a negative regulator of cell cycle. 
 
MicroRNAs potentially constitute a central role in the molecular mechanism underlying 
the development and progression of subclinical endometritis. This unravels a new play 
ground for scientists in the quest to develop miRNA-based therapy on the hypothesis 
that the use of miRNA inhibitors and mimics could help to rescue dysregulated 
molecular pathways and biological functions triggered by the incidence of subclinical 
endometritis. 
 
The primary attempt to detect and elucidate miRNA expression during oocyte 
maturation produced a remarkable list of new bovine microRNAs and set of miRNAs 
with dynamic expression pattern during oocyte maturation. Hence, it appears important 
to dissect the specific functions of individual miRNAs with a motive to use this 
information in the breeding purpose so that to tackle the ever declining dairy cattle 
fertility. The investigation on the involvement of uterine miRNAs in the development of 
subclinical endometritis revealed microRNAs as the core component of molecular 
mechanism that explain the association of the incidence of subclinical endometritis with 
reduced dairy cattle fertility. As the approach used was basically integrative, there is a 
need to sharpen down the investigation to the most important molecular pathways and 
biological functions from the perspective of the aberrantly expressed miRNAs. This 
could be attained partly by using invitro endometrial cell culture model. 
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6.  Summary 
 
The developmental process in mammals begins during oogenesis and oocyte maturation 
is a decisive process during which oocytes acquire their intrinsic ability to support the 
subsequent stages of development in a stepwise manner. This process involves complex 
events of nuclear and cytoplasmic maturation which generally involves storage of 
mRNAs, proteins, transcription factors and chromosomal segregation. As there is 
selective transcription and translation of transcripts in the course of oocyte maturation, 
the role microRNAs as posttranscriptional gene expression regulators seems quite 
apparent. MicroRNA identification and expression analysis are the first and key steps in 
the long journey to understand the role of these posttranscriptional regulators in bovine 
pre-implantation embryo development. In line with this, identification and expression 
profiling of microRNAs during invitro oocyte maturation was performed using a 
heterologous microRNA microarray platform (human, mouse and rat). As miRNAs are 
posttranscriptional gene regulators, identification and expression profiling constitute 
core elements of miRNA studies but it appears less informative of their specific role in 
diverse biological processes. With this notion, the bioinformatically predicted target 
genes for selected miRNAs were systematically filtered from on line data bases and 
investigation of the spatio - temporal expression pattern of the miRNAs and the 
predicted targets in the same sample was conducted and gave a clue for the miRNA-
mRNA interaction. Then after, the attempt to dissect the specific functions of miR-99a 
and miR-100 commenced with the validation of their interaction with Bovine 
homologue tribbles 2 (TRB2) using luciferase reporter assay. The result indicated that 
miR-99a and miR-100 potentially down regulate TRB2 gene which is the negative 
regulator of the cell cycle, and by so doing these miRNAs may promote cumulus cell 
proliferation. 
 
In parallel and complementary to the above experiments, the potential role of 
microRNAs in the pathophysiology of the uterus in the context of bovine subclinical 
endometritis was investigated as there is precisely orchestrated interplay between the 
ovary and the uterus through the gonadotropin hormones. Subclinical endometritis is 
one of the most prevalent uterine diseases which is associated with reduced fertility in 
cattle. It is a well established fact that the inflammatory response to post partum 
bacterial infection during subclinical endometritis is associated with the expression of 
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pro-inflammatory mediators which affect embryonic development by acting either on 
the oocyte, developing embryo, endometrium and/or hypothalamic-pitutary-gonadal 
axis. The already suggested model for the development and progression of subclinical 
endometritis appears inconclusive with the emerging role of miRNAs as potent 
regulators of uterine gene expression in human and mouse models. Then, hypotheses 
was set and tested using genome wide RT² miRNA PCR array consisting of 354 well 
characterized human miRNA primers and uterine cytobrush samples taken from cows 
with subclinical endometritis and healthy. The approach that was used to unravel the 
molecular mechanism that lead incidence of subclinical endometritis to loss of fertility, 
from the miRNA perspective was entirely integrative. Specific class of miRNAs were 
observed to be aberrantly expressed in endometrium of cows with subclinical 
endometritis. These aberrantly expressed miRNAs were evidenced to target set of genes 
that constitute pathways and biological functions which are inherent to the endometrium 
during estrous cycle and pregnancy. This has an interesting implication in that up or 
down regulation of miRNAs during subclinical endometritis could result in 
dysregulation of target genes that may trigger malfunctioning of the pathways and 
biological functions that these genes constitute. Once the tight uterine gene regulation is 
in peril, imbalance in hypothalamic-pitutary-gonadal axis could occur and negatively 
affect folliculogenesis, oocyte maturation, embryo implantation and development and 
uterine receptivity in which the combined or individual effect describe loss of fertility in 
cattle. 
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7.  Zusammenfassung 
 
Der Entwicklungsprozess von Säugetieren beginnt bereits während der Oogenese. Die 
Eizellen Maturation ist dabei ein maßgebender Prozess, bei dem die Eizelle ihre 
wesentlichen Fähigkeiten zur schrittweisen Unterstützung der nachfolgenden 
Entwicklungsstufen erlangt. Dieser Prozess ist an den komplexen Ereignissen der 
nuklearen und cytoplasmatischen Maturation beteiligt, die sowohl an der Speicherung 
von mRNAs, Proteinen und Transkriptionsfaktoren einschließt als auch die 
chromosomale Segregation. Während der Eizellen Maturation tritt eine selektive 
Transkription und Translation von Transkripten auf, wobei die Rolle der miRNAs als 
posttranskriptionelle Genexpression Regulatoren ziemlich offensichtlich zu sein scheint. 
Dabei sind die ersten und wichtigsten Schritte die Identifikation sowie die 
Expressionsanalysen der miRNAs, um die Rolle dieser posttranskriptionellen 
Regulatoren während der präimplantären Embryonalentwicklung beim Rind besser zu 
verstehen. Deshalb wurde die Identifikation und das Expressionsprofiling der miRNAs 
während der invitro Maturation der Eizelle mit Hilfe von heterologen miRNA 
Microarrayplattformen (Mensch, Maus und Ratte) durchgeführt. Da die miRNAs 
posttranskriptionelle Genregulatoren sind, stellen sowohl die Identifikation als auch das 
Expressionsprofiling die Kernelemente der miRNA Studien dar. Allerdings scheinen 
diese weniger informativ für ihre spezifische Rolle, während der unterschiedlichen 
biologischen Prozesse, zu sein. Daher wurden die bioinformativ vorhergesagten 
Targetgene für die ausgewählten miRNAs systematisch aus online Datenbanken 
gefiltert. Zudem wurde eine Untersuchung des räumlich- zeitlichen Expressionsmodells 
der miRNAs und ihren vorhergesagten Targets in denselben Proben durchgeführt, dies 
soll Rückschlüsse auf die miRNA- mRNA Interaktion geben. Ein weiteres Experiment 
wurde durchgeführt, um die spezifischen Funktionen von miR-99a und miR-100 zu 
analysieren, dabei wurde die Interaktion mit dem Bovinen Homologen Tribbles 2 Gen 
(TRB2) mittels eines Luciferease Reporterassays überprüft. Die Ergebnisse zeigen, dass 
miR-99a und miR-100 möglicherweise TRB2, einen negativen Regulator des 
Zellzyklus, herunter regulieren. Somit könnten die miRNAs die 
Kumuluszellproliferation anregen. 
 
Parallel und ergänzend zu dem vorherigen Experiment, wurde die mögliche Rolle der 
miRNAs bei der Pathophysiologie des Uterus im Zusammenhang mit der subklinischen 
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Endometritis des Rindes untersucht. Da ein präzise instrumentalisiertes Wechselspiel 
zwischen den Ovarien und dem Uterus durch das Gonadotropine Hormon bestehen 
könnte. Die subklinische Endometritis ist eine der am häufigsten verbreiteten uterinen 
Krankheit, die in Verbindung mit einer reduzierten Fruchtbarkeit beim Rind steht. Ein 
bekannte Tatsache ist, dass die Entzündungsreaktion auf bakterielle Infektionen post 
partum während einer subklinischen Endometritis mit einer Expression von pro-
entzündlichen Mediatoren einhergeht, die die embryonale Entwicklung beeinflusst, da 
sie sowohl auf die Eizelle, die Entwicklung des Embryos, das Endometrium als auch die 
hypothalamische- hypophysäre- gonadäre Achse einwirken. Das bereits existierende 
Modell zur Entwicklung und Verlauf der subklinischen Endometritis scheint mit dem 
Auftreten der miRNAs als mögliche Regulatoren der uterinen Genexpression im 
menschlichen sowie Mausmodell nicht mehr ausreichend zu sein. Daher wurde eine 
neue Hypothese aufgestellt und diese mittels eines RT2 miRNA PCR Arrays, das aus 
354 Vetiefungen besteht, die menschlichen miRNA Primer enthalten, an uterinen 
Cytobrush Proben, die sowohl von gesunden Kühen als auch Kühen mit subklinischer 
Endometritis stammen, überprüft. Der Ansatz, der hier genutzt wurde, um die 
molekularen Mechanismen zu entschlüsseln, die zu einer subklinischen Endometritis 
und somit zu einem Verlust der Fruchtbarkeit führen, war völlig integrativ vom 
Gesichtspunkt der miRNA aus. Spezifische Klassen von miRNAs zeigten eine 
abweichende Expression im Endometrium von Kühen mit subklinischer Endometritis. 
Mit Hilfe dieser abweichenden Expression der miRNAs konnte gezeigt werden, dass 
diese eine Reihe von Genen steuern, die die Pathways und biologische Funktionen 
unterstützen, welche zum Endometrium während dem Östruszyklus und der 
Schwangerschaft gehören. Eine interessante Schlussfolgerung lässt sich daher 
aufstellen. Die hoch oder herunter Regulierung der miRNAs während der subklinischen 
Endometritis könnte zu einer Dysregulierung der Targetgene führen, weshalb die 
Pathways und biologischen Funktionen, für die diese Gene verantwortlich sind, 
versagen könnten. Wenn die enge uterine Genregulation in Gefahr geraten, könnte ein 
Ungleichgewicht in der hypothalamischen- hypophysären- gonadären Achse auftreten 
und die Entwicklung der Follikel, die Eizellen Maturation, die Embryo Implantation, 
dessen Entwicklung sowie die uterine Aufnahmefähigkeit negativ beeinflussen, so dass 
diese einzeln oder kombiniert zu einem Verlust der Fruchtbarkeit beim Rind führen 
könnten. 
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